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Abstract: 
The emergence of antibiotic-resistant bacteria has presented an increasing 
challenge to infection control. Conventional methods of antibacterial treatment involving 
high dose of antibiotics or surgical intervention have proven insufficient for eradicating 
persistent infections, such as those associated with medical implants. It is well recognized 
that bacterial populations commonly contain a small percentage of phenotypic variants, 
known as persister cells, which are metabolically inactive and extremely tolerant to 
antibiotics. When the antibiotic treatment is stopped, surviving persister cells can 
regenerate the bacterial population with a similar percentage of persister cells. Thus, 
persistence presents a great challenge to curing chronic infections.  
In this study, we introduced a novel method for controlling bacterial persistence 
based on a phenomenon we named electrochemical control of persister cells (ECCP). We 
demonstrate that bacterial persister cells can be effectively eliminated by low-level direct 
currents (DCs); e.g. treatment with 70 μA/cm2 DC for 1 h using stainless steel (SS) 304 
reduced the number of viable planktonic persister cells of Pseudomonas aeruginosa 
PAO1 by 98% compared to the untreated control. In addition to persister killing by 
applying DC alone, synergistic effects were observed when treating persister cells with 
70 μA/cm2 DC and 1.5 μg/mL tobramycin together using SS 304 electrodes. The same 
level of DC was also found to be cidal to biofilm associated persister cells of P. 
aeruginosa PAO1. Based on this discovery, the electrophysiological properties of P. 
aeruginosa PAO1 cells treated with 70 μA/cm2 DC using carbon and SS 304 electrodes 
were characterized both at the cellular and genetic levels to understand the mechanism of 
   
ECCP. We found that DC treatments affected surface charge and membrane integrity of 
P. aeruginosa, leading to increase intracellular concentration of metal cations as observed 
via scanning electron microscopy-energy dispersive spectroscopy (SEM-EDS) analysis. 
Moreover, electrochemical treatments mediated via carbon electrodes provoked the 
permeabilization of the cells to extracellular materials, and increased their susceptibility 
to antibiotics, which led to complete eradication of the persisters. These findings are 
corroborated by DNA microarray analysis, which revealed that DC treatments have 
profound effects on the physiology of persister cells, altering the regulation of genes 
involved in antibiotic resistance, pyocin-related functions, and SOS response. 
Comparative transmission electron microscopy (TEM) studies of the stationary phase P. 
aeruginosa PAO1 cells confirmed that DC treatments resulted in the 
compartmentalization of intracellular contents, release of outer membrane vesicles, or 
cell lysis.  
To design novel systems to effectively control infections associated with biofilms 
and persister cells, the safety and the efficacy of ECCP were evaluated in co-culture 
models with human epithelial cells and P. aeruginosa PAO1. In addition, a pilot animal 
study was conducted to investigate the effects of electrochemical currents using a rabbit 
model of sinus infections. P. aeruginosa PAO1 was used to induce rhinosinusitis in 
rabbits, which were then treated with antibiotics, or antibiotics with electrical current, and 
compared with the untreated controls. The results of this study validated the effectiveness 
of electrochemical treatment in reducing both biofilms and planktonic cells in vivo. 
Overall, these findings improved the understanding of the electrophysiology of bacterial 
persister cells, and provided new insight for designing novel systems to effectively 
   
control infections associated with biofilms and persister cells. 
 
Keywords: Persisters, biofilms, direct current (DC), electrochemical treatments, 
electrodes, metal cations, 2-chamber system, co-culture, epithelial cells, rabbit model, 
sinusitis.  
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CHAPTER 1 
MOTIVATION, HYPOTHESIS, AND OBJECTIVES 
 
 
 
 
 
 
 
  
 2 
1.1 MOTIVATIONS 
1.1.1 Antibiotic-resistant infections 
The discovery of penicillin in 1929 opened an exciting era of antibiotic therapy, in 
which millions of lives were saved from microbial infections. Over the years, however, 
microorganisms have developed an extraordinary level of resistance against commonly 
used antibiotics. For the past two decades, the so-called ESKAPE pathogens
1
 
(Enterococcus faecium, Staphylococus aureus, Klebsiella pneunomoniae, Acinetobacter 
baumanii, Pseudomonas aeruginosa, and Enterobacteriaceae) have caused an increasing 
problem of drug-resistant infections. In addition, species including Clostridium difficile 
and Streptococcus pneunomoniae have been reported in major cases of hospital-acquired 
infections in the U.S. last year, affecting 250,000 and 1,200,000 people, respectively 
(Antibiotic resistance Threats in the United States, 2013 CDC report). Such drug-
resistant infections are associated with high mortality and morbidity, as well as massive 
financial loss. For example, in 2008 alone, the cost of inpatient services associated with 
antibiotic-resistant infections was estimated to $20 billion
2
, with a $35 billion loss of 
work productivity.  
 
Antibiotic resistance is inherent to the bacterial cell and its occurrence in 
nosocomial infections seriously compromises the safety of many surgical procedures. In 
addition to the development of drug resistance through mutation and gene transfer, 
bacteria also tolerate antibiotics through intrinsic mechanisms, especially those associated 
with implanted medical devices. Metals, ceramics and polymers are among the materials 
commonly used for making medical devices. However, once a medical device is 
 3 
implanted in the host, it is immediately surrounded with blood plasma and become 
rapidly coated with proteins such as fibrin and fibronectin
3
. These substrates carry 
receptors for bacterial pathogens, which, if present, can form multicellular structures, 
known as biofilms 
4
. Biofilm cells are embedded in a slimy polysaccharide matrix 
secreted by the attached cells. The biofilm matrix can retard the penetration of certain 
antibiotics. In addition, the presence of the persisters, a dormant sub-population that is 
highly tolerant to antibiotics, renders biofilms more difficult to eradicate. After antibiotic 
treatments, the surviving persister cells could wake up and regenerate new cell 
populations within the biofilm. Collectively, biofilm cells are 500-5000 times more 
tolerant to antibiotics than their planktonic counterparts. Due to close contact, biofilm 
cells can exchange genetic material and spread drug resistant genes
5
. As a consequence, a 
chronic infection can develop and lead to prolonged hospitalization, device failure, or 
related complications such as implant replacements, amputations and even the death of 
the patient 
6
.  
 
1.1.2 New antimicrobial strategies 
Bacterial resistance to antibiotics presents an increasing threat to public health 
and economy. To address this problem, new methods need to be developed to effectively 
prevent biofilm formation and eradicate biofilm and persister cells. Over the past two 
decades, a number of molecules have been shown to be promising candidates, since they 
target biofilm formation and virulence, instead of general growth of microbes. Biofilm 
inhibition can also be pursued by engineering antifouling surfaces with specific surface 
chemistry and topography. Topographic and (bio) chemical modifications can inhibit 
 4 
initial attachment of bacterial cells to device surfaces by repelling or directly killing 
bacterial cells. A variety of techniques have been developed to functionalize surfaces 
with covalent bonds or electrochemical interactions. Functional groups can be linked to 
metal surfaces by coating with self-assembly monolayer (SAM), polyelectrolytes, 
nanogel, and layer-by-layer coatings 
7,8
.  
 
Since most of the medical devices are made with metal materials, it is important 
to understand the interaction between bacterial cells and metals or their corrosion 
products. Fe, Cr, Ni, Co and Mn are listed among the cations comprised in stainless steel 
(SS) and these metal cations were reported with various effects on bacteria. Cations 
generated from SS at µM 
9
 to mM range 
10
 exhibited low cidal effects on P. aeruginosa, 
suggesting that this bacterium can tolerate a slow release of metal ions as it occurs during 
electrochemical corrosion. However, the use of electrical factors could improve the 
killing effects of these cations on bacterial cells. Several studies have shown that 
electrical currents (DCs in the range of µA to mA/cm² and 100 kHz to 10 MHz of 
alternating currents or ACs) delivered for several hours (in most cases) with diverse 
electrode materials have bacteriostatic or biocidal effects on bacteria 
11-15
. Similar 
currents were also found to enhance the effects of antibiotics on biofilms, an interesting 
phenomenon known as bioelectric effects
16-19
. For instance, Busscher et al. demonstrated 
that the detachment of bacteria from medical relevant SS could be achieved using 
electrical currents in the mA range
20-22
. The treatment of bacteria with relatively low 
electrical current and antibiotics has shown that individual cells, biofilm-embedded cells 
 5 
and persisters of P. aeruginosa can be successfully controlled
23
. These preliminary 
studies set a new perspective for the treatment of implant-associated infections. 
 
1.2 RESEARCH HYPOTHESIS AND OBJECTIVES 
 Biofilm formation and bacterial persistence play a very important role in chronic 
infections. Antibiotics consistently fail to control such infections due to slow growth and 
dormancy of the biofilms and persister cells. Thus, antimicrobial approaches that work 
independently of the bacterial growth phase have a good potential to control bacterial 
persistence and medical implant-associated infections.  
 The discovery of bioelectric effects brought an exciting opportunity for engineering 
new therapeutic methods. However, the underlying mechanism of this phenomenon is not 
well understood, which limits the applications of this technology. Inspired by previous 
works on bioelectric effects, we hypothesize that appropriate levels of electric current can 
kill bacterial persister cells and such effects can be enhanced though synergistic effects 
with antibiotics. To test this central hypothesis and reveal the underlying mechanism, this 
study was conducted with the central goal of understanding the effects of DC on persister 
cells at both cellular and genetic levels, as well as in vivo using a rabbit model of sinusitis. 
  
 The major goals and specific aims are summarized in Fig. 1.1. The proposed study 
was carried out in three specific aims: 
Aim 1 (Chapter 3 & 4): To study the effects of low-level DC on the viability of PAO1 
persister cells is characterized. P. aeruginosa PAO1 is selected as the model of this 
study to test the effects of DC on its persistence. Our results showed that the persister 
 6 
cells can be eradicated after treatment with 70 µA/cm
2
 DC for 1 h, a phenomenon named 
as electrochemical control of persister cells (ECCP). This phenomenon was further 
investigated to understand how the physiochemical factors (current/voltage, ions, and 
antibiotics) affect the viability of the persister cells.   
Aim 2 (Chapter 5, 6, 7 & 8): To understand the mechanisms of ECCP by 
characterizing the effects of DC on the morphology, the electrophysiology and the gene 
expression of the PAO1 cells. The effects of ECs on the electrophysiology of persister 
cells were characterized using electrochemical measurements including zeta-potential, 
SEM-EDS. Also, the morphological changes of P. aeruginosa cells due to DC treatment 
were investigated using SEM, TEM, and AFM. The effects of electrochemical stresses 
were also studied using DNA microarrays to identify genes affected by DC. The 
interaction between the antibiotic and the metal cations were also investigation to 
comprehend synergy in electrochemical treatments. 
Aim 3 (Chapter 8 & 9): To evaluate the safety and efficacy of ECCP in a co-culture 
model and a rabbit model. In these tests, the efficacy of ECCP was evaluated in vitro 
using a co-culture model of human cells and P. aeruginosa PAO1. Also the effectiveness 
of electrochemical treatments in killing biofilm cells was investigated in a rabbit model. 
 7 
 
Figure 1.1: Overall plan for the study of the Electrochemical Control of Bacterial 
Persister Cells (ECCP). The specific aims and major subtasks of each aim are shown. 
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2.1. UNMET CHALLENGES IN CONTROLLING BACTERIAL INFECTIONS 
2.1.1. Implant-associated infections 
The preponderance of antibiotic-resistant microorganisms in public and medical 
environments constitutes a serious concern to health-care. The ability of certain 
microorganisms to persist on dry surfaces from days to weeks, and in some extreme cases, 
even months, increases the risk of cross-contaminations and disease outbreaks 
1
. For 
instance, it is reported that Enterococcus faecium could reside on inanimate surfaces for 
up to 4 months 
2
, Staphylococcus aureus for up to 7 months 
2
, Klebsiella pneumoniae up 
to 30 months 
3,4
, Acinetobacter baumanii up to 5 months 
5-7
, Pseudomonas aeruginosa up 
to 60 months 
3,6,8
, and Enterobacter species for 5 to 49 days 
6
. These six pathogens 
constitute the so-called ESKAPE pathogens, and are known for escaping from the 
treatment of commonly used antibiotics. By persisting on surfaces for such long period of 
time, these microorganisms could compromise the safety of many medical procedures, 
especially the implantation of medical devices. 
 
Each year, millions of individuals receive medical implants to substitute failing 
body components. Such procedures, however, can lead to major complications due to the 
adherence of antibiotic-resistant microorganisms. Indeed, infection associated with 
indwelling medical devices accounts for half of the cases of hospital-acquired infections
9
. 
The mechanism of cell adhesion to indwelling medical devices relies on multiple 
physicochemical factors, by which bacteria overcome a series of repulsive forces (e.g. 
Van der Waals forces), and hydrophobic interactions to initiate attachment and stable 
adherence to the substrate
10,11
. Some electrochemical interactions between metal-based 
 12 
surfaces and the host cells are viewed as one of the most common source of bacterial 
infection. Once a medical device is implanted in a host, the surface is immediately 
surrounded by blood plasma. Because of physical properties of the implanted devices 
such as wettability (or hydrophilicity), surface roughness, and the surface charge, the 
implants are rapidly coated with body fluid involving platelets and glycoproteins such as 
fibrin and fibronectin
12
. Fibronectins commonly possess specific sets of receptors that 
mammalian cells bind during normal wound healing 
13
. However, these receptors are also 
used by bacteria to attach to tissues and indwelling devices covered with the host proteins. 
The role of fibronectin in promoting S. aureus contamination has been confirmed in vivo 
14
. S. aureus expresses fibronectin-binding proteins FnBPA and FnBPB, which promote 
such adherence of this bacterium to the terminal domain of the 5 type I module of the 
fibronectin 
15
.  
 
The attachment of bacteria to indwelling medical devices lead to the formation of 
a slimy bacterial macrostructure, known as biofilm, with the bacterial cells embedded in a 
self-produced polysaccharide matrix. The diffusion barrier presented by this matrix and 
the slow growth of the biofilm cells collectively render the biofilm cells up to 1000 times 
more tolerant to antibiotics than their planktonic counterparts. The challenges represented 
by biofilm infections associated with implanted medical devices can be even bigger due 
to the physicochemical properties of the devices. In the case of metal-based devices, wear 
and reduction of the oxide layer covering metals generates free metabolites and ions, 
which contribute to the proliferation of the cells and the biofilms
11,16
. As a consequence, a 
 13 
chronic infection can develop, which could lead to other complications such as device 
failure, prolonged hospitalization, sepsis, and even patient death
17
. 
 
2.1.2. Bacterial antibiotic-resistance  
Antibiotic-resistant infections can cause prolonged hospitalization and require 
higher doses of antimicrobials to treat, if work at all. Recently, the combination of 
multiple antibiotics has become the most preferred approach to control these infections. 
However, finding the right combination can be challenging since many species are 
resistant to more than one antibiotic. P. aeruginosa, for instance, was found to resist to 
many antibiotic including fluoroquinolones, β-lactams and aminoglycosides18.  
 
Bacteria can resist drugs through acquired mechanisms such as reduced 
permeability of outer membrane due to mutation, degrading the drug molecules through 
enzymatic processes and modifying the intracellular targets of the antibiotic. For example, 
the process of inactivation of aminoglycosides can occur by acetylation, phosphorylation 
or adenylation at critical sites of this molecule 
19
.  
 
In addition to resistance based on mutations and activities against specific 
antibiotics, bacteria can also obtain resistance through intrinsic mechanisms such as the, 
extrusion of antibiotics by drug efflux pumps and by forming biofilms
20
. The 
transmembrane efflux pumps play an important role in drug resistance. Nikaido and 
colleagues showed that CmLA is a transporter that can pump chloramphenicol out of P. 
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aeruginosa. According to this model, an amphililic antimicrobial may cross the bilayer 
membrane but will be driven out of the cell by the efflux transporter.  
 
2.1.3. Bacterial Biofilms 
Biofilms are sessile communities of microorganisms organized in a self-created 
extracellular matrix, which separates the cells from their immediate environment and 
provides the cells with protection against external physicochemical stresses. Due to the 
ubiquitous presence of biofilms in nature, the first time a biofilm was observed can be 
dated back to the invention of the microscope. However, the concept of biofilm was not 
introduced until William Costerton published his seminar paper describing bacterial 
biofilm as a well-organized community of microorganisms. Since then, many studies 
have been published attempting to elucidate the mechanisms of biofilm formation and 
their significance
21
. Previous studies have well-characterized the structural 
organization
22,23
 of biofilms and their implications to the medical field
24
.  
 
In 2008, Monds et al.
25
 proposed a model of microbial biofilm formation 
comprising five steps including reversible and irreversible attachments of the cells, 
microcolonies formation, maturation (formation of the 3D structure) and finally 
dispersion which allows the biofilm cells to return planktonic state. The initial attachment 
of bacterial cells to a surface is reversible and involves motility 
26
. Gram-negative 
bacteria, such as Pseudomonas aeruginosa, motility functions via flagella and pili allow 
the cells to sense the local environment
27
 and initiate irreversible adhesion leading to 
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secretion of polymeric substance. Caiazza et al.
28
 reported that the cytoplasmic protein 
SadB contributes to the irreversible attachment and the development of microcolonies.  
 
The production of the EPS matrix is a dynamic process involving communication 
with the host environment and among bacterial cells through quorum-sensing
29-31
. The 
molecular mechanism behind the EPS product is not fully understood; however, it is well 
known that the structure of the EPS is dependent on carbon source availability
32
. In fact, 
polysaccharides, glycolipids, amino acids, proteins and even extracellular DNAs (e-
DNAs) have all be found as key components of the EPS matrix of certain species
33
. It is 
important to know that EPS is not s solid material but have pores and  channels for 
nutrients and waste removal
34
.  Collectively, the EPS matrix constitutes a diffusion 
barrier for both antimicrobials and nutrients. Therefore, a concentration gradient exists 
for added compounds, resulting in the starvation of the cells located in the most inner part 
of the biofilm, and associated drug tolerance. 
 
Although the functions of EPS components are not fully understood, it is clear 
that the EPS matrix provides important protection to bacterial cells from hydrostatic and 
chemical challenges. Dispersion of bacterial cells occurs when the EPS matrix is 
disrupted using surfactants such as Triton-X 100
35
. In dental and hydraulic environments, 
high shear stress is required to remove biofilm plaques. Dispersion caused by these types 
of applications is known as passive dispersion
36
. In contrast, an active dispersion is a 
coordinated event where biofilm-embedded bacterial cells initiate detachment to become 
free-swimming cells. It is believed that active detachment is a survival strategy for 
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biofilm cells to live in low-nutrient conditions and plays an important role in spreading 
infections
37
. The return to a planktonic state is highly dependent on the intra and extra-
biofilm signaling and requires the activities of EPS degrading enzymes. The generation 
of reactive oxygen intermediates (e.g. hydrogen peroxide) or reactive nitrogen 
intermediate (e.g. nitric oxide) from the host environment can result in cell lysis and 
therefore induce the expression of matrix degrading enzymes as stress response 
38
.  
 
As discussed above, bacterial drug resistance is based on multiple mechanisms. 
For planktonic cells, the mutation of drug targets, the activities of the efflux pumps, the 
modification or degradation of drug molecules by secreted enzymes all contribute to 
multidrug resistance. In contrast, the biofilm cells exhibit common resistance to 
essentially all antibiotics up to one thousand times higher than the cells in their 
planktonic state. An important factor of biofilm associated drug resistance resides in the 
structure of exopolysaccharide matrix protecting the cells. As discussed previously, the 
EPS matrix regulates the nutrient transport and assists the biofilm development. One of 
the main features of the biofilm is the oxygen and nutrient concentration gradients 
between the outside and inside of the biofilm. During antibiotic treatment the 
concentration gradient allows the inner cells to survive better due to the low drug 
concentration and low metabolic activities (antibiotics are more effective against 
metabolically active cells)
39
. Meanwhile, the death and lysis of the other larger cells add 
e-DNA to the biofilm. Lawenza has demonstrated that e-DNA provokes a cation 
limitation within the biofilm which modified the LPS structure. As a consequence, the 
LPS modification lowers the permeability of the bacterial outer membrane and induces 
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drug resistance. For example, addition of e-DNA at a sub-inhibitory concentration results 
in a 2560-fold increase in cationic peptide resistance and 640-fold increase in 
aminoglycoside resistance
40
. Hence, the production of the EPS matrix does not only 
provide the biofilm cells a physical barrier, but also influence the physiology of the 
biofilm cells and the interaction between drug molecules and bacteria. 
 
2.1.4. Bacterial persistence 
In addition to the above mechanism, recent research has shown that a 
subpopulation of metabolically inactive cells, known as persister cells are also highly 
tolerant to antibiotics. The first indication of persister cells was reported in 1944 by 
Joseph Bigger, who noticed a failure of penicillin to sterilize S. aureus infections
41
. 
However, with the emergence of the antibiotic-resistant strain, its persister cells were 
largely overlooked for decades. About 40 years after Bigger’s intriguing finding, Harris 
Moyed conducted a study to understand (at the genetic level) the phenotypic variance 
between successive generations of E. coli persisters isolated with ampicillin (Amp). It 
was discovered that the high persistence gene (hipA) increased the frequency of persister 
cells; however, its deletion did not prevent Hip mutants from forming persisters
42
.  Kim 
Lewis and colleagues conducted similar experiments and discovered that a small 
subpopulation of E. coli, P. aeruginosa, and S. aureus could survive high drug 
concentrations and maintain a constant cell density after treatment with increasing 
concentrations of ampicillin (Amp), ofloxacin (Ofx), and ciprofloxacin (Cip) & penicillin. 
When this surviving population was cultured again without antibiotics, it harbored a 
similar subpopulation, which could tolerate the antibiotics to the same extent
43
. This 
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finding proves that the persister cells are phenotypic variants with increased tolerance to 
antibiotics.  
 
Since then, studies have been conducted to better understand bacterial persistence, 
and understand its relevance to multidrug-resistance
44,45
. Later, it was found that the 
persister cells also exist in biofilms
46
 and play a role in chronic biofilms infections
47
. 
Now, it is well established that the presence of the persister cells renders biofilms more 
difficult to eradicate. In the absence of antibiotics, the persister cells have the ability to 
wake up and regenerate new cell populations within the biofilms
48
. The clinical relevance 
of persister cells becomes more clear with the isolation of P. aeruginosa strain having 
high persistence frequency from cystic fibrosis patients
49
.  
 
Many studies have been conducted to understand the mechanism of persister 
formation and develop strategies to control bacterial persistence. Genetic studies have 
revealed that persister genes are redundant. In addition to hipA, genes such as GlpD 
(encoding sn-glycerol-3-phosphate dehydrogenase), plsB (encoding sn-glycerol-3-
phosphate acyltransferase), respectively, phoU, and hfg (encoding for regulators), and 
hha and cspD (encoding for toxins) have all been reported to control persister formation 
in E. coli 
50-52
. Other studies on the effects of physicochemical factors have shown that 
antibiotics
53
, signaling molecules
54-56
, and oxidative stress
57
 could induce persister 
formation. The strategies to control persister cells reported to date include those using 
peptides
58
, quorum sensing inhibitor molecules
59-61
, metal elements
62,63
, and direct 
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current
64
 (part of this research). The physicochemical factors can either kill the persisters 
alone, or sensitize them to antimicrobials. 
 
2.2. ELECTROCHEMICAL TREATMENTS OF BACTERIAL CELLS 
2.2.1. Effects of electric currents on bacterial cells 
2.2.1.1. Alternating currents 
The study of the effects of electric currents on bacteria is not new. Treatment of 
bacterial cells with alternating currents (AC) was reported in 1915 by Beattie et al.
65
, and 
in 1919 Anderson et al.
66
. In 1925, Beattie and Lewis reported the bactericidal effects of 
2 A (ampere) AC corresponding to a field comprised between 3000-4000 V, which was 
then used for sterilization of milk
67
. Over the years, more studies were performed to 
explain the mechanism of the bactericidal effects of electric current. Hence, in 1962, 
Brandt et al. proposed that the bactericidal effects of the electric discharges were due to 
the generation of oxidizing species and free radical
68
.  
 
Three years later, Barnett Rosenberg discovered that treatment with alternating 
current at 2 A (corresponding to 50x10
5
 c/s) generated using platinum electrodes resulted 
in 300 times elongation of E. coli K12 cells
69
. However, the bacteriostatic effects 
observed were not linked to reactive oxygen radicals, as they were not found into the 
solution. Instead, the oxidation of the platinum electrodes lead to the formation of Pt-
based species which interfere with the genetic material of the cells, preventing them to 
complete cells division
70
. This finding led to the development of the exciting field of 
metallodrug complexes, which has found applications in cancer chemotherapy
71
.  
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The lethal effects of low-level AC on bacteria were also investigated. For instance, 
Pareilleux et al.
72
 demonstrated that low-level AC ranging from 10 to 200 mA using 
platinum or stainless steel (SS) electrodes affected the viability of E. coli. While 20 mA 
AC did not have any effects of the cell viability, the cells were killed by 4 logs and 7 logs, 
with the treatments using 60 mA and 120 mA AC, respectively. However, Rower et al.
73
 
reported different results during the testing of E. coli cells with Platinum wire. It 
appeared that the 15-30 mA AC level generated using platinum did not have any effect 
on cell viability.  
 
2.2.1.2. Direct currents (DC) 
The effects of DC on the viability of bacterial cells were first tested in the early 
70’s. Treatment of E. coli with total DC comprised between 1 and 140 using platinum 
electrodes were described for their bactericidal effects by Rowley et al.
73
. However, 
different effects were reported when the study was performed in vivo. The treatment of 
wounds infected with P. aeruginosa using copper-mediated DC ranging from 200-1000 
μA for 72 h exhibited bacteriostatic effects74.  
 
The effects of the electrodes material have been investigated by Baranco et al.
75
, 
who determined that antimicrobial activity of the lower level DCs in the range of 40 to 
400 μA (mediated using SS, platinum, gold or silver electrodes) on the viability of S. 
aureus, and observed variable levels of killing.  
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Later, the activity of silver ions in the presence of low-level DC ranging between 
5-40 μA were tested on oral bacteria by Thibodeau et al.76  and demonstrated that 
supplementation of silver ions to DC treatment had dose-dependent killing effects on oral 
bacteria, resulting in 2 to 6 logs of killing in the range of DC tested compared to the 
untreated control. This study demonstrated that silver ions could maintain its 
antimicrobial activities even in the presence of reduced current. This study brought more 
attention to the antimicrobial activities of silver ions, which were then used to test on 
Gram-positive and Gram-negative microorganisms such as S. aureus, P. aeruginosa
77-79
. 
The studies of bacterial control with electrical currents are summarized in Table 2.1. 
 
2.2.2. Effects of electrochemical factors on bacterial cells 
In most of the previous studies, high field strength discharges were performed in 
short time pulses to determine the effect on cells viability. Gilliand et al. 
91
 investigated 
the effects of multiple cycles of 10 kV electrical discharges generated using copper 
electrodes on bacterial cells including E. coli, Streptococcus faecalis, vegetative cells and 
spores of Bacillus subtilis. The result of that study demonstrated cells lysis occurred and 
the effects were attributed to the generation of cupric ions, which increase the toxicity 
level of the treating solution, and result in cell killing. However, the cells responded 
differently to the treatments based on their size. For instance, bacteriophages were more 
readily killed by the treatment than bacterial cells. Similar studies were performed by 
Hulsheger et al.
92,93
 and demonstrated that Gram-negative bacteria were more resistance 
to the electric shock generated by strong electric fields. 
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Table 2.1: Effects of electric currents (AC and DCs) on bacterial cells 
 
Current/Voltage 
Level 
DC 
electrodes 
material 
Bacterial Species Findings Ref 
2 A  AC Platinum wire E coli 
Bacteriostatic 
effects 
Rosenberg et 
al.69 
1 mA, 14 mA, and 
140 mA 
DC Platinum wire E coli 
bactericidal 
effects 
Rowley et al.73 
1 mA DC 
Copper mesh in 
gauze  
P aeruginosa 
bactericidal 
effects 
Rowley et al.74 
DC; 40 and 400 μA DC 
Silver, platinum, 
gold, stainless 
steel 
S aureus 
bactericidal 
effects 
Baranco et al 
75 
5 μA DC Silver Oral bacteria  
bactericidal 
effects 
Thibodeau et 
al76 
100 μA DC Silver wire 
S. aureus,  
P. aeruginosa 
bactericidal 
effects 
Ong et al 77 
26 μA - 800 μA DC 
Silver wire and 
silver nylon 
Gram-positive, 
Gram-negative 
bactericidal 
effects 
Laatsch et al.79 
0.7-1.8 mA/cm2 DC 
CDC biofilm 
reactors 
S. epidermidis,  
Gram negative 
bactericidal 
effects 
Sandvik et al.80 
3.1 mA/cm2 DC Platinum wire 
Klebsiella 
pneumoniae, P 
fluorescens, P 
aeruginosa 
reduction of 
cathodic biofilms 
Stoodley et 
al.81  
−800 to +800 μA DC 
 
Streptococcus oralis 
J22 
Reversible 
attachment 
Poortinga et 
al.82,83 
65uA DC Indium tin oxide 
Streptococcus oralis 
J22, Staphylococcus 
epidermidis 3399, 
and A. naeslundii 
147, A. naeslundii 
T14V-J1 
Detachment  
Van Der 
Borden et 
al.84,85 
60 μA and 100 μA DC Stainless-steel S epidermidis  Detachment  
Van Der 
Borden et al.86 
3.7 μA/mm2 DC Stainless-steel Mixed-Species  
loss of 
bioelectric 
effects 
Shirtliff et al.87 
20-2000 μA DC 
Stainless steel or 
graphite 
cylinders 
Pseudomonas 
aeruginosa, 
Staphylococcus 
aureus, and 
Staphylococcus 
epidermidis 
bactericidal 
effect 
Del pozo et 
al.88 
200 μA DC stainless steel 
Staphylococcus 
epidermidis 
Electricidal 
effect in rabbit 
model of 
osteomyelitis 
Del Pozo et 
al.89 
180A/m2 DC Agarose E coli 
augmentation of 
biomass 
Chang et al.90 
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 Further analyses were conducted by Gilliand et al. 
94
 to evaluate the 
effects of 10 kV electrical discharges generated using aluminum electrodes. Under these 
conditions, it was discovered that some metabolic activities of the cells, as well as their 
membrane properties were altered by the treatment. However, it was believed that cell 
death was induced by the heat, mechanical shock engendered by the flows of ions and 
reactive oxygen species surrounding the cells. According to Zimmermann et al.
95,96
, the 
ions flow of ions generated by the high electric field could disrupt of the cell membrane. 
These results corroborate with other findings, confirming that the lethal activities of 
electric fields are through the direct effects on cell properties and indirect effects 
associated with heat, ion flow or generated reactive species
97-99
.  
 
Recently, the effects of low electric field on bacterial growth have caused 
attention in the field of orthopedic and dental implants. The interaction between body 
fluid and alloys used for these implants generate an electrical potential, a phenomenon 
known as galvanism. On dental implants this potential could be as high as 900 mV. Some 
studies have been conducted to explore the effects such electric potential on oral bacterial 
cells. In a recent study, Zituni et al.
100
 demonstrated that S. aureus was found more 
sensitive to the low level fields compared to E. coli, suggesting that oral galvanism could 
potentially affect oral ecosystem. The studies of bacterial control with electric fields are 
summarized in Table 2.2. 
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Table 2.2: Electric field effects on bacterial cells 
Current/Voltage 
Level 
DC 
electrodes 
material 
Bacterial Species Findings Ref 
effects of electric field (ACs) 
20 kV 0.1-50Hz PEF 
pulse generator 
equipped cell 
E coli K12 
Antimicrobial 
effects 
Hulsheger et 
al.93 
20 kV 0.1-50Hz PEF 
pulse generator 
equipped cell 
P. aeruginosa, S. 
aureus, E. coli, E. coli 
K12, Klebsiella 
pneumoniae, Listeria 
monocytogens I, 
Listeris monocytogens 
II, Candida albicans 
Antimicrobial 
effects 
Hulsheger et 
al.92 
1-4V HVPC 
Silver nylon 
cloth 
P aeruginosa, S. 
aureus, and Candida 
albicans 
Antimicrobial 
effects 
Marino et al.101 
150-300V HVPC Stainless-steel 
P aeruginosa, S. 
aureus, and E. coli 
Antimicrobial 
effects 
(Cathode) 
Kincaid et 
al.102 
500V HVPC Stainless-steel 
P aeruginosa, S. 
aureus, and E. coli, 
Klebsiella 
Antimicrobial 
effects 
Szuminsky et 
al.103 
10V/m  HVPC Gold electrode 
P aeruginosa, S. 
aureus, and E. coli 
Anodic field 
inhibition 
 Zituni et al.100 
0.1-50Hz PEF 
 
P aeruginosa 
antibiotic 
susceptibility 
increases 
Ali et al.104 
10 MHz LIEF 
insulated 
electrode 
P aeruginosa 
inhibition in a 
lung model of 
infections 
Giliadi et al.105 
15-30V HSEF titanium  
Staphylococcus 
aureus 
decrease of 
biofilms on  
anodized 
nanotubular  
Ercan et al.106 
0.5 to 5 V HSEF 
Interdigitated 
electrodes 
P aeruginosa 
biofilm 
inhibition 
Perez-Roa et 
al.107 
1.5V HSEF stainless steel 
Pseudomonas 
aeruginosa 
Biofilm 
removal 
Dargahi et 
al.108 
LIEF: Low intensity electric field 
   
PEF: Pulse Electric Field 
   
HVPC: High Voltage Pulse Current 
   
HSEF: High strength electric field 
   
 
 
2.2.3. Medical implication of the electrochemical currents 
Although AC has been found to sterilize milk using ampere-level AC generated 
with the high electric field, and cause the filamentous structure of E. coli due to 
bacteriostatic effects of, the attempt to apply electric currents to cure infection was not 
taken until 1974. Rowley et al.
74
 performed the first in vivo study of DC treatment and 
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demonstrated that the co-treatment of P. aeruginosa infected wounds with 200-1000 μA 
total DC using copper mesh electrode and aerosporim-polymyxin B sulfate resulted in 
synergistic killing effects, a phenomenon. In 1992, Khoury and Costerton 
109
 discovered a 
phenomenon, names as  bioelectric effects, in which synergistic killing of biofilm cells 
was obtained using 15 μA/cm2 DC or 1.5 V/cm2 and antibiotics including Tob. Costerton 
et al.
110
 further investigated the mechanism of the bioelectric effects, which led to a 
renewed interest in the field of DC treatment of bacterial infection. 
 
Since the published report of Costerton
109,110
, a number of studies have been 
published to describe the effect of DC or AC in killing medical relevant planktonic and 
biofilm cells. In 1995, Jass and Costerton
111
 demonstrated the effect of 1mA DC and Tob 
on killing P. aeruginosa biofilm cells in an electrical colonization cell
111
.  In a similar 
setting, it was found that the activity of ciprofloxacin (Cip) polymyxin B was enhanced 
by 2 logs in a 12 h treatment and 3 logs in a 24 h treatment with 20 mA/cm
2
 DC
112
. More 
bacterial species including Klebsiella pneumonia, Pseudomonas fluorescens, P. 
aeruginosa were tested with DC. For instance, Wellman et al. 
113
 used a mixed biofilm 
culture system composed of K. pneumonia and P. aeruginosa to demonstrate dose 
dependent bioelectric effects with increasing level of DC. To understand the effects of 
DC on the morphology of the biofilms, Stoodley et al. tested the bioelectric effects on the 
biofilms of multiple species including Klebsiella pneumoniae, P. fluorescens, P. 
aeruginosa, Streptococcus oralis J22, on platinum wire electrode and found that the 
viability of cathodic biofilm cells was reduced by 74%, while the biofilm on the anode 
increased in size after 3 days of treatment
81
. 
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Table 2.3: Synergistic killing effects between electric currents and antibiotics 
 
Overtime, more complex electrochemical system was constructed to study to 
understand of role of ROS in DC treatment. Stewart et al.
114
 tested DC using carbon or 
SS electrodes were generated across an electrochemical chamber containing P. 
aeruginosa in the presence or absence antibiotic. The synergy between Tob and DC was 
studied under various pHs to control the concentration of dissolved oxygen. It was 
Current/Voltage 
Level  
electrode 
materials 
Antibiotics 
Bacterial 
Species 
Findings Ref 
effect of direct current 
1 mA DC 
Copper 
mesh in 
gauze  
Polymyxin B P aeruginosa synergy 
Rowley et 
al.74 
9-20 mA/cm2 DC 
Electrical 
colonization 
cell (ECC) 
Tobramycin  P aeruginosa synergy Jass et al. 111 
 9 mA/cm2  DC 
Electrical 
colonization 
cell (ECC) 
Ciprofloxacin 
polymyxin B 
P aeruginosa  synergy Jass et al.112 
1 mA DC 
Platinum 
wire 
Tobramycin  Mixed- Species synergy 
Wellman et 
al.113 
2 mA DC 
Stainless 
steel wire 
Tobramycin  
Pseudomonas 
aeruginosa 
synergy 
Stewart et 
al.114 
20-2000 μA DC 
Stainless 
steel or 
graphite 
cylinders 
Cefepime, 
Ciprofloxacin, 
Tobramycin, 
Daptomycin, 
Erythromycin, 
Linezolid, 
Minocycline, 
Moxifloxacin, 
Rifampin, 
Trimethoprim-
sulfamethoxazole, 
Vancomycin 
Pseudomonas 
aeruginosa, 
Klebsiella 
pneumoniae, 
Staphylococcus 
epidermidis, 
Escherichia coli, 
and 
Streptococcus 
gordonii. 
synergy 
Del Pozo et 
al.115 
       4V/cm, 100 kHz 
and 50 MHz 
AC 
Conductive 
electrodes 
Chloramphenicol 
S aureus, P. 
aeruginosa 
synergy 
Giliadi et 
al.116 
<100 μA/cm2 DC 
stainless 
steel 
Tobramycin P aeruginosa Synergy 
Costerton et 
al.110 
 - 2.1 mA/cm2 
with +/- 12 V/cm 
DC 
Stainless 
steel 
kathon, 
glutaraldehyde, 
and quaternary 
ammonium 
compound 
Pseudomonas 
aeruginosa 
Synergy 
Blenkinsopp 
et al.117 
6 mA/cm2 current 
density, 5-20 MHz 
RFC 
stainless 
steel 
gentamicin and 
with 
oxytetracycline 
P aeruginosa Synergy 
Caubet et 
al.118 
RFC: Radio frequency current 
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concluded that the ROS contributes to the enhanced killing of the P. aeruginosa cells. 
The species electrolytes and their roles in the efficacy of the DC treatment were studied 
by Shirtliff et al.
87
. It was found that the chloride ions in the electrolyte are important to 
achieve synergistic killing effects in killing bacteria with DC and antibiotics. 
 
The effects of electrochemical factors on bacteria have also been evaluated in 
vivo. Busscher et al.
82,84-86
 first reported that bacterial adhesion on metal surfaces could 
be controlled by weak electric field or currents (either positively or negatively depending  
on the direction of current  between -800 to 800 μA)82,83. This technology was translated 
in two in vivo studies, in which adhesion of  Staphylococcus epidermidis to stainless 
steel-based implant was prevented
86
 and biofilms were removed by applying the current 
before the treatment
85
. The studies of bacterial control with electrochemical factors are 
summarized in Table 2.3. 
 
Overall, these study shows that the electrochemical factors including DC, AC, 
electric field and generated species could be used to effectively control bacterial cells. 
However, there is still a little known of the mechanism of these effects. Instead, the 
phenomena described the bactericidal activity of electrochemical treatments of various 
species. However, the genetic or cellular understanding of electrochemical control of 
bacterial cells could lead to the development of more effective design, which could 
improve antibiotic activity, and reveal new target for bacterial control through 
antimicrobial. Moreover, it is unknown if these technologies could remediate the 
challenge associated with the presence of the persister cells. Thus, this study aims to 
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contribute to the field of electrochemical treatment of bacteria by revealing the 
mechanisms of killing of drug resistant persister cells using DC. 
 
2.3 TECHNIQUES APPLIED IN THE STUDY 
2.3.1 Electrochemical measurements 
Electrochemical treatment of bacterial cells: This study aims to understand the response 
of PAO1, a model bacterial strain to low-level direct currents (DCs). Thus, the 
electrochemical treatments are performed in the chronopotentiometric or galvanostatic 
mode. An electrochemical cell can be constructed in a 3-electrodes configuration. 
Stainless steel (SS) 304, carbon, or TGON (a graphite-based material) were used as 
working and counter electrodes, together with an Ag/AgCl saturated reference electrode 
in this study. Three electrochemical systems were designed for this study: (1) a 1-
chamber system that hosts all the electrodes in a single cuvette (See Chapter 3 and 4); (2) 
a 2-chamber system consisted of 2 chambers (hosting the counter and the working 
electrode separately) connected with a salt bridge (See Chapter 4). (3) A flow cell system, 
which contains all the three electrodes and allows imaging of the experiment (Chapter 8). 
Using a potentiostat, a constant low-level DC is applied and the number of viable cells is 
quantified. In addition, anodic or cathodic electrode potential (Epa or Epc) as well as the 
electric field (E) are recorded to differentiate the effects of the electrochemical factors 
(DC, electric field, potential, redox reactions) on the viability of the persisters. 
 
Electrode polarization: To study the electrochemical properties of an electrode, a 
polarization curve need to be recorded. A polarization curve provides critical information 
 29 
Figure 2.1: Cyclic voltammogram. 
about the rate of charge exchanges between the electrodes and electrolytes, which could 
be obtained by performing a scan on a range of potential while recording the current 
density. The corrosion potential (Ecorr) or open-circuit potential (OCP) is the equilibrium 
potential, at which the cathodic and the anodic currents are equal. The current at OCP is 
usually referred to as icorr. The OCP potential is important for determining if the electrode 
behaves as an anode or a cathode. During an active corrosion, the overpotential (the 
difference between the electrode potential and the OCP) increases as a function of current 
density; whereas the current density does not change during passivation of the electrode 
in spite of overpotential. Polarization curves have been a very useful tool for determining 
the electrochemical species released at different time points of an electrochemical 
treatment 
24
. This method is used in this study to compare the electrochemistry of 
different electrode materials. 
 
Cyclic Voltammetry (CV). CV was performed to investigate the electrochemical 
properties of the Tobramycin (Tob), the 
primary antibiotic supplemented to the DC 
treatment in this study, to understand 
synergistic interaction between metal ions 
and antibiotics in persister control. In 
principle, a CV plot displays electric 
potential associated with the redox reactions 
of a compound. In this method, a series of 
voltages is applied in a forward or reverse order to an inert electrode (e.g. gold, platinum 
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or glassy carbon) at a specific scan rate to evaluate the rate of electron exchange between 
the material and the solution of interest. The forward scan of the working electrode leads 
to the oxidation of the reactants until complete depletion, which is represented by the red 
peak in Fig. 2.1. Then, the oxidation current drops due to diffusion limitation of the 
reactants. When a reducing potential is applied (reverse scan), electrons are supplemented 
to the reactants until the amount of reactants available at the electrode deplete. The rate of 
charge exchange is proportional to the recorded current, and is used to generate a cyclic 
voltammogram (Fig. 2.1). Thus, the reversibility of a reaction could be determined based 
on the value of peaks at cathodic or anodic electrode potentials (Epc or Epa). If the redox 
reaction is reversible, the peak of Epc is equal to that of Epa. In this study, this method was 
are used to determine the stability of metal drug complexes formed during the 
electrochemical treatment of PAO1 cells in the presence of Cr ions and Tob. 
 
Zeta potential: Measurement of the surface charge of colloidal systems is a very useful 
tool for predicting the effect of ionic strength on particle (e.g. coagulation of 
flocculation)
25. Zeta potential or ζ-potential characterizes the electrokenetic potential of a 
charged particle in a colloidal suspension or the electrostatic potential between the 
particle and the charge molecules in the vicinity of particle. Once a charged particle is 
suspended in an aqueous solution, ionic bonds are formed between the particle and 
molecules with countercharges, referred to as the stern layer (Fig. 2.2). Additional 
molecules from charges opposite to that of the particle could interact with the stern layer 
to counterbalance the overall charge of the particle and form a so-called diffused layer. 
The diffuse layer is separated from the rest of the solution by a slipping plane. The 
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potential of the double-layer contributes to the ζ-potential and is proportional to both the 
surface potential of the particle and the ionic strength of the solution. The electrophoretic 
mobility (μ) of the particle across a well-defined electric field (E) is used to determine the 
ζ-potential according to the following relationship26:    
ζ 
   
     
        
 
 
 
in which ζ: Zeta-potential 
μ: electrophoretic mobility 
η: viscosity of the suspension 
εₒ: permittivity of the free space 
εᵣ: permittivity of the suspension 
Figure 2.2: Illustration of the zeta potenital of a negatively charged particle in 
an aqueous solution (Updated from Larryisgood) 
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ν: velocity of the particles 
Bacteria commonly possess a charge surface due to their transmembrane lipoproteins. 
The surface charge of the cell contributes greatly to the cell homeostasis and to the ability 
of the cell to control influx and efflux of small molecules. Thus, cell depolarization could 
lead to disruption of the membrane functions and cell death
27,28
. In this study the ζ-
potential was used to evaluate the surface charge of DC-treated PAO1 cells and control 
cells to investigate the effects of the DC treatments
29
. 
 
2.3.2 Spectroscopy Techniques 
Inductively Coupled Plasma-Mass Spectroscopy (ICPMS): ICP-MS is a powerful 
technique that can quantitatively characterize the elements in a sample, including both 
metal and some non-metal species. In contrast to many other mass spectroscopy systems, 
ICP-MS relies on the ionic state of the analytes in a chamber filled with an electrically 
conductive gas (e.g. argon), referred to as plasma. The plasma is energized at a 
radiofrequency by means of an electric coil, which results in the desolvation, atomization, 
and ionization of the sample. Using a quadrupole mass spectrometer, the ions are then 
separated based on a mass-to-charge ratio
30
. This method was used in this study to 
determine the composition of the electrolyte generated during DC treatments. ICP-MS 
was also used to quantify the amount of metal ions interacting with the cells in the 
absence and presence of an antibiotic. 
 
Nuclear Magnetic Resonance (NMR): NMR relies on the ability of atomic nuclei to 
absorb and emit electromagnetic radiation in the presence of a static magnetic field. The 
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quantum magnetic properties of the atomic nuclei are determined by the specific structure 
of a compound and could be attributed to particular chemical elements at a known 
resonance frequency. The state of the atomic nuclear energy generated at these resonance 
frequencies is collected to elaborate the NMR spectroscopy on the basis of population 
distribution. For the purpose of this study, NMR-HSQC (heteronuclear single-quantum 
coherence) was performed on solutions containing metal ions and antibiotics including 
tobramycin (Tob) and kanamycin (Kan). HSQC is a two dimensional heteronuclear 
experiment which characterizes the correlation between proton and carbon of the 
molecule of interest. It is a powerful tool to determine structural changes in chemical 
compounds under different conditions. In this study, HSQC-NMR was used to investigate 
the structural dynamics of Tob and Kan and evaluate the possibility of formation of 
antibiotic-metal ion complexes. 
 
Ultraviolet (UV) - visible Spectroscopy: The UV-visible spectroscopy measures the light 
absorbance of compounds exposed to light wavelengths ranging from 200 to 800 nm.  
During a UV-visible scan, light is projected through a sample, which absorbs some of the 
UV or visible photons. An absorption spectrum for the scan is created by computing the 
ratio of the transmitted (detected) light over the total light projected. Because of the 
electromagnetic radiation generated by the photon is rich in energy, the absorbance 
results in additional energy being transmitted to the molecules (sample). These molecules 
originally possess an electronic potential energy, a vibrational potential energy, and a 
rotational potential energy 
31
. Therefore, the radiation could generate enough energy to 
increase the electronic potential energy of the molecules and change the electronic the 
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configuration by moving the electrons from a lower energy level to a higher one, e.g. a 
non-bonding-antibonding (n-π*) or a bonding –anti-bonding (π-π*) transition. Hence, 
structural change in molecule could be identified by the change in band and intensity of 
the absorbance spectrum. For instance the transition metals absorb light at wavelength 
between 300 and 700 nm. Therefore, the change of the electronic configuration of a 
molecule after mixing with another compound could be determined by the broadening of 
the absorbance band and the change in the intensity of the band. In this study, UV-visible 
spectroscopy was used to evaluate the interactions between Cr
3+
 and Tob.  
 
2.3.3 Imaging 
Atomic Force Microscopy: Atomic force microscopy (AFM) is a type of surface imaging 
technique, which evaluates the topographic profile of a sample based on intermolecular 
interactions between the tip of a cantilever and the sample. During surface scan, a light is 
emitted on the cantilever and the deflection of the light is detected to generate the image 
of the scanned surface. AFM has been a very useful tool to study the viscoelastic 
properties of samples including bacterial cells. In our study, AFM was performed to 
determine the change in the stiffness of PAO1 cells before and after electrochemical 
treatments. 
 
Electron Microscopy (EM):  Electron microscopy is an imaging technique that uses 
electrons instead of light. Because electrons emit very lower wavelength in comparison to 
photon, EM has the advantage of showing very small features. To capture an EM image, 
a high voltage is generated between a negatively charged filament and a positively 
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charged anode to drive an electron beam from the filament. The beam is oriented toward 
the sample by a series of electrostatic and electromagnetic lenses. When an electron hits 
the sample, it is deflected as back-scattered electron (BSE), secondary electron or X-ray, 
which is captured by a detector to generate an image. In this study, two types of EM are 
used: The scanning electron microscopy (SEM) and transmission electron microscopy 
(TEM). To perform SEM, the sample is coated with a conductive material, such as gold 
or platinum. The interaction between the electron beam and the sample is recorded to 
generate the SEM images. In contrast to SEM, TEM samples are stained with contrast 
agents, which are made of heavy metals. The contrast agents that penetrate the cells are 
detected to generate the TEM images. TEM and SEM in this study were used to 
investigate the changes that occur to the PAO1 cells treated with DC.  
 
Fluorescence Microscopy: Fluorescence microscopy is a widely used optical microscopy 
technique, in which a sample is stained with fluorescent dyes that can absorb and emit 
light at different wavelengths. In this study, fluorescence microscopy was used to 
evaluate change in the cell viability or to track the movement of bacteria under the DC 
treatments. 
 
2.3.4 Genomics and Proteomics 
Information about the expression profile of genes and proteins is invaluable for 
understanding the physiology of the cells. In this study, DNA microarray analysis was 
performed to obtain the transcriptional profiles of PAO1 cells with or without DC 
treatment. Gene profiling with DNA microarrays is a mature technology, which can 
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quantify the expression level of every genes in an organism. This method relies on  
hybridization of complementary DNAs (cDNAs) with the DNA probes on the microarray, 
allowing the identification and the quantification of the expressed genes 
32
.  
Similar to DNA microarrays, techniques have been developed to obtain protein 
expression profile of an organism. One of such methods, 2D gel electrophoresis was used 
in this study to determine the difference in protein expression between cells treated with 
DC vs. untreated cells.  
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CONTROLLING PSEUDOMONAS AERUGINOSA PERSISTER 
CELLS BY WEAK ELECTROCHEMICAL CURRENTS AND 
SYNERGISTIC EFFECTS WITH TOBRAMYCIN 
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3.1. ABSTRACT 
It is well recognized that bacterial populations commonly contain a small percentage of 
phenotypic variants, known as persister cells, which are dormant and extremely tolerant 
to antibiotics. When the antibiotic treatment is stopped, surviving persister cells can 
regenerate the bacterial population with a similar percentage of persister cells. Such 
persistence presents a great challenge to curing chronic infections, such as those 
associated with implanted medical devices. In this study, we report that bacterial persister 
cells can be effectively eliminated by low-level direct currents (DCs); e.g. treatment with 
70 µA/cm² DC for 1 h using stainless steel (SS) 304 reduced the number of viable 
planktonic persister cells of Pseudomonas aeruginosa PAO1 by 98% compared to the 
untreated control. In addition to persister killing by applying DC alone, synergistic effects 
were observed when treating persister cells with 70 µA/cm² DC and 1.5 µg/mL 
tobramycin together using SS304 electrodes. The same level of DC was also found to be 
cidal to biofilms-associated persister cells of P. aeruginosa PAO1. These results are 
helpful for developing more effective methods to control chronic infections associated 
with implanted medical devices. 
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3.2. INTRODUCTION 
The rapid development and spreading of multidrug resistant bacteria is a major 
challenge to public health. Bacteria can become drug resistant through both intrinsic and 
acquired mechanisms. Intrinsic mechanisms are based on specific cellular structures and 
functions (e.g. drug extrusion by efflux pumps), which offer bacteria general protection 
from a variety of antibiotics and facilitate the further development of resistance through 
acquired mechanisms based on genetic mutations and horizontal gene transfer 
1,2
. One of 
the major intrinsic mechanisms of resistance is biofilm formation, by which bacteria 
attach to surfaces and develop multicellular structures with cells embedded in an 
extracellular matrix 
3-5
. With the high tolerance to antibiotics, biofilms cause serious 
medical problems. For example, biofilm formation on medical devices accounts for half 
of the cases of nosocomial infections in the U.S. and leads to repeated surgeries, and in 
more serious cases, amputations and deaths 
6
. 
 
In addition to the formation of multicellular structures, it is well documented that 
bacterial cultures commonly contain a small fraction (0.1-1% in general) of dormant cells, 
known as persister cells 
7-9
. Because most antibiotics are only effective against 
metabolically active cells, persister cells can survive the challenge of antibiotics at 
concentrations significantly higher than those required to lyse regular cells of the same 
genotype 
9-11
. When the antibiotic concentration drops under a threshold after treatment, 
the surviving persisters can revert to an active state and regenerate the bacterial 
population with a similar percentage of persister cells. Persister population increases 
significantly when bacteria form biofilms or when a bacterial culture enters stationary 
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phase 
10
, rendering both states highly tolerant to antibiotic treatment 
10,11
. In addition to 
dormancy, persisters embedded in biofilms are also protected from host immune systems 
by the polysaccharide matrix 
12
. Thus, innovative technologies are needed to effectively 
eliminate persister cells, especially those in biofilms. 
 
Due to the dormant nature of persister cells, antimicrobial approaches that work 
independently of bacterial growth phase have good potential to control bacterial persister 
cells. Rosenberg 
13
 reported that alternating electrical currents generated with platinum 
electrodes have bacteriostatic effects rendering Escherichia coli cells elongated. Later, 
direct currents (DCs) in the range of µA to mA/cm² and 100 kHz to 10 MHz alternating 
electric fields were reported for their cidal effects on bacteria after a relatively long 
period (several hours in most cases) of treatment 
14-19
. Although the mechanism of these 
observations is not well understood, similar currents were also found to enhance the 
effects of antibiotics on biofilms, an interesting phenomenon known as bioelectric effect 
18,20,21
. Consistently, a total current of 100 µA DC applied to surgical stainless steel pins 
has been found to prevent Staphylococcus epidermidis infection around percutaneous 
pins in goats 
22
.  
 
The capability of controlling biofilm cells by DCs and alternating currents (ACs) 
led to our hypothesis that appropriate levels of electrochemical currents/potentials can 
also kill bacterial persister cells. To test this hypothesis, persister cells of the Gram-
negative pathogen Pseudomonas aeruginosa PAO1 were challenged with 70 µA/cm
2
 DC 
in this study. This strain was chosen because P. aeruginosa is one of the most important 
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pathogens with clinical significance including medical device-associated infections 
23-25
. 
The effects of DC on both planktonic persister cells and those in biofilms were studied. 
The possible mechanisms are discussed. 
 
3.3.MATERIALS AND METHODS 
3.3.1. Bacterial strain and growth media.  
The wild-type P. aeruginosa PAO1 was cultured in Luria-Bertani (LB) medium 
26
 
containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Each overnight culture 
was incubated at 37°C with shaking at 200 rpm.  
 
3.3.2. Colony forming units.  
The colony forming units (CFUs) were counted to quantify the number of viable P. 
aeruginosa PAO1 cells in planktonic cultures and in biofilms. For planktonic samples, 10 
µL of each sample was diluted in a 10× series using 0.85% NaCl solution and spread on 
LB agar plates (1.5% agar). The CFUs were counted on the next day after incubation 
overnight at 37°C. The biofilm cells were collected by sonication of the biofilm samples 
in 0.85% NaCl solution for 1 min first 
27
 and then well mixed and diluted with 0.85% 
NaCl solution for counting CFU as described above. No significant effects of sonication 
on the viability of P. aeruginosa PAO1 was found (viability was not changed after 2 min 
of sonication confirmed by counting CFU). 
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3.3.3. Isolation of persister cells.  
Previous work has demonstrated that P. aeruginosa persisters can be isolated by lysing 
the regular cells with 25 µg/mL ciprofloxacin (Cip) for 3.5 h 
9
. In order to determine the 
sufficient Cip concentration for our strain, P. aeruginosa PAO1 cells were challenged 
with various concentrations of Cip (0 - 200 µg/mL) for 3.5 h and the killing was 
evaluated by counting CFU of surviving cells. Briefly, P. aeruginosa PAO1 was cultured 
in LB medium over night at 37°C. Then the cells were collected by centrifugation 
(Sorvall Legend RT+, Thermo scientific, Asheville, NC) at 8,000 rpm for 10 min at room 
temperature, and washed twice with 0.85% NaCl solution before being treated with 
different concentrations of Cip for 3.5 h at 37°C. After treatment, the cells were washed 
three times with 0.85% of NaCl solution to remove Cip and the debris of lysed cells. The 
number of viable persister cells was then quantified by counting CFU as described above. 
Five replicates were tested for each condition. 
 
3.3.4. Growth rate measurement.  
Four antibiotics were tested including tobramycin (Tob), chloramphenicol (Cm), 
kanamycin (Kan) and spectinomycin (Spec). An overnight culture of P. aeruginosa 
PAO1 was used to prepare subcultures in 96 well plates (Costar® No. 9017, Corning Inc, 
Corning, NY) with a start OD600 of 0.05. Each well contained 200 μL of LB medium 
supplemented with one of the above antibiotics at different concentrations. The 
concentrations tested ranged from 0 to 10 µg/mL for Tob, 0 to 40 µg/mL for Cm, 0 to 90 
µg/mL for Kan and 0 to 80 µg/mL for Spec. The OD600 of cultures was read every hour 
over a period of 6 h. The growth curves were obtained to calculate the specific growth 
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rates and to identify the antibiotic concentrations that reduce the specific growth rate of P. 
aeruginosa PAO1 by around 50%. These reference concentrations were used to study the 
synergy between antibiotics and electrochemical currents (ECs). 
 
3.3.5. Effects of DC on planktonic cells.  
The susceptibility of P. aeruginosa PAO1 to low level DCs was investigated according to 
the following procedure. P. aeruginosa PAO1 cells in three different physiological stages 
were tested including persister cells isolated from stationary cultures, total cells in 
stationary cultures (with 99% as regular cells) and total cells in exponential cultures (with 
more than 99.9% as regular cells). The persister cells were isolated by treating the 
stationary phase cultures of P. aeruginosa PAO1 with 200 µg/mL Cip for 3.5 h as 
described above. To study the effects of DC on regular cells in stationary cultures, P. 
aeruginosa PAO1 grown overnight (99% as regular cells) were harvested by 
centrifugation at 8,000 rpm for 10 min at room temperature. To estimate the effects of 
DC on regular cells in exponential phase, overnight cultures were used to inoculate LB 
medium to an OD600 of ~0.005 and the cells were harvested by centrifugation when 
OD600 reached 0.7. The harvested cells, as described above (99.9% as regular cells), were 
washed twice with 0.85% NaCl solution, resuspended in 0.85% NaCl solution and treated 
with and without 70 µA/cm
2
 DC. To deliver the DC, an electrochemical cell was 
constructed by inserting two SS304 electrodes along the opposite sides of a plastic 
cuvette (Thermo Fisher Scientific, Pittsburg, PA). A silver wire (0.015” diameter, A-M 
Systems, Sequim, WA) was placed in bleach for 30 min to generate an Ag/AgCl 
reference electrode. The reference electrode was then placed in the cuvette. A 70 µA/cm
2
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DC was generated using a potentiostat (Potentiostat WaveNow, Pine Research 
Instrumentation, Raleigh, NC) in a 3-electrodes configuration as shown in Fig. S1. Using 
the AfterMath software (Potentiostat WaveNow, Pine Research Instrumentation, Raleigh, 
NC), a galvanostatic mode was selected to monitor the DC level and record the voltage 
across the system over an hour. During the treatment, 100 µL of sample was taken every 
20 min to evaluate the viability of bacterial cells by counting CFU. Both SS304 and 
carbon electrodes were used to generate DCs. To compare the effects of electrode 
materials, the same conditions were also tested in the presence of 1.5 µg/mL Tob to study 
the synergy between DC and antibiotics. 
 
3.3.6. Effects of DC on biofilm-associated persister cells.  
P. aeruginosa PAO1 biofilms were formed on sterile SS304 coupons (3.5 cm x 0.95 cm x 
0.05 cm). Briefly, an overnight culture of P. aeruginosa PAO1 was used to inoculate a 
petri dish containing 20 mL of LB medium and sterile coupons. The culture was 
incubated for 24 h at 37°C without shaking to allow biofilms to form on the coupons. The 
coupons with attached biofilms were then removed from the petri dish using sterile 
forceps and washed gently three times with sterile 0.85% NaCl solution. The control 
coupons were transferred to a 15 mL polystyrene conical tube (BD Falcon, Becton 
Dickinson and Company, Franklin Lakes, NJ) containing 8 mL of 0.85% NaCl solution 
and the biofilm cells were released from the surface by sonication for 1 min (Ultrasonic 
cleaner Model No B200, Sinosonic Industrial Co., Ltd, Taipei Hsien, Taiwan) to assess 
the total number of cells. Then the suspension was treated with 200 µg/mL Cip to count 
the CFU of viable persister cells. Other biofilm coupons were used either as working or 
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counter electrodes. According to the setup, the oxidation of the SS304 occurred at the 
working electrode. Therefore, a biofilm coupon was referred to as anodic biofilm (AB) 
electrode when it was set as the working (positively charged) electrode of the potentiostat 
or as cathodic biofilm (CB) electrode when the biofilm coupon was placed as the counter 
(negatively charged) electrode in the electrochemical cell. In either case, the biofilm was 
treated galvanostatically with 70 µA/cm
2 
DC for 30 min in the presence and absence of 
15 µg/mL Tob. Higher Tob concentration was used for biofilms due to the intrinsic 
tolerance of biofilms. Each coupon was then transferred to a 15 mL polystyrene conical 
tube containing 8 mL of 0.85% NaCl solution and the cells were removed from the 
surface by sonication for 1 min after treatment. The number of viable cells detached from 
the biofilm during DC treatments (in the 0.85% NaCl solution) was also quantified by 
counting the CFU in the solution. Each sample containing cells was also incubated with 
200 µg/mL Cip at 37°C for 3.5 h to isolate biofilms-associated persister cells. The total 
numbers of cells (without Cip treatment) and persisters (with Cip treatment) were 
quantified by counting CFU as described above. 
 
3.3.7. Effects of SS304 electrolytes.  
To understand if the effects of DC on persister cells were due to the chemical species 
generated by the electrochemical reactions, 0.85% NaCl solution without bacterial cells 
was treated with the same level of DC (70 µA/cm
2 
generated using SS304 electrodes) for 
20, 40 and 60 min, respectively. Then the P. aeruginosa PAO1 persister cells were 
incubated in these pretreated 0.85% NaCl solutions for 1 h with and without 1.5 µg/mL 
Tob. The untreated control samples were exposed to 0.85% NaCl solution without an DC 
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for 1 h in the presence or absence of 1.5 µg/mL Tob. The CFU of each sample was 
quantified as described above after treatment. To understand if the movement of ions or 
some short-life chemical species are important to ECCP, P. aeruginosa PAO1 persister 
cells were resuspended in a 0.85% NaCl solution that was pretreated with 70 µA/cm
2
 DC 
for 1 h (with SS304 in the absence of cells). Then 70 µA/cm
2
 DC was applied to treat 
persister cells using carbon electrodes in the presence of electrolytes generated by SS304 
electrodes. Samples were taken every 20 min to monitor the cell viability by counting 
CFU. This experiment was conducted with three replicates and consistent results were 
obtained. 
 
3.3.8. Susceptibility of P. aeruginosa PAO1 persisters to electrochemically generated 
ions.  
To further investigate the mechanism of the ECCP, we characterized the effects of the 
ions electrochemically released from SS304 on PAO1 persister cells. The elements of 
released ions were identified using inductively coupled plasma mass spectrometry (ICP-
MS).  The principle of the ICP-MS analysis is to sort the atoms of a sample based on 
their atom-to-charge ratio. The samples collected at several time points (20 min, 1 h and 
2 h) of the DC-treated 0.85% NaCl solution were diluted by 1000 fold using 0.85% NaCl 
solution; and then vaporized and ionized with high temperature argon plasma in the 
vacuum chamber of a quadrupole mass spectrometer. The Perkin-Elmer ELAN
®
 6000 
ICP-MS system (Perkin-Elmer, Inc., San Jose, CA) was used to determine the 
concentrations of the most abundant metal cations released from carbon and SS304 
electrodes. To specifically study the effects of the ions identified by ICP-MS, Fe
2+
, Fe
3+
, 
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Cr
2+
, Cr
3+
, Cr
6+
, Mn
2+
 and Ni
2+
 ions (from Sigma) were tested against P. aeruginosa 
PAO1 persister cells. Stock solutions of these cations were prepared and diluted in a 10× 
series using 0.85% NaCl solution. Persister cells isolated from stationary phase cultures 
of P. aeruginosa PAO1, as described above, were washed and resuspended in 0.85% 
NaCl solution containing different concentrations of cations to an OD600 of 0.7. The 
persister cells were then incubated at 37°C for 1 h with shaking at 200 rpm. The CFU of 
each sample was quantified before and after exposure to the ions. To understand if any 
ions are responsible for persister control, the effects of these seven ions on persisters 
were also evaluated in the presence of 70 µA/cm
2 
DC generated with carbon electrodes. 
CFU was quantified at 20 min interval over 1 h of the DC treatment to determine the cell 
viability. 
 
3.3.9. Statistical analysis. 
Minitab ® 16 Software was used to conduct t-test and one-way ANOVA analyses. 
Differences with p < 0.05 were considered as statistically significant. 
 
3.4. RESULTS 
3.4.1. Isolation of P. aeruginosa PAO1 persister cells.  
An important characteristic of persister cells is their capability to survive the attack of 
antibiotics at concentrations well above the lethal dose for regular cells with the same 
genetic makeup 
5
. As shown in Fig. 1, the majority of P. aeruginosa PAO1 cells (isolated 
from stationary phase cultures) were killed by less than 50 μg/mL of Cip, while a small 
portion (~1%) survived the challenge of Cip at concentrations up to 200 μg/mL. Thus, 
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200 µg/mL was chosen to ensure the complete elimination of regular cells. In the 
stationary phase cultures, persister cells represented around 1% of the total population 
under our experimental condition. This result is comparable to P. aeruginosa persister 
population (0.1 - 2.5%) reported in the literature
9,10
.  
 
3.4.2. Effects of DC on planktonic persisters and regular cells of P. aeruginosa PAO1.  
P. aeruginosa PAO1 was found to be highly susceptible to low-level DC. Treatment with 
70 µA/cm
2 
DC using SS304 electrodes was found to effectively eliminate planktonic 
(suspended in liquid) persister cells. As shown in Fig. 2A, the viability of persister cells 
was reduced by ~2 logs after treatment for 60 min compared to the untreated control 
(one-way ANOVA, p < 0.001). The same current level was also found effective against 
planktonic regular cells in stationary phase (represented by the total stationary phase cells, 
99% of which are regular cells). For example, around 2 logs of killing were achieved 
after treatment with 70 µA/cm
2 
DC for 60 min (Fig. 2B). Compared to the regular and 
persister cells in stationary cultures, the treatment was found more effective against 
regular planktonic cells in exponential phase (represented by total cells from exponential 
cultures, 99.9% of which are regular cells) since no viable cells were identified after 
treatment for 60 min (Fig. 2C). These data suggest that low-level DCs are effective 
against P. aeruginosa PAO1 in both exponential (with rapid growth) and stationary (with 
no net growth but metabolically active cells) phases and in persister stage. Importantly, 
the above data suggest that the efficacy of DC on persister cells is comparable to that on 
regular cells in stationary phase. These effects are advantageous compared to antibiotics, 
most of which are ineffective against slow growing cells and persisters 
28-30
. 
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3.4.3. Synergistic effects between DC and Tob.  
In addition to rapid elimination of persister cells by DC alone, synergistic effects were 
also observed between DC and the antibiotic Tob. Tob at 1.5 µg/mL was selected as it 
reduced specific growth rate of PAO1 by 50% (data not shown) but did not kill existing 
cells (regular cells in exponential & stationary phases and persister cells) significantly 
(Fig. 2A, B&C). This allowed us to study the synergy with DC treatment more clearly. 
While treatment with 1.5 µg/mL Tob alone for 1 h had no significant effect on the 
viability of persister cells and total cells from stationary phase cultures (Fig. 2A&B), the 
cidal effects of DC treatment was improved by Tob when SS304 was used to mediate the 
DC treatment. As shown in Fig. 2A&B, treatment with 70 µA/cm
2
 DC alone for 60 min 
reduced the number of viable persister cells and total cells in stationary phase (99% as 
normal cells) by 97.7 ± 1.7% and 99.7 ± 0.0% (less than 3 logs), respectively. In 
comparison, treatment with 70 µA/cm
2 
DC and 1.5 µg/mL Tob together caused around 5 
logs of killing in both cases (one-way ANOVA, p< 0.001 for both cases). This 100 - 1000 
times of enhancement in efficacy demonstrated a clear synergy between the DC treatment 
and Tob in killing PAO1 including persister cells. We named this interesting 
phenomenon as electrochemical control of persisters (ECCP). Synergistic effects between 
DC and Tob were also observed during treatment of exponential cultures. While the DC 
treatment exhibited rapid killing of P. aeruginosa PAO1 cells in exponential phase (99.9% 
as regular cells), the cells were eradicated 20 min sooner when treated with the same 
level of DC in the presence of 1.5 µg/mL Tob (Fig. 2C). Compared to Tob, however, no 
apparent synergy was found with the other three antibiotics tested including Cm, Kan and 
Spec (data not shown). In particular, it is interesting that no synergy was observed 
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between DC and Kan. Tob and Kan are both aminoglycosides targeting bacterial protein 
synthesis. These two antibiotics have similar structures but the number and position of –
OH and –NH2 groups vary slightly. These variations may be responsible for the 
difference in their antimicrobial effects against P. aeruginosa, difference in interaction 
with ions, and consequently their effects in persister control with DC. Collectively, these 
findings suggest that the right combination of ions and antibiotics should be used to 
obtain ECCP against a specific bacterial species. 
 
3.4.4. Effects of electrode materials.  
To understand if ECCP can also be achieved using other electrode materials and to 
understand the effects of electrochemically generated ions, the above experiments were 
repeated using carbon electrodes. It was found that the same DC level mediated by 
carbon electrodes was also effective in killing persister cells, although the effects were 
slightly less compared to SS304 electrodes. When treated with 70 µA/cm
2
 DC using 
SS304 electrodes, the number of viable persister cells isolated from stationary phase 
cultures was reduced by about 2 logs (97.7 ± 1.7%) in 60 min (Fig. 2A); while the killing 
achieved with the same current density using carbon electrodes was 95.6 ± 5.4% (Fig. 3). 
Also, no clear synergy with antibiotics was noticed when carbon was used as the 
electrode material. As shown in Fig 3, DC treatment using carbon electrodes in the 
absence and presence of Tob exhibited 95.6 ± 5.4% and 96.0 ± 5.4% killing of persister 
cells, respectively (one-way ANOVA, p = 0.43). Different potentials were required for 
SS304 and carbon working electrodes to maintain the same current level (70 µA/cm
2 
DC). 
When SS304 was used as electrodes, the voltage applied gradually decreased from 400 
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mV to 100 mV in 60 min. In comparison, the potential required to maintain 70 µA/cm
2
 
DC for carbon electrodes increased from 500 mV to 800 mV during treatment (Fig. S2). 
This difference is likely due to the different redox reactions that occurred at the electrode 
surfaces and the subsequent changes in the electrode surfaces. Such differences may 
cause different potencies in persister control by these two electrode materials. However, 
the finding that the same DC level generated with carbon electrodes was also effective in 
killing persister cells suggests that certain electrochemical products, such as reactive 
oxygen species may be important (see discussion below).    
 
3.4.5. Effects of DC on biofilm-associated persister cells.  
In addition to planktonic persisters, the effects of DC on biofilm-associated persisters 
were also studied. Similar to the persister population found in the stationary culture of 
PAO1, the persisters in our PAO1 biofilms was also found to represent around 1% of the 
total number of biofilm cells. This is higher than 0.1% reported in a previous study 
10
, 
presumably due to difference in culture conditions. The results shown in Fig. 4A&B 
indicate that the sign of the current (+: anodic; -: cathodic) plays an important role in 
killing biofilms-associated persisters. For the biofilms on the anodes, although the total 
number of PAO1 biofilm cells were reduced by 67.1 ± 5.9% (t test, p = 0.001) compared 
to the control, the number of persister cells were not significantly reduced by DC (t test, p 
= 0.47, Fig. 4A). In contrast, on the cathodic biofilm electrodes (negatively biased), the 
total number of biofilm cells was reduced by 85.9 ± 3.0% with the DC treatment only (t 
test, p < 0.001, Fig 4A), although the percentage of persister cells was not significantly 
reduced (t test, p = 0.15). The presence of 15 µg/mL Tob significantly increased the 
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efficacy of the DC (a higher concentration of Tob was used here since biofilms are more 
tolerant to antibiotics than planktonic cells). On the cathode, for example, the total 
number of biofilm cells was reduced by 97.1 ± 1.0% (t test, p < 0.001) and only 31.5 ± 
10.0% of persisters survived the treatment (t test, p = 0.04) (Fig. 4B), indicating a 
synergy in killing biofilm-associated persister cells. Collectively, the above data suggest 
that the cathode was more effective than the anode in killing biofilms- associated cells 
(both regular and persister cells) (one-way ANOVA, p < 0.007 in both cases). The 
finding that DC is more potent against the biofilms on cathodes suggests that the presence 
of reduction products is important for ECCP (see Discussion section below).  
 
To further study the effects on biofilm-associated persisters, the impact of longer 
DC treatment on cathodic biofilms-associated persister cells was also investigated in the 
absence and presence of Tob. As shown in Fig. 5A, the killing of biofilm-associated 
persister cells was 95.9 ± 4.0% after 2 h of DC treatment in the absence of Tob. In 
comparison, the DC treatments of biofilms on the cathode with 70 µA/cm
2 
DC for 1 and 
2 h were more effective with the addition of 15 µg/mL Tob (Fig. 5B). The viability of 
biofilm-associated persister cells was reduced by 99.4 ± 0.1% after 2 h of treatment (one-
way ANOVA, p < 0.006, for both cases), consistent with the synergy observed with 30 
min treatment.  
 
3.4.6. Effects of electrolytes generated by SS304 electrodes.  
As described above, the SS304 electrodes were found more effective than carbon 
electrodes in killing persister cells with the same level of DC. This finding led to the 
 60 
question that if some of the electrochemical products generated by SS304 are highly 
effective in killing persister cells. To answer this question, the effects of electrochemical 
products were tested. As shown in Fig 6, exposure of PAO1 persister cells to SS304 ions 
released after 20, 40 and 60 min treatment of 0.85% NaCl solution with 70 µA/cm
2 
DC 
did not significantly affect the viability of cells. Compared to the control sample 
incubated for 1 h in untreated 0.85% NaCl solution, none of the treatments with SS304 
electrolytes reduced the number of viable PAO1 persister cells by more than one log. In 
addition, no clear synergy was observed between the pretreated 0.85% NaCl solution and 
1.5 µg/mL Tob (t-test, p > 0.17 for all conditions). These results suggest that the 
electrochemical products released by SS304 alone are not sufficient to cause the same 
level of killing as DC exhibited. Thus, the movement of ions or the presence of some 
other short-life species generated by DC may be important for eradication of persister 
cells achieved using SS304 electrodes. To test this hypothesis, PAO1 persister cells were 
treated for 1 h with 70 µA/cm
2
 DC using carbon electrodes in 0.85% NaCl solution 
pretreated with SS304 electrodes as described above. While 95.6 ± 5.4% of persister cells 
were eradicated by the treatment using carbon electrodes alone, 98.4 ± 2.0% (around 2 
logs, one-way ANOVA, p < 0.001) were killed with the addition of electrolytes generated 
by SS304 electrodes (Fig. 3). Thus, DC treatment using carbon electrodes and a solution 
containing SS304 electrolyte exhibited stronger antimicrobial activities on persisters than 
the treatment using carbon electrodes alone. Moreover, DC treatment using carbon 
electrodes with SS304 electrolytes (Fig. 3) exhibited efficacy in persister killing similar 
to the treatment using SS304 electrodes alone (Fig. 2A)  (98.4 ± 2.0% vs. 97.7 ± 1.7%), 
however, no synergy with Tob was observed by using carbon electrodes (Fig. 3) (one-
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way ANOVA, p = 0.31). These results indicate that the movement of ions or other 
charged electrochemical products and the presence of some cathodically generated 
chemical species may be important for ECCP. 
 
3.4.7. Susceptibility of P. aeruginosa PAO1 persisters to the electrochemically 
generated ions.  
The data from ICP-MS analysis of 0.85% NaCl solution pretreated with 70 µA/cm
2 
DC 
using SS304 electrodes showed that the amounts of Fe, Cr, Ni, and Mn ions released 
during the treatment increased over time (Fig. S3). By applying 70 µA/cm
2 
DC with 
SS304 electrodes, 0.82 µM Fe, 0.27 µM Cr, 0.10 µM Ni and 0.02 µM Mn were released 
within 1 h. These concentrations of Fe, Cr, Ni and Mn represent 67.8%, 22.3%, 8.3% and 
1.6%, respectively, of the amount of total ions released during the treatment using SS304. 
However, only trace amount of Cr, Ni and Mn (ranging from 1-10 nM) was released by 1 
h of treatment mediated with carbon electrodes.  
 
To test the effects of each ion species specifically, the PAO1 cells were exposed 
for 1 h to various concentrations of the ions at different oxidation states. The results 
showed that, without an electrical field, PAO1 persisters could tolerate at least 40.6 µM 
Fe
3+
, 251.4 µM Fe
2+
, 150.0 µM Cr
6+
, 150.0 µM Cr
3+
, 4.0 µM Cr
2+
, 10 µM Ni
2+
, 10 µM 
Mn
2+ 
(Fig. S4). These concentrations are about 50-300, 15-560, 100 and 500 times higher 
than the concentrations of Fe, Cr, Ni and Mn detected in the 0.85% NaCl solution 
pretreated for 1 h with 70 µA/cm
2 
DC, respectively. Thus, the presence of any of these 
ions themselves is not sufficient for killing PAO1 persister cells. 
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The above finding supports our hypothesis that the movement of some of these 
ions might be important for ECCP. To further test this hypothesis, the effects of these 
seven ions on persister cells were investigated in the presence of 70 µA/cm
2 
DC 
generated with carbon electrodes. According to the results shown in Fig. 7A, Fe
2+
, Fe
3+
, 
Cr
2+
, Cr
3+
 and Cr
6+
 ions were found more effective than Mn
2+
 and Ni
2+
 ions in killing 
PAO1 persister cells in the presence of 70 µA/cm
2
 DC. Since treatment using anodic 
carbon electrodes in the absence of these ions only reduced persister viability by around 1 
log and the ions were not effective without a DC, the movement of these ions or 
electrochemical conversion of them to a particular state and the generation of reactive 
oxygen species (see Discussion) may be important for ECCP.  
 
To understand if any specific ions released from SS304 by DC may have synergy 
with Tob during ECCP, we repeated the above experiment in the presence of 1.5 µg/mL 
Tob. The data demonstrated that the activity of some ions could be altered by Tob. The 
most apparent effects were observed for 60 min treatments. As shown in Fig. 7B, the 
effects of Cr
2+
 and Cr
6+
 on killing persister cells with DC was significantly compromised 
by Tob (t test, p < 0.001 for both ions). In comparison, Ni
2+
, Cr
3+
 and Fe
2+
 exhibited 
synergy with Tob with 84.5 ± 1.2%, 38.1 ± 5.7% and 20 ± 7.4% additional killing, 
respectively, compared to Tob-free samples (t test, p < 0.001 for all conditions). These 
results confirmed that specific interactions between ions and antibiotics could alter the 
efficacy of ECCP. 
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To understand the kinetics of release of Fe
2+
 and Fe
3+
 and their roles in the killing 
of persisters during DC treatment with SS304 electrodes, DC polarization curves of 
carbon, SS304 and Fe were recorded. Using the same electrochemical cell described in 
Fig. S1, anodic polarization tests of SS304, carbon and 99.5% c.p. Fe electrodes were 
performed in sterile 0.85% NaCl solution. A voltammogram was recorded from -2 V to 1 
V (vs. Ag/AgCl potential) at a polarization scan rate of 1 mV/s to obtain the polarization 
curves of SS304, carbon and Fe. Under the tested condition, Fe electrodes displayed a 
corrosion potential (Ecorr) of -900 mV (vs. Ag/AgCl potential). As shown in the Fig. S5, 
Fe underwent active corrosion for all potentials above -900 mV. This finding suggests 
that Fe was continuously converted to Fe
2+
 or Fe
3+
 until the anodic current density 
reached 10 mA/cm
2 
DC. SS304 electrodes, however, displayed a double corrosion 
behavior separated by a passivation phase. The initial active corrosion of SS304 was 
short and occurred at potential comprised between the open-circuit potential (OCP, -700 
mV) and -500 mV (vs. Ag/AgCl potential). The passivation of SS304 electrodes was 
initiated at a potential of -500 mV and was completed at -100 mV. The potentiodynamic 
curve (Fig. S2) of treatment with 70 µA/cm
2 
DC revealed that the potential due to our DC 
treatment using SS304 fell in the range of passivation of the material (-500 mV to 500 
mV, Fig. S5). In contrast, carbon electrode underwent anodic corrosion associated with 
an increased potential (Ecorr) of -100 mV. This corroborates the finding that the voltage of 
DC treatment with carbon electrodes almost doubled in 1 h (increased from 500 mV to 
800 mV).    
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3.5. DISCUSSION 
Previous works proposed a few possible mechanisms by which electric currents 
affect bacterial cells. For instance, generation of high voltage across the cell membrane of 
microorganisms induced structural changes by depolarization, which can lead to cell 
death 
31
. The diffusion of fast moving ions and antibiotics into biofilms was also 
suggested as a mechanism of the bioelectric effect in that the permeability of the biofilm 
matrix was enhanced and the most inner cells were exposed to antimicrobials 
15,21
. In this 
study, we discovered that drug-tolerant bacterial persister cells can be eliminated by low 
level DCs and synergistic effects exist between DCs and certain antibiotics, e.g. Tob. We 
refer to this phenomenon as electrochemical control of persisters (ECCP). Although the 
mechanism of ECCP is not fully understood, our data suggest that the presence of certain 
transient reductive species including reactive oxygen species at the cathode and the 
movement of metal cations may be essential. We expect that electrochemical currents 
conducted using various materials could result in different ions released and consequently 
affect bacterial viability differently. Carbon and SS304 were used in this study as 
representative electrode materials. It is interesting to note that, while both electrodes were 
effective in delivering DC to kill persister cells, synergy with Tob was only observed for 
SS304 electrodes, but not carbon electrodes. DC treatment using SS304 was more potent 
than what was obtained using carbon electrodes and a lower voltage was required for 
maintaining the same current level (70 µA/cm
2 
DC). The most abundant elements in 
SS304 are Cr (18-20%), Ni (8-10.5%) and Fe (~ 66%). Because carbon electrodes release 
only trace amounts of Cr and are also effective in killing persister cells, Cr is not 
necessary for ECCP. As shown in the polarization curves (Fig. S5), SS304 electrodes 
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displayed corrosion behavior that was different from that of carbon and pure Fe 
electrodes. Initially, anodic corrosion of SS304 occurs with the oxidization of Fe at low 
negative voltages, followed by passivation of the material at a higher potential (around -
500 mV). Typically during passivation of SS304, ultra-thin films of metal oxide of Cr2O3, 
Fe2O3, or FeO form on its surface (between -500 mV and 400 mV), preventing further 
active corrosion of the metal. These thin film oxides normally provide resistance to 
corrosion. In our case, only SS304 exhibited a spontaneous passivation behavior. The 
current density associated with the formation of the passive film was 10 µA/cm
2 
DC, 
which is lower than the 70 µA/cm
2 
DC used for the ECCP experiments. This implies that 
the voltages needed initially were above the breakdown potential for SS304 which 
resulted in the induction of pitting. Once pitting is initiated, the voltage required to 
propagate the pits became much lower as seen in Fig. S2. These results indicate that, 
during the treatment of persisters, the working electrode of SS304 underwent pitting 
corrosion, which can possibly lead to the formation of Fe
2+
/Fe
3+
, Cr
3+
, Mn
2+
, Ni
2+
, OH
-
, 
and Cl
-
. The natural capability of SS304 to resist to corrosion is due to the presence of Cr 
which forms passive films. As reported by Qiu et al. 
32
, Cr constitutes 80% of the 
passivation film formed in response to galvanic corrosion of SS304. On the other hand, 
Ni adds to the resistance of SS304 to corrosion by lowering the passive current density 
(like a noble material) and allowing this protection to happen at lower voltages during 
corrosion 
32-34
.  
 
The contribution of the cathode in ECCP has also been exemplified with the 
enhanced cell killing in our cathodic biofilms (Figs. 4&5). The cathode (counter electrode) 
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attains a potential necessary to maintain the current density whenever a change occurs in 
the resistance of the anode. This goes along with the type of reactions that should occur 
on each electrode. Typically, the electrochemical reaction of iron may generate ferric 
cations on the anode, but reactive oxygen species (ROS) on the cathode. Some possible 
reactions of the electrochemical treatment of SS304 under our experimental condition are 
35
: 
Oxidation reaction 
Fe → Fe2+ + 2e- 
Fe
2+→ Fe3+ + e- 
2Cr + 3H2O → Cr2O3 + 6H+ + 6e- 
2H2O → H2O2 + 2H
+
+ 2e
-
 
Fe
2+
 + H2O2→ Fe
3+
 + 
•
OH + OH
-
 
 
Reduction reactions  
O2 + H2O + e
-
 → HO2
•
 + OH
-
 
H2O2 + 2e
-
 → 2OH - 
O2 + 2H2O + 4e
- → 4OH- 
O2 + 2H2O + 2e
- → H2O2 + 2OH
- 
2 Fe
3+
 + 2 e
-→ 2 Fe2+ 
Fe
3+
 + H2O2→ Fe
2+
 + 
•
OOH + H
+
 
2 Fe
3+
 + 2H2O →2 Fe
2+
 + H2O2 + 2 H
+ 
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The killing achieved with carbon electrodes, which do not release any cation 
significantly, suggests that the byproducts of electrochemical reactions generated at the 
counter electrode or cathode may be involved in the phenomenon of ECCP as well. The 
graphite sheet used for the carbon electrodes is made with 99.5% of very fine grains of 
carbon that could be released from the anode during the treatment. Also, it is well 
documented that at pH between 6.5 and 9, the electrolysis of graphite in water generates 
carbonates (HCO3
-
) at an electrode potential of 0.4V and progressively releases CO2 
when the potential approaches 1V 
33
. Thus, in our 0.85% NaCl solution-electrode system, 
DC treatment may generate oxygen species such as hydrogen peroxide (H2O2), hydroxyl 
radical (
•
OH), hypochlorous acid (HOCl), and other short-live species at the cathode of 
both electrode materials. These agents may be the reason of the similitude in the persister 
killing experienced with the DC treatments using either electrode materials without an 
antibiotic. However, the synergistic killing effects recorded in the treatment using SS304 
and Tob indicate that Fe ions may contribute to a greater extent to ECCP against P. 
aerugionsa. One interesting observation of treatment with carbon electrodes was the 
increase in resistance of the treated cell suspension over time (doubled progressively over 
one hour of experiment), which may also be due to the release of the carbon particles 
within the solution. This increase in resistance consequently increased the voltage 
required for maintaining the current level, which in turn could alter the electrochemical 
reactions and have an adverse effect on the synergy with antibiotics under certain 
conditions. On the other hand, Fe is the most abundant element released from the anode 
of SS304 as shown by the ICP-MS analysis (Fig. S3). The anodic breakdown of the oxide 
film and the pitting corrosion of SS304 induced a significant drop of the material 
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resistance and consequently a voltage decrease. Because the synergy with Tob is 
observed with SS304, but not with carbon electrode, optimization of the electrode 
materials is expected to further improve the efficacy of ECCP. Different bacterial species 
may also respond to ECCP differently and it will be interesting to test the effects of ECs 
on the persister cells of different bacterial species to identify the general and species-
specific effects. 
 
While persisters can tolerate very high concentrations of Cr and Fe ions, they 
become susceptible to low concentrations of the same ions in the presence of an electrical 
field (Fig. S4 & Fig. 7). The synergistic effects between DC and Tob proved that the 
tolerance of persisters to antibiotics can be altered by low level DC. The effects of DCs 
on persister cells at the genetic level are still unknown. We reported recently that similar 
DC treatment induced Bacillus subtilis genes responsible for ions transport 
36
. The effects 
of DC on the membrane structure and function of persister cells and permeability to 
antibiotics, however, are yet to be explored and are part of our ongoing work. We 
hypothesize that certain levels of electrochemical current (EC) may positively (wakeup) 
or negatively (killing) affect these targets and provide new mechanisms to kill bacterial 
persister cells. In addition to antibiotics, DC may also have synergy with other factors. 
We recently discovered that the human immune factor, granulocyte-macrophage colony-
stimulating factor (GM-CSF) has remarkable activities to sensitize bacterial persister 
cells to antibiotics (Choudhary et al. unpublished). It will be interesting to test if DC has 
synergy with this and other immune factors in persister control as well.  
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Elimination of persister cells with low-level EC and synergy with antibiotics has 
promising applications in infection control. Such treatments are expected to be safe to 
humans and the environment; e.g., longer duration of treatments at similar or higher EC 
levels have been shown to stimulate the proliferation of fibroblasts by increasing collagen 
and DNA synthesis, to trigger migration of immune cells, and to promote the healing of 
lower extremity wounds 
37
. Further knowledge on these topics will help understand the 
mechanism of persister formation and associated tolerance to antimicrobials. It will also 
facilitate the development of more effective infection control through local delivery of 
low level ECs to implanted medical devices and skin. For example, by applying an 
appropriate EC and antibiotics through the area of skin with bacterial infection may help 
eliminate persister cells and promote healing. Alternatively, metallic components of an 
implanted medical device can be used as electrodes to help eliminate persister cells and 
associated biofilms.  
 
3.6. CONCLUSIONS 
 Overall, this study demonstrated that bacterial persister cells can be efficiently 
killed with low level DCs and synergy with tobramycin. Such electrochemical control is 
effective against both planktonic and biofilm persisters, and only requires DCs at µA/cm
2
 
level and less than 60 min. Comparison between carbon and SS304 electrodes in killing 
persisters indicated that transient chemical species generated during reduction reaction of 
the electrode material may be essential for ECCP. In addition, the movement of the metal 
cations from the working electrodes could play an important role in the control of 
persisters and the synergy with antibiotics.  
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FIGURE CAPTIONS 
Figure 3.1. Viability of P. aeruginosa PAO1 cells after 3.5 h treatment of planktonic 
stationary cultures with different concentrations of Cip. Five replicates were 
tested for each condition. Means and standard errors are shown. 
Figure 3.2. Effects of DC treatment using SS 304 electrodes on planktonic P. 
aeruginosa PAO1 cells. All samples were treated with 70 µA/cm
2
 DC for 1 
h with and without 1.5 µg/mL Tob. (A) Planktonic persister cells. (B) 
Regular cells in stationary phase. (C) Regular cells in exponential phase. 
Four replicates were tested for each condition. Means and standard errors 
are shown.  
Figure 3.3. Effects of DC treatment using carbon electrodes on planktonic P. 
aeruginosa PAO1 persister cells. Addition of SS 304-electrolytes from DC-
treated 0.85% NaCl solution enhanced the killing of persister cells by 70 
µA/cm
2
 DC mediated with carbon electrodes. The electrolytes were 
generated by treating 0.85% NaCl solution with 70 µA/cm
2
 DC for 1 h using 
SS 304 electrodes. Six replicates were tested for each condition. Means and 
standard errors are shown.  
Figure 3.4. Effects of DC on persisters and regular cells in biofilms. Cathodic and 
anodic P. aeruginosa PAO1 biofilms were formed on SS 304 coupons (with 
24h incubation) and treated with 70 µA/cm
2
DC for 30 min in the presence 
or absence of 15 µg/mL Tob. The cells were collected from the coupons by 
sonication and the persister population was isolated after treatment with 200 
µg/mL Cip for 3.5 h. The viability of the cathodic and anodic biofilm cells 
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was compared to the untreated control. (A) DC treatment only. (B) DC 
treatment with 15 µg/mL Tob. Four replicates were tested for each condition. 
Means and standard errors are shown. 
Figure 3.5. Effects of longer EC treatment on persisters and regular cells in cathodic 
biofilms. Cathodic P. aeruginosa PAO1 biofilms were formed on SS 304 
coupons and treated with 70 µA/cm
2
 DC for 1 and 2 h in the presence or 
absence of 15 µg/mL Tob. The cells were collected from the coupons by 
sonication and the persister population was isolated after treatment with 200 
µg/mL Cip for 3.5 h. The viability of the cathodic and anodic biofilm cells 
was compared to the untreated control. (A) DC treatment only. (B) DC 
treatment with 15 µg/mL Tob. Two replicates were tested for each condition. 
Means and standard errors are shown. 
Figure 3.6. Effects of SS 304-generated electrolytes on P. aeruginosa PAO1 persister 
cells. Sterile 0.85% NaCl solution was pretreated for 20, 40 or 60 min with 
70 µA/cm
2
 EC and the persister cells were exposed to the electrolytes for 1 
h in the presence or absence of 1.5 µg/mL Tob. The untreated control 
sample was exposed to 0.85% NaCl solution only for 1 h in the presence or 
absence of 1.5 µg/mL Tob. The number of viable cells was quantified by 
counting by CFU. Three replicates were tested for each condition. Means 
and standard errors are shown. 
Figure 3.7. Effects of metal cations at different oxidation states on PAO1 persister cells 
during EC treatment mediated with carbon electrodes. PAO1 persisters were 
resuspended in 0.85% NaCl solution containing Fe2+, Fe3+, Cr2+, Cr3+, 
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Cr6+, Ni2+, Mn2+ at the same concentrations released after 70 µA/cm2 DC 
treatment for 1 h using SS 304 electrodes. (A) DC treatment only. (B) DC 
treatment with 1.5 µg/mL Tob. At least two replicates were tested for each 
condition. Means and standard errors are shown.  
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Figure 3.3 
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Figure 3.6 
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Figure 3.7  
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CHAPTER 4  
PERSISTER CONTROL USING TGON 805 IN SINGLE AND DUAL 
CHAMBER SYSTEMS 
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4.1. ABSTRACT 
Electrochemical treatment of bacteria is a promising approach since it is effective 
in killing both the normal and persister cells. To further develop this technology for 
possible medical applications, it is important to understand the killing mechanisms of the 
electrochemical currents. In this chapter, the activity of the electrical field/potential, 
currents density and electrochemically-generated ions were investigated to determine 
how the electrochemical factors could be optimized to improve persister control. 
Electrode materials including stainless steel (SS) 304 and TGON 805 (a graphite-based 
material with electrochemical property similar to carbon electrode) were employed to 
develop various electrochemical systems, and to test their effects on Pseudomonas 
aeruginosa persister cells. Our findings demonstrated that the increase of the current 
density from 35 μA/cm2 DC to 70 μA/cm2 DC using TGON 805 resulted in persister 
killing from 65% to 100%; however, no killing was observed when the TGON 805 
electrodes were separated in two individual chambers connected with a salt bridge. Under 
similar setting, the electrochemical species generated at cathodic SS 304 electrodes with 
70 μA/cm2 DC reduced the viability of persister cells by 99.6%. 
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4.2. INTRODUCTION 
Control of microorganisms with electrochemical factors has been of a great 
interest to the field of bioelectrochemistry, and has led to the development of novel 
strategies for sterilization
1,2
 and bioremediation
3,4
. However, the implementation of these 
techniques to control antibiotic-resistant bacterial infections remains challenging, in part 
due to the limited understanding of the electrophysiology of living cells, and lack of 
information regarding the electrochemical factors that affect cells.  
 
The improved understanding of bacterial biofilms and the discovery of the 
persister cells, a dormant and antibiotic-tolerant microbial subpopulation, have 
contributed to the development of novel approaches to control multi-drug resistance and 
chronic infections in vitro and in vivo. For instance, treatment of P. aeruginosa biofilm 
with 70 μA/cm2 DC can sensitize the treated cells to commonly used antibiotics such as 
Tob, Cip. DC was also found to enhance the activity of antibiotics on biofilm-embedded 
cells, a phenomenon referred to as bioelectric effects
5-7
. Moreover, metal cations in the 
mM range have been found to kill biofilm and persister cells. This is intriguing because 
DC treatment can also generate metal cations. However, as described in chapter 3, the 
metal ions alone (without DC) are not effective against persister cells, emphasizing on the 
importance of DC current. DC treatment of the persister cells of P. aeruginosa PAO1 
using carbon and SS 304 electrodes resulted in the killing of 95.6 ± 5.4% and 97.7 ± 
1.7%, respectively
9
. Under these conditions, the effects of the DC treatments were 
attributed to the electrochemical properties of the electrode materials and to the 
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movement of the electrochemical species and SS304-released cations generated during 
the treatments.  
 
The control of the Gram-positive and Gram-negative bacteria with direct or 
alternating electric currents and potentials has been demonstrated in many in vitro studies. 
For instance, electric field comprised between 1V to 4V and generated with silver-nylon 
material 
10
 or gold electrodes 
11
 exhibited antibacterial activities against P. aeruginosa, 
Staphylococcus aureus, and Escherichia coli. In studies focusing on direct currents (DC) 
at μA to mA levels, the cidal12 or inhibitory13 effects on bacterial cells have been 
demonstrated using platinum, gold, stainless steel (SS) electrodes. However, in the most 
experimental systems, the effects of electric current, electric potential and 
electrochemical products are mixed; it is challenging to determine what factors are the 
most important. In Chapter 3, we demonstrated that carbon electrodes can generate low 
level DC and kill PAO1 persister cells. However, we found that carbon electrode could 
also release carbon particles that hinder the study of the effects of carbon-mediated DC at 
the cellular level. Meanwhile, we learned that TGON was made out of graphite fibers, 
which could be convenient for further study. In this chapter, the response of persister 
cells to electrochemical currents and fields generated with SS304 and TGON 805 (a 
carbon-based electrode) was investigated in a single and dual chamber systems to study 
the electrochemical factors separately.  
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4.3. MATERIALS AND METHODS 
4.3.1. Bacterial strain and growth media.  
The wild-type P. aeruginosa PAO1 was cultured in Luria-Bertani (LB) medium 
15
 
containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. All overnight cultures 
were incubated at 37°C with shaking at 200 rpm.  
 
4.3.2. Colony Forming Units (CFUs). 
The colony forming units (CFUs) were counted to quantify the number of viable P. 
aeruginosa PAO1 cells before and during the electrochemical treatments. A volume of  
20 μL of each sample was diluted in a 10× series using 0.85% NaCl solution and 10 μL 
of the last 6 dilutions was plated on LB agar plates (1.5% agar). The CFUs were counted 
on the next day after incubation overnight at 37°C.  
 
4.3.3. Electrochemical properties of TGON 805 
TGON 805 was purchased from Laird Technologies (Schaumburg, IL, USA). The 
manufacturer describes TGON 805 as a material made with more than 98% carbon. 
Before the material was used for the study, the electrochemical properties of TGON 805 
were investigated. First, the composition of TGON 805 was examined using SEM with 
energy dispersive spectroscopy (SEM-EDS) (Joel 5600, Joel, Japan). To verify that the 
electrochemical properties of TGON 805 are similar to that of carbon, a polarization 
curve of TGON 805 was recorded over the range of -2 V to 1V, and compared to that of 
carbon, as reported in Chapter 3 (Fig. S3.5-Appendix I). 
 
 89 
4.3.4. Effects of the DC treatment using TGON 805 
The persister cells of P. aeruginosa PAO1 were isolated by treating the stationary phase 
cultures for 3.5 h with 200 µg/mL Cip. The harvested cells were washed twice with 0.85% 
NaCl solution, resuspended in 0.85% NaCl solution and treated with 35, 52.5 or 70 
µA/cm
2
 DC for 1 h. To deliver DC, an electrochemical cell was constructed by inserting 
two TGON 805 electrodes along the opposite sides of a plastic cuvette (Thermo Fisher 
Scientific, Pittsburg, PA). A silver wire (0.015” diameter, A-M Systems, Sequim, WA) 
was placed in bleach for 30 min to generate an Ag/AgCl reference electrode, which was 
then placed in the cuvette. DC was generated using a potentiostat (Potentiostat WaveNow, 
Pine Research Instrumentation, Raleigh, NC) in a 3-electrodes configuration as shown in 
Fig. 4.1. Using the AfterMath software (Potentiostat WaveNow, Pine Research 
Instrumentation, Raleigh, NC), a galvanostatic mode was selected to monitor the DC 
level and record the voltage across the electrochemical cell during the 1 h treatment. The 
cathodic potential was recorded using a voltmeter, while the anodic potential was 
recorded directly by the potentiostat. During the treatment, 100 µL of sample was taken 
every 20 min to evaluate the viability of PAO1 persister cells by counting CFU.  
 
4.3.5. Effects of TGON 805 –released ions 
In Chapter 3, we demonstrated that the electrochemical products generated by 70 µA/cm
2
 
DC using SS 304 did not affect the viability of PAO1 persister cells in the absence of 
DC
9
. To understand if the killing of the persister cells under DC using TGON were due to 
the chemical species generated by DC treatment using TGON 805, 0.85% NaCl solution 
without bacterial cells was treated with 70 µA/cm
2 
DC generated using TGON 805 
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electrodes for 20 min, 40 min and 60 min, respectively. Then the PAO1 persister cells 
were incubated in these pretreated 0.85% NaCl solutions for 1 h to evaluate the effects of 
electrochemical species generated by TGON 805. The untreated 0.85% NaCl solution 
was used as a control. Viability of PAO1 cells was determined by counting CFU as 
described above.  
 
4.3.6. Effects of electric field/potential 
According to our electrochemical setup in this thesis research, the oxidizing currents 
were generated by the working electrodes. To more specifically evaluate how the electric 
potential and the electrochemical species generated at the working and counter electrodes 
affect the viability of PAO1 persister cells, a 2-chamber electrochemical cell connected 
by a salt bridge was constructed (Fig. 4.2). The counter electrodes were introduced in one 
chamber (counter chamber) of the electrochemical cell, while working and the Ag/AgCl 
electrode were placed in the other chamber (working chamber). Three milliliters of the 
PAO1 persister cell suspensions (OD600 of 0.7) were introduced in the chambers to treat 
the cells in the galvanostatic mode with 70 µA/cm
2 
DC using SS304 and TGON 805 for 
60 min. The number of viable cells present in each chamber was quantified by counting 
CFU in the solution as described above. This configuration provided different set of 
parameter to evaluate the effects of the treatments on the persisters. Under this condition, 
the salt bridge had a resistance of 22 kΩ. Because of the high resistance of the salt bridge 
connecting the chambers, only local fields that were determined by the anodic electrode 
potential (Epa) or cathodic electrode potential (Epc) were present in each corresponding 
chamber. The current profiles in both the working and the counter chambers were the 
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same; however, different electrochemical gradients were established in the two chambers 
due to the specific types of species generated in each chamber. 
 
4.3.7. Statistical analysis. 
SAS Software was used to conduct t-test and one-way ANOVA. Differences with p < 
0.05 were considered as statistically significant. 
 
4.4. RESULTS 
4.4.1. Effects of DCs generated using TGON 805 in the single chamber system 
The electrochemical analysis of TGON 805 using SEM-EDS showed that 99.9% of 
TGON is made up of carbon. In contrast to previously used graphite electrodes (Chapter 
3), TGON exhibits interesting electrical properties because of its conductivity. The 
oxidation of TGON is initiated with a potential of -0.33 V vs. -0.07 V for carbon 
electrodes (Fig. 4.2), which suggests that TGON 805 could conduct electric current at 
lower potentials compared to carbon electrodes. To test the effects of the electrochemical 
currents generated using TGON 805 electrodes on PAO1 persister cells, the 
electrochemical cell shown in Fig. 4.1 was constructed to deliver different levels of DC 
and monitor the killing of PAO1 persister cells by counting CFUs. As shown in Fig. 4.3A, 
treatment of the persister cells with 70 μA/cm2 DC for 40 min resulted in eradication of 
PAO1 persister cells corresponding to 7 logs of killing. In comparison, treatment with 
52.5 μA/cm2 and 35 μA/cm2 DC for 60 min kill persister cells by 99.7 ± 0.0% (3 logs) 
and 65.1 ± 3.1 %, respectively. Although, similar electric fields were established under 
the current levels tested, the killing effects were highly different between 40 min and 60 
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min of treatment. Though, the killing effects were significantly different among three 
current levels, the electric potential varied very little (2.4 V – 2.7 V) and the electric 
potential during the treatment with 70 μA/cm2 DC was not significantly different from 
that with 52.5 μA/cm2 DC (one-way ANOVA, p=0.09). 
 
4.4.2. Effects of TGON 805-released electrochemical species  
To evaluate if the electrochemical products generated with the 70 μA/cm2 DC treatment 
using TGON 805 had bactericidal effects on the cells, the persister cells were exposed for 
1 h to 0.85% NaCl solutions pre-treated with 70 μA/cm2 DC using TGON 805 for 20 min, 
40 min and 60 min respectively. Fig. 4.4 shows that the exposure of PAO1 persister cells 
to 0.85% NaCl solutions pretreated with DC using TGON 805 significantly reduced the 
viability of the cells. The cell viability decreased by 61.4 ± 10.1% (one-way ANOVA, 
p=0.009) after 1 h incubation in the 20 min DC-treated 0.85% NaCl solution. No 
significant difference was found between the samples treated for 20 min, 40 min and 60 
min (one-way ANOVA, p>0.13). These results justified that some species generated 
during the treatment with 70 μA/cm2 DC using TGON 805 have cidal effects on PAO1 
persister cells. 
 
4.4.3. Effects of the electric potential 
To understand the importance of electric field in ECCP, the PAO1 persister cells were 
introduced in an electrochemical cell comprising counter and working chambers 
connected with a high resistance salt bridge. The persister cells were treated with 70 
μA/cm2 DC and the number of viable cells in the chambers was quantified over 1 h. As 
 93 
shown in Fig. 4.5A, the level of killing previously achieved in the single chamber system 
(with all three electrodes) with 70 μA/cm2 DC using TGON was not attained in the 2-
chamber system, suggesting that current density and the electrode potential were not 
enough for the complete eradication of the persister cells. However, more cells were 
found in the working chamber containing a positively charged anode, compared to the 
counter chamber with negatively charged cathode. The number of cells in the counter 
chamber was reduced by 47.7 ± 18.4% after 60 min of treatment, while the number of 
persister cells in the working chamber increased by 55.3 ± 18.7% during the same time 
period. However, the field profile of the chambers illustrated in Fig. 4.5B demonstrated 
that the Epa was stronger than the Epc. This led us to speculate if the persister response 
under this condition was linked to a galvanotaxic behavior or to the electrochemical 
species generated of in each chamber. 
 
To comprehend if the electrochemical species or the field profile was the most 
determining factors for persister control under this condition, the persister cells of PAO1 
were treated in the similar configuration using 70 μA/cm2 DC mediated using SS 304. As 
shown in Fig. 4.6A, the DC treatment resulted in persister cell killing, in both the 
working and the counter chambers. The number of viable persister cells in the counter 
chamber was 99.6 ± 0.3%, corresponding to 3 logs reduction in cell viability. In contrast, 
the number of persister cells in the working chamber was reduced by 73.8 ± 2.5%. 
Consistent with the treatment of the PAO1 persister cells with 70 μA/cm2 DC using 
TGON 805 in the 2-chamber system, improved killing activity was observed in the 
counter chamber. Unlike the treatment with TGON, however, the electric potential profile 
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of the electrodes showed that Epa was 10-15 times lower than the than Epc. The potential 
at the cathode was maintained as 1V, while the potential at the anode decreased from 0.2 
V to 0.05 V. The results suggest that the reduction of persister cell viability in the 
working chamber was not caused by the electric potential, but instead by the 
electrochemical products moved across the electrochemical cell. 
 
4.5. DISCUSSION 
This study investigated the response of PAO1 persister cells to electrochemical 
stresses generated under various settings. To comprehend the effects of some 
electrochemical factors on ECCP, two electrochemical cells were constructed, and the 
effects of electric field, electric potential, current density and generated electrochemical 
species were examined. Our results demonstrated that the control of the persister cells by 
low-level electrochemical currents is the most effective when all electrodes where 
inserted on a single chamber. By varying the current density between 35 and 70 μA/cm2 
DC, dose dependent killing of PAO1 persister cells was observed in TGON 805-mediated 
treatments. However, such changes in current density led to little variation in the electric 
field suggesting that the rate of the electrochemical reaction at the electrodes may be a 
determining factor in ECCP. In the dual chamber system, the oxidation of TGON 805 
occurred at the anode in the working chamber, while the generation of the reactive 
oxygen species (ROS), known for inducing cell killing through oxidative damage of the 
DNA
17,18
, occurred at the cathode. Consistently, more killing was observed for the cells 
in the counter chamber. The finding that 61% PAO1 persister cells were killed by TGON 
treated 0.85% NaCl solutions in the absence of DC suggests that ROS may play a role. 
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However, the electrochemical properties of electrode materials have a great 
impact on the persister cells. The anodic current density of 70 μA/cm2 DC generated with 
SS304 in the presence of a minimal electric potential comprised between 0.2 V and 0.05 
V resulted in 73.8 ± 2.5% decreased viability of the persister cells that are located in the 
working chamber. In contrast, a higher electric potential of 1V was generated in the 
working chamber during the 70μA/cm2 DC treatment using TGON 805. Under the latter 
condition, however, the anodic current density of 70 μA/cm2 DC failed to reduce the 
viability of persister cells. These results suggest that the movement of the metal cations 
resulting from the oxidation of SS304 may disrupt the integrity of the cells membrane 
and cause cells death, consistent with our previous finding (Chapter 4). In fact, 
intracellular accumulation of metal cations, such as those derived from iron or chromium 
elements, is well known to induce oxidation damage and cell killing
19-21
. Our data 
provide evidence that the rate of generation of specific cationic species (moving from the 
anode towards the cathode), instead of the difference in potential across of working 
chamber, controls the fate of PAO1 persister cells under these conditions.  
 
It is interesting that the electric potential of cathodic SS 304 and TGON 
electrodes were comparable (1V vs. 0.9V) to each other and the current density in both 
conditions was similar. However, the viability of the persister cells after the treatment 
with cathodic SS 304 electrode was reduced by 99.6 ± 0.3%, while the number of viable 
persisters under treatment with TGON electrodes was reduced by 55.3 ± 18.7%. Further 
study will help understand if the TGON 805-treated cells found in the counter chamber 
were killed or moved to the working chamber by galvanotaxis.  
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 Understanding the effects of the electrical potential, electric current and 
electrochemical products on the viability of bacteria is important for designing the in vivo 
study. Treatments of persister cells in the 2-chamber system provided valuable 
information for the design of in vivo model of electrochemical treatment. A major 
challenge in delivering appropriate levels of currents to deep tissue is linked to the 
resistance of skin and tissues. The 2-chamber configuration presents an interesting model 
to evaluate the effectiveness of an electrochemical treatment while accounting for the 
resistance in the path of the ionic flow. Our results revealed that the cathodic electrode 
potential and the related electrochemical species of SS304 contributed to the 
effectiveness of the treatment. Although TGON 805 was also very effective in 1-chamber 
configuration, the potency of the treatment was diminished in the 2-chamber system, 
suggesting that this material may perform poorly in vivo due to the impedance of animal 
tissues. In comparison, the effects of the electrochemical cationic species generated with 
SS304-mediated were significant. The findings of this study indicate that persister cells 
could be effectively controlled with cathodic current/potential, and suggest that SS 304 
may be appropriate for in vivo control of bacterial infections. 
 
4.6. CONCLUSIONS 
The comparative study of the effects of the electrochemical agents on the viability of 
persister cells had demonstrated that DC, electrical field/potential and the related 
electrochemical species contribute differently to the potency of the electrochemical 
systems. While the density at current flow and the type of ions moving across an 
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electrochemical cell directly impact the viability of cells, their effects could be enhanced 
in the presence of cathodic oxidative stress, and in the presence of a greater electric field. 
The 2-chamber electrochemical system revealed that effective control of persister cells 
could be achieved in spite of a high resistance in the path of the electrochemical flow, 
which could be experimented in infection models in vivo. 
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FIGURE CAPTIONS 
Figure 4.1. Schematic representation of the electrochemical cell system for generating 
electric currents in this study. The single chamber electrochemical cell (A) was 
constructed by inserting two electrodes (4.5 cm x 0.95 cm x 0.05 cm) in a 
plastic cuvette. The working, counter and reference electrodes were connected 
to a potentiostat to deliver the desired current. In the 2-chamber electrochemical 
cell (B) the working and the Ag/AgCl reference electrode were placed in the 
working chamber, while the counter electrode was introduced in the counter 
chamber. The chambers were connected by a salt bridge. 
Figure 4.2. SEM-EDS was performed to determine the composition of TGON. A 
representative SEM image (A) shows that TGON 805 is composed of graphite 
fibers. The polarization curve of TGON 805 electrodes is also shown (B). 
Voltages ranging from -2V to 1V (vs. Ag/AgCl potential) were generated across 
sterile 0.85% NaCl solution using TGON 805 electrodes.  Voltammograms 
were recorded at a polarization scan rate of 1 mV/s.  
Figure 4.3. Effects of DC treatment on P. aeruginosa PAO1 planktonic persister cells. 
All samples were treated in the 1-chamber electrochemical cell with 70 µA/cm
2
 
DC using TGON 805 for 1 h (A). The electric field of the treatment was 
recorded (B). 
Figure 4.4. The effects of TGON 805-generated electrolytes on P. aeruginosa PAO1 
persister cells. Sterile 0.85% NaCl buffer was pretreated for 0, 20, 40 or 60 min 
with 70 µA/cm
2
 DC and the persister cells were exposed to the electrolytes for 1 
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h in the absence of Tob or electrical current/field. The number of viable cells 
was quantified by counting CFU.  
Figure 4.5. Effects of DC treatment on P. aeruginosa PAO1 planktonic persister cells. 
All samples were treated in a 2-chamber electrochemical cell with 70 µA/cm
2
 
DC using TGON 805 for 1 h (A). The electric field of the treatment was 
recorded (B). 
Figure 4.6. Effects of DC treatment on P. aeruginosa PAO1 planktonic persister cells. 
All samples were treated in the 2-chamber electrochemical cell with 70 µA/cm
2
 
DC using SS 304 for 1 h (A). The electric field of the treatment was recorded 
(B). 
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CHAPTER 5 
 SENSITIZING PSEUDOMONAS AERUGINOSA CELLS TO ANTIBIOTICS BY 
ELECTROCHEMICAL DISRUPTION OF MEMBRANE FUNCTIONS 
 
 
 
 
 
 
 
Henry Lars Peterson contributed to the study of the protein expression of P. aeruginosa 
cells treated with direct current using SS 304 electrodes. Shiril Sivan contributed to the 
nanoindentation of the cells using AFM. 
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5.1 ABSTRACT 
The increasing prevalence of antibiotic-resistant bacteria referred to as ESKAPE 
pathogens (Enterococcus faecium, Staphylococus aureus, Klebsiella pneunomoniae, 
Acinetobacter baumanii, Pseudomonas aeruginosa, and Enterobacteriaceae) has 
presented a great challenge to infection control. P. aeruginosa in particular, in addition to 
its intrinsic multi-drug resistance, develop community protection mechanisms by forming 
multicellular structures, known as biofilms, which harbor a subpopulation of dormant 
cells such as the persister cells. Conventional methods of antibacterial treatment 
involving high doses of antibiotics or surgical interventions have proven insufficient for 
eradicating persistent infections associated with these structures. Recently, we reported 
that bacterial persister cells can be eliminated through synergistic effects between low-
level electric current and antibiotics, a phenomenon we named electrochemical control of 
persister cells (ECCP). To understand the mechanism of ECCP, the electrophysiological 
changes in P. aeruginosa cells induced by DC treatment were characterized at the cellular 
and genetic levels. TEM and SEM-EDS analyses revealed that DC treatments affected 
membrane integrity and functions of P. aeruginosa, owing to the increase in cellular 
concentration of metal ions and a subsequent change in the cell surface charge. DC 
treatments also led to the compartmentalization of cellular contents, release of outer 
membrane vesicles, and cell lysis. Moreover, electrochemical treatments mediated via 
carbon electrodes provoked the permeabilization of the cells, increased their 
susceptibility to antibiotics, and led to complete eradication of the persisters. These 
results provide new insight for designing novel systems to effectively control infections 
associated with biofilms and persister cells. 
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5.2. INTRODUCTION 
Each year, millions of medical devices with various complexities are implanted in 
humans to palliate failing body components. The implantation of biomaterials can lead to 
recurrent complications associated with the adherence of microbial pathogens on these 
devices and the development of chronic infections in the surrounding tissues. Such 
implant-associated infections account for around half of the cases of hospital-acquired 
infections. In the U.S. alone, 5% of the 2 million individuals receiving fracture fixation 
each year are infected with bacteria adhering to the implants. The incidence is even 
higher when it comes to ventricle-assisted heart implants, which have a 40% infection 
rate 
1
. According to the Center of Diseases Control, $45 billion was spent in 2007 to 
cover the inpatient services associated with infections acquired in US hospitals 
2
. This 
constitutes a high burden for the healthcare system and seriously affects the life quality of 
these patients 
3
.  
 
 Chronic and drug-tolerant infections remain as major challenge for modern 
medicine. In recent years, few antibiotics have been developed and approved by the U.S. 
Food and Drug Administration (FDA). In the past three decades (1980-2009), 29, 23 and 
9 antibiotics were approved, respectively 
4
. However, 26 among the antibiotics approved 
between 1980 and 1999 have been withdrawn already 
4
, an alarming decline that raises 
calls for more action toward the development of new therapeutics 
5
. In comparison, new 
antibiotic-resistant bacteria are emerging with an increasing frequency 
6
.  
 
 Multiple intrinsic and acquired mechanisms of bacterial cells provide them with 
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remarkable resistance against antibiotics. It is well documented that bacteria can obtain 
resistance by degrading antibiotics or modifying their cellular targets
7
. Bacteria can also 
regulate their membrane properties to selectively control nutrient up-take while extruding 
antibiotics using efflux pumps 
8,9
. In addition to these mechanisms, the failure of 
antibiotics in curing chronic infections is also partially due to the ineffectiveness of these 
drugs against dormant or slow growing cells. In general, antibiotics corrupt the major 
growth-related pathways, such as DNA replication, by interacting with cellular targets 
10
. 
Increasing evidence indicates that bacterial populations contain a small percentage of 
phenotypic variants, known as persister cells, which are dormant and extremely tolerant 
to antibiotics. Although persister cells represent less than 1% of the total population 
11
, 
they can wake up from their dormant state after antibiotic treatment, and regenerate a 
new bacterial population with similar percentage of persister cells. Such persistence 
presents a great challenge to treatment of chronic infections 
12,13
. Beyond these intrinsic 
capabilities of individual persister cells to survive the attack of the antibiotics, bacteria 
can also obtain high-level tolerance to antibiotics by attaching to surfaces and forming 
biofilms, a condition that is very common with implant-associated infections and cystic 
fibrosis 
1,13,14
. Biofilm cells are embedded in an extracellular matrix produced by attached 
cells and comprised of polysaccharides, proteins, and extracellular DNA. Biofilms also 
harbor many slow growing cells including persister cells. Consequently, a large number 
of biofilm-associated cells can tolerate antibiotics at concentrations up to 1000 times 
higher than those required to kill their planktonic (free swimming) counterparts 
15
. These 
challenges emphasize the need for novel techniques that could eradicate bacterial 
infections involving persister cells and biofilms. 
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 To control biofilm formation, antifouling and antimicrobial surfaces are being 
developed with topographic modification and antimicrobial coatings. However, these 
surfaces are not ideal for long-term prevention against bacterial colonization and cannot 
treat existing biofilms. Other approaches involving physical, chemical and electrical 
factors may be advantageous.  Recently, we introduced a novel method for controlling 
bacterial persistence based on a phenomenon we named electrochemical control of 
persister cells (ECCP). We reported that persister cells isolated from Pseudomonas 
aeruginosa could be killed by 98% using low-level direct current (70 μA/cm2 DC) for 1 h. 
Also, DC was found to enhance the killing activities of Tob in a combined treatment, 
showing an interesting synergy equivalent to 5-log killing
11
. To understand the 
mechanism of ECCP, we use complementary approaches to systematically characterize 
the electrophysiological changes in P. aeruginosa induced by the electrochemical 
treatments at the cellular levels. The data will help better understand the mechanism of 
ECCP and design novel therapeutic systems against chronic infections associated with 
biofilms and persister cells. 
 
5.3. MATERIALS AND METHODS 
5.3.1. Bacterial strain and Persister isolation  
The wild-type P. aeruginosa PAO1 (henceforth PAO1) was cultured in Luria-Bertani 
(LB) medium 
16
 containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Each 
overnight culture was incubated at 37°C with shaking at 200 rpm. To isolate persister 
cells, the cells from overnight cultures were harvested by centrifugation (Sorvall Legend 
RT, Thermo Scientific, Asheville, NC) at 8000 rpm for 10 min, washed twice with 0.85% 
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NaCl, and treated with 200 μg/mL Cip for 3.5 h at 37°C with gyratory rotation (200 rpm). 
Finally, the cells were washed three times with 0.85% NaCl to remove the antibiotic and 
the debris of lyzed cells. 
 
5.3.2. Synergy between DC and antibiotics: sequential treatment 
To understand the mechanism of electrochemical control of persister cells (ECCP), the 
efficacy of the antibiotics in killing persister cells was evaluated following DC treatment. 
To evaluate the ability of DC alone to reduce bacterial persistence, DC treatment was 
performed before persister isolation. Thus, stationary phase PAO1 cells were collected 
from overnight cultures by centrifugation and washed twice with 0.85% NaCl. The cells 
were then resuspended in 0.85% NaCl to reached OD600 of 0.9. A 3 mL cell suspension 
was transferred to a polystyrene electrochemical cell to perform DC treatment as 
previously described 
11
. Using either carbon or SS 304 electrodes, a current density of 70 
µA/cm
2
 DC was generated across the electrochemical cell to treat the samples for 60 min. 
Immediately after the DC treatment, the samples were well-mixed and 1 mL of the 
samples was diluted in 10× series using 0.85% NaCl, spread on LB agar (1.5% agar) and 
cultured at 37ºC for 16 h to quantify the total number of viable cells by counting colony-
forming units (CFUs). Similarly the total number of viable cells within the untreated 
samples was quantified. However, to determine the number of cells that remain as 
persister cells, the DC-free and the DC-treated samples were introduced in 
microcentrifuge tubes and treated for persister isolation as described above. Then the 
samples were resuspended in 0.85% NaCl, and 10× serial dilutions were performed to 
 113 
culture the viable persister cells on LB agar plates (1.5% agar) overnight. Finally, CFU 
were counted to evaluate the change in the persister level. 
 
The ability of DC to sensitize PAO1 persister cells to various antibiotics was also 
investigated on PAO1 persister cells isolated from overnight culture. The persister cells 
were first resuspended in 0.85% NaCl at OD600 of 0.6 and then, treated with 70 µA/cm
2
 
DC using carbon or SS 304 electrodes for 1 h. Immediately thereafter, the DC-treated 
persister cells were further challenged with 1.5 µg/mL Tob, 60 µg/mL kanamycin (Kan), 
or 60 µg/mL spectinomycin (Spec) for 1 h. To evaluate if the cells could recover cellular 
functions after DC treatment is stopped, the antibiotics were added to the suspensions of 
DC-treated persister cells 15 or 30 min following DC treatments. The viability of 
persister cells was assessed after the sequential treatments by plating the samples on LB 
agar plates in a 10× serial dilution and counting CFU. Furthermore, to assess if cell 
recovery was dependent on nutrient availability, PAO1 persisters were challenged with 
70 µA/cm
2
 DC using either carbon or SS 304 electrodes for 60 min. Immediately after 
DC treatments, the cells were introduced in 96 well plate containing LB medium with or 
without antibiotics to an OD600 of 0.05. The cells were incubated at 37° C in the presence 
or absence of 1.5 µg/mL Tob, 60 µg/mL Spec, and 60 µg/mL Kan for 6 h and the growth 
curves were recorded by reading OD600 using a fluorescence microplate reader (Biotek, 
VT, USA).  
 
5.3.3. Membrane integrity of P. aeruginosa PAO1 cells 
First, propidium iodine (PI), a membrane impermeable dye, was used to evaluate 
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membrane integrity. The stationary phase cells of PAO1 were resuspended in 0.85% 
NaCl to OD600 of 1.5 and treated with DC using carbon or SS 304 electrodes, as 
described above. Immediately and at 15 and 30 min after DC treatment, 1.5 µL PI was 
added in 1 mL sample to stain the cells for 15 min. The cells were then washed using 
0.85% NaCl to remove non-specifically bound dye and the absorbance of PI by the cells 
was determined using a fluorescence plate-reader at excitation and emission wavelength 
of 530/25 and 590/35 nm, respectively (Synergy 2 Multi-Mode Microplate Reader, 
Biotek, VT) 
 
A complementary approach using Transmission electron microscope (JEOL 
2000EX, JOEL, Japan) was used to examine the membrane integrity of the treated and 
untreated cells. One hundred µL of the samples was fixed in 400 µL of 2.5% 
glutaraldehyde. The cells were attached to a copper grid (T400H-Cu, Electron 
Microscopy Science, PA) and allowed to fully dry at room temperature. Different 
staining methods have been tested to optimize imaging quality. Initially, the samples 
were stained with methylamine vanadium (NanoVan®, Nanoprobes Inc., NY) to observe 
the morphology of cells through TEM. To acquire a well-defined contrast among cellular 
features such as intracellular compartments, a complementary approach was taken to 
stain the DC-treated cells for 15 s with uranyl acetate, which heavy metal elements 
provides better contrast agents compared to methylamine vanadium. The staining was 
followed by three successive washes with HPLC grade water, drying of the grid at room 
temperature, and TEM imaging. To investigate the effects of DC on the membrane 
integrity of the cells, further analysis was performed to acquire transections of the cells 
 115 
and examine the structural changes in the cell membranes at 20, 40 and 60 min of the DC 
treatments. To achieve this, PAO1 cells in stationary phase were treated with DC using 
carbon or SS 304 electrodes for 20, 40 and 60 min; and all the samples, including the 
untreated cells, were collected by centrifugation at 5000 g for 5 min. After fixing cells in 
2.5% glutaraldehyde for 1 h, the cells were collected by centrifugation and treated with 
2% osmium for 1 h to cross-link the lipid molecules in cell membrane. The cell pellets 
were then dehydrated with increasing content of ethanol e.g. 50, 70, 80, 90 and 100% 
(dehydration in 100% ethanol was repeated three times). Then, the cell pellets were 
rinsed three times with a solution of propylene oxide (100 %), and gradually embedded in 
increasing concentration (50%, 75%, and 100%) of Araldite 502 epoxy resin (Electron 
Microscopy Sciences, PA) prepared with propylene oxide. After the third embedment in 
100% epoxy resin, the samples were incubated overnight in a 60º C oven to allow the 
resin to polymerize. Using the MT2-8 ultra-microtome (Sorvall Porter-Blum), the resin-
embedded samples were cut into 80 nm thin sections and were successively stained for 30 
s with 2% uranyl acetate and Sato’s lead citrate 17 before imaging with TEM. 
 
5.3.4. Ion accumulation in P. aeruginosa PAO1 cells  
Recently, we proposed  that the generation and the movement of metal ions are important 
to ECCP
11
. To investigate how DC-induced movement of metal ions affect bacterial cells, 
the intracellular accumulation of the ions was investigated. PAO1 cells in the stationary 
phase were collected from an overnight culture, washed twice with 0.85% NaCl, and 
resuspended in 0.85% NaCl to an OD600 of 1.5. The cells were introduced to an 
electrochemical cell as described above, and a current density of 70 μA/cm2 DC was 
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maintained across the samples for 1 h using carbon and SS 304 electrodes, respectively. 
The DC-treated samples and the untreated control were deposited on a gold-coated glass 
slides. The samples were vacuumed for 24h before they were examined using SEM with 
energy dispersive spectroscopy (SEM-EDS) (Joel 5600, Joel, Japan) to determine the 
relative cellular concentration C, P, N, O, Fe, Cr, Mn, and Ni.  
 
5.3.5. Surface charge of P. aeruginosa PAO1 cells 
To evaluate the cellular activity of the DC treatments, the surface charge of treated cells 
were assessed and compared with untreated control. Following previous protocols 
18,19
 
with slight modifications, the interaction between cells and charged particles (e.g. ions) 
were characterized by measuring the Zeta (ζ) Potential. In principle, the ζ-Potential 
device utilizes a light scattering technique to measure the electrophoretic mobility of 
particles of a specific size within the electric field. To investigate how the change in 
surface properties relates to cellular activity and the accumulation of extracellular 
materials, such as metal ions, PAO1 cells in stationary growth phases were washed and 
resuspended in 0.85% NaCl to OD600 of 0.6 and DC treatment (70 μA/cm
2
 DC) using 
carbon and SS 304 was performed for 1 h. DC-treated cells, untreated control, and cells 
exposed to electrochemical byproducts of the DC treatments for 1 h were collected in 15 
mL conical tubes and stored on ice before the ζ-potential measurement. Finally, 200 µL 
of cell suspension was transferred into a BI-SCP polystyrene cuvette (Brookhaven 
Instruments, NY) containing 2800 µL of distilled water (resulting in 10 mM NaCl 
solution) to measure the ζ-Potential using the Zeta 90 PLUS potential analyzer 
(Brookhaven Instruments, Holtsville, NY).  
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5.3.6. Mechanical properties of P. aeruginosa PAO1 cells 
To understand if DC treatment affects membrane integrity and associated mechanical 
properties of the cells, the elastic property of the cell membrane were characterized 
through measurement of the young’s modulus and the hardness of the cells  using atomic 
force microscopy (AFM) (Digital Instruments Nanoscope III, Veeco, NY). Stationary 
phase cells of PAO1 were treated for 1 h with or without DC using carbon and SS 304 
electrodes, respectively, as described above. The DC-treated cells and the untreated 
control cells were fixed with 2.5% glutaraldehyde in PBS for 1 h and washed twice with 
Millipore water. The samples were allowed to dry on gold-coated glass coupons, which 
were previously cleaned with 190 proof ethanol. NSC14/AIBS probe (MikroMasch, CA, 
USA), with a force constant of 5.7 N/m, was used in tapping mode to locate the bacterial 
cells. Once the coordinates of the cells were recorded, the device was switched to the 
contact mode to perform nanoindentation on the cells (an indent on a sterile substrate was 
made first to set the deflection sensitivity of the tip). Then, a series of single indents on 
the cells was performed to acquire all the force curves by following a protocol described 
previously 
20
. 
 
5.3.7. Statistical analysis. 
SAS Software was used to conduct t-test and one-way ANOVA analyses. Differences 
with p < 0.05 were considered as statistically significant. 
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5.4. RESULTS 
5.4.1. DC treatment reduced persistence in PAO1 stationary phase cells  
Recently, we reported that co-treatment of PAO1 persister cells with DC and Tob 
exhibited synergistic effects in killing PAO1 persister cells. To reveal the mechanism 
ECCP, we were interested in understanding the effects of DC on the electrophysiology of 
the persister cells. In this study, we first tested if DC treatment alone can reduce 
persistence.  Thus, planktonic PAO1 cells were treated with 70 µA/cm
2
 DC using carbon 
or SS 304 electrodes, and the numbers of viable persister cells were determined. As 
shown in Fig. 5.1, the electrochemical treatment reduced the original level of persistence. 
For example, when the 70 µA/cm
2
 DC was delivered using carbon electrodes, 74.0±3.1 
% stationary phase cells was killed. In comparison the number of the persister cells was 
reduced by 92.5 ±1.0 % (one-way ANOVA, p=0.0025), a decreased of more than 1 log. 
The effects were even greater when the DC treatment was performed with SS 304. Under 
this condition, 99.2±0.1% stationary phase cells were eliminated. However, 95.5±0.6% of 
the persister cells become susceptible to 200 µg/mL Cip (one-way ANOVA, p=0.0022). 
Overall, these results demonstrate that the susceptibility of the persister cells to Cip was 
increased following the DC treatment, suggesting that DC could reduce persistence.  
 
5.4.2. Sequential treatment with DC followed by Tob led to complete eradication of 
persister cells.  
Persistence reduction through DC treatment led to speculating on the ability of DC to 
alter membrane property of PAO1 cells and increase their permeabilization to antibiotics. 
To test this hypothesis, we first treated the PAO1 persister cells with 70 µA/cm
2
 DC 
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using SS 304 or carbon electrodes for 1 h. Then the tolerance of the persister cells to 
antibiotics Tob, Kan and Spec was investigated immediately after the DC treatments. 
According to the results shown in Fig. 5.2A, pre-treatment of persister cells with 70 
µA/cm
2
 DC using carbon electrodes significantly improved killing by 1.5 µg/mL Tob. No 
viable persister cells were found after the treatment, corresponding to a 7-log reduction in 
persistence (one-way ANOVA, p=0.0004). This is 2-log more than the killing achieved 
by co-treatment with DC & 1.5 µg/mL Tob
11
. Interestingly, sequential treatment with DC 
followed by Kan and Spec did not exhibit the same effects (Fig. 5.2A). In fact, persister 
killing after pre-treatment with DC was not significantly enhanced with 60 µg/mL Kan 
(one-way ANOVA, p=0.08) and with 60 µg/mL Spec (one-way ANOVA, p=0.6). Similar 
results were also obtained for Kan and Spec when DC was applied using SS 304 
electrodes; e.g. no further enhancement of persister killing was observed with subsequent 
treatment using 60 µg/mL Kan (one-way ANOVA, p=0.5), and 60 µg/mL Spec 
(insignificant increase, one-way ANOVA, p=0.054). Interestingly, sequential treatment 
with DC using SS 304 followed by 1.5 µg/mL Tob (one-way ANOVA, p=0.52) did not 
exhibit synergy either (Fig. 5.2B). This sequential treatment only showed killing by 2 
logs, which is similar to the killing achieved with DC alone using SS 304.  
 
To understand if DC treatment can cause irreversible damage to the viability 
functions of the persister cells, a 15 or 30 min recovery time was given between DC and 
antibiotic treatments. In all tested conditions, the recovery did not improve the antibiotic 
tolerance of persister cells pretreated with DC. These findings demonstrated that DC 
might induce long-lasting damage, which could hinder the persisters’ ability to maintain 
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cellular and membrane functions, and properly respond to subsequent antibiotic attacks. 
To confirm this analysis, the conditions following the DC treatments were adjusted to 
allow PAO1 persister cells to recover in LB medium and evaluate the ability of the DC-
treated cells to replicate in the presence of nutrients with and without antibiotics. As 
shown in Fig. 5.3A, the growth rate of cells treated with carbon electrodes declined 
during the 6 h incubation in LB, even in the absence of antibiotics. However, no 
significant increase in the viability of the persister cells treated with SS 304 was recorded 
in the presence and absence of antibiotic. The cell density remained constant in the 
presence and the absence of antibiotics (Fig. 5.3B). The above findings strongly support 
that PAO1 persister response to DC treatments varies according to the carbon and SS 304 
electrodes. 
 
5.4.3. DC treatment affected the mechanical properties of P. aeruginosa PAO1.  
DNA microarray analysis revealed major differences between the treatments mediated 
with carbon and SS 304 electrodes, and demonstrated that genetic pathways such as 
protein secretion, transport of small molecules, SOS response, and pyocin-related genes 
of PAO1 persister cells were significantly affected by DC treatment. To understand if DC 
treatments affect the membrane integrity and permeability of PAO1, DC-treated PAO1 
cells were stained with PI, a membrane impermeable dye that stains DNA, and the 
membrane integrity of the cells was measured using the Synergy 2 Multi-Mode 
Microplate Reader (Biotek, VT, USA). As shown in Fig. 5.4, PAO1 cells were more 
permeable to PI after DC treatment using carbon electrodes than the untreated control or 
DC treatment with SS 304. Overtime, however, the permeability of the cells treated with 
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DC using carbon decreased once the treatment is stopped. This observation was not 
recorded with cells treated using SS 304, which permeability was lower and remained 
constant after the treatment was interrupted. These findings suggest that DC may affect 
membrane integrity of PAO1, and the damage due to the treatments appeared to 
irreversibly lead to the failure of the cell to recover completely in LB medium over 6h, as 
shown in Fig. 5.3A,B.  
  
These findings are corroborated with TEM analysis, which was used as a 
complementary approach for the assessment of the membrane integrity and morphology 
of PAO1 cells following DC treatment. The stationary phase PAO1 cells were treated 
with DC using SS 304 or carbon electrodes and the cells were imaged using TEM. 
Significant, but different, morphological changes were observed for PAO1 cells treated 
with carbon and SS 304 electrodes. Compared to the untreated PAO1 cells (Fig. 5.5A), 
the cells treated with 70 μA/cm2 DC mediated with carbon electrodes showed two main 
configurations: dark areas near the poles of these treated cells (Fig. 5.5B2), which were 
more apparent when the samples were stained with uranyl acetate (Fig. 5.5B3, B4), and 
disintegrated cell membrane suggesting loss of membrane integrity (Fig. 5.5B1). In 
contrast, the cells treated using SS 304 electrodes exhibited more membrane damage 
leading to the release of cellular contents (Fig. 5.5C1). Interestingly, it appears that DC 
treatment of PAO1 using SS 304 electrodes for 1 h resulted in the release of OMVs (see 
Fig. 5.5C2), which confirms secretion of extracellular proteins or that the cells subjected 
to the SS 304 mediated treatment underwent loss of the membrane integrity and functions 
under DC using SS 304. 
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 To further investigate these differences, TEM analysis was performed on cross-
sections of stationary PAO1 cells treated with DC for 20, 40 or 60 min. Compared to the 
untreated control (Fig. 5.6A1, A2), compartmentalization of intracellular materials is 
visible at 20 min of DC treatment using carbon electrodes (Fig. 5.6B1). At 40 min of the 
treatment, the size of the inclusion body increased and the cells experienced some 
morphological deformations around the cell membrane (Fig. 5.6B2). The deformation of 
the cell membrane was more apparent at 60 min of the DC treatment using carbon, during 
which the intracellular features of the cells became less visible and some cells ruptured 
(Fig. 5.6B3). Under this condition, intact cells were barely seen. The effects of SS 304-
DC on the membrane of the treated cells were different than that on the cells treated using 
carbon. As shown in Fig. 5.6C1, intracellular changes were observed after the first 20 
min of the DC treatment. After 40 min of the treatment, the outer membrane of the cells 
treated using SS 304 became loose and localized accumulation of inner material around 
the inner cell membrane was observed (Fig. 5.6C2). More membrane damage was 
noticed at 60 min of the DC treatment, which may have led to cell lysis as shown in Fig. 
5.6C3. 
  
Since DC treatments induced morphological changes and altered the integrity of 
PAO1 cells, we expected that DC treatment may affect the mechanical properties of these 
cells. To test this, nanoindentation was performed on DC-treated cells and the untreated 
control, which were previously fixed in 2.5% gluteraldehyde and allowed to dry on gold-
coated substrates before the test. The force curves of the cell membranes were recorded 
and the slope of the linear region (k) of the unload curve (Supplementary data Fig. 5.S2) 
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was used to derive the mechanical properties including the stiffness (Young’s modulus), 
and the hardness of the cell membranes. The mechanical properties of the cells were 
determined according to the theory defined by Sneddon et al. 
21
 and based on the Hertz 
model 
22,23
. For our condition, the modulus was defined as: 
Modulus: E 
   (    )
           
; with Poisson ratio ν=0.5 
Hardness: H  
    
  
 
Based on the characteristics of the probes suggested by the manufacturer such as the 
radius of curvature “R” of the tip and the depth of the indent “I” ( nm) performed on the 
sample, the contact area “Ai” (nm2) between the tip and the sample was computed 
according to the following: 
Area of indentation: Ai = [π * I * 
   (   )
   (   )
         (nm2) 
In our conditions, the Young’s modulus of the control sample of PAO1 cells was found to 
be 0.39±0.05 GPa (Table 2). Compared to the untreated control, DC treatment applied for 
1 h at 70 μA/cm2 using SS 304 did not cause significant change in the stiffness of the 
PAO1 cells (0.36±0.17 GPa, one-way ANOVA, p=0.95).  The average indent performed 
on the cells treated with SS 304 was 36.0±14.4 nm, compared to 28.9±3.6 nm for the 
untreated control. However, significant change in the cell stiffness was recorded after DC 
treatment with 70 μA/cm2 DC using carbon electrodes for 1 h. Due to the effects of the 
treatment using carbon electrodes, the modulus of the PAO1 cells reached 3.0±1.5 GPa 
(one-way ANOVA, p=0.001), corresponding to a maximum indent of 11.9±0.5 nm.  The 
comparison of the DC treatments showed major differences in the cell stiffness or 
 124 
hardness. The cells treated with carbon electrodes were 8 times harder than those treated 
with SS 304 electrodes (3.08±0.0 GPa vs. 0.36±0.1 GPa; one-way ANOVA, p<0.0001). 
This finding correlated with large difference in the maximum force of the indents. Under 
DC treatment using carbon, PAO1 cells withstood a maximum load of 391.8±16.6 nN vs. 
276.1±8.0 for the cells treated with 70 μA/cm2 DC using SS 304 (one-way ANOVA, 
p=0.008), suggesting an impediment of the mechanical properties of the cell membrane 
due to the carbon treatment. As described previously, the inner compartmentalization of 
the cells occurring under DC using carbon electrodes and the loosening of the outer 
membrane under DC using SS 304 might explain these differences in the hardening and 
the softening of the cells. These results strongly supported that the electrochemical 
treatments had variable effects on the membrane function of the cells.  
 
5.4.4. Electrically-induced interaction of P. aeruginosa PAO1 with metal ions results 
in surface charge disruption 
To determine the origin of polar compartmentalization within the cells and to understand 
the localized accumulation around the cell inner membrane as observed on the TEM 
images, further study was conducted on the chemical composition and the surface charge 
of the DC-treated and untreated cells. Stationary phase PAO1 cells were treated for 1 h 
with 70 μA/cm2 DC using carbon and SS 304 electrodes, and the concentration of SS 
304-relevant metal ions (e.g. Fe, Cr, Ni, Mn), as well as the content of some organic 
elements such as C, O, K and S were investigated to study how the electrode materials 
affect the chemical composition of the cells. The SEM-EDS data shown in Fig. 5.7 
revealed that DC treatment of PAO1 cells in the presence of SS 304-releasedmetal ions 
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resulted in the cellular accumulation of Fe and Cr ions. The weight percentage of Fe and 
Cr was 23.9±9.2% and 5.0±1.8%, respectively, in the cellular composition of the cells 
treated with DC using SS 304 electrode. However, the relative concentration of P and N 
in the cells treated with DC using SS 304 was lower compared to the control. However, 
the difference was only significant when DC treatments using SS 304 was compared to 
that using carbon electrodes, as cells treated with carbon contained 2.9% and 8.2% more 
P and N elements, respectively, compared to the cells treated with SS 304 (one-way 
ANOVA, p=0.046 for P, and p=0.0499 for N); This may suggest that DC treatment 
induced the release of cellular proteins from cells treated with SS 304. This finding led to 
the hypothesis that electrically-induced movement of charged elements or interactions 
between cells membrane and metal ions may affect the surface properties of the cells, and 
consequently their membrane functions. To test this hypothesis, the net surface charge of 
the stationary phase cells previously treated with 70 μA/cm2 DC using carbon or SS 304 
were measured using the Zeta 90 PLUS potential analyzer (Brookhaven Instruments, 
Holtsville, NY). Under our conditions, stationary PAO1 cells maintained a ζ-Potential of 
-27.6±1.3 mV in 10 mM of NaCl solution (Fig. 5.8). However, the net charge of the cells 
was different in the presence of DC-generated ions. The stationary phase cells treated 
with DC using SS 304 electrodes became less negatively charged (-23.4±0.9 mV; one-
way ANOVA, p=0.013), presumably due to the accumulation of the metal ions. 
However, the cells were more negatively charged than when they are resuspended in SS 
304-electrolyte only (-19.5±1.5; one-way ANOVA, p<0.0001), which may be explained 
by the fact that the intact cells have better interaction with the positively charged metal 
ions (see Discussion). 
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In contrast, no significant change in the chemical composition of the PAO1 cells 
was found after DC treatment using with carbon electrodes. This suggests that the dark 
areas shown in the SEM images of DC-treated cells were primarily due to the 
accumulation of intracellular materials, instead of the intracellular accumulation of 
carbon particles. Therefore, the polar compartmentalization of proteins could have 
originated from inclusion bodies formed under the DC condition using carbon, which 
were confirmed by SDS-PAGE gel and shown in the supplementary data. Contrary to the 
treatment using SS 304, DC treatment using carbon electrodes did not affect the net 
charge of the cells. The surface charge of the DC-free cells remained unchanged in the 
presence of carbon-released particles, and when the cells were treated with 70 μA/cm2 
DC using carbon electrodes. The net surface charge of the cells in the presence of carbon 
only was -27.3±1.0 (one-way ANOVA, p=0.84) and that in the presence of DC was -
28.7±0.8 (one-way ANOVA, p=0.53). These results showed that DC generated by carbon 
electrodes have less effect on the surface charge of the cells compared to the treatment 
using SS 304. 
 
5.5. DISCUSSION 
The study of the electrical properties of bacterial cell has contributed to the understanding 
that net electrical forces (current or field resulting from the membrane potential) are 
required to facilitate the permeation of chemical compounds across the cell membrane. 
Recent interests in bioelectrochemistry and electrophysiology have demonstrated that the 
permeability of the bacterial cell membrane could be effectively controlled by the means 
a small electrical pulses, presenting great opportunities to better characterize the affinity 
 127 
between antibiotics and their cellular targets, or design new strategies to improve the 
availability of biocides and antimicrobials within the pathogens 
24
. Today, many 
techniques are being developed, which could track and measure electrophysiological 
changes induced by the cross-membrane transport of small molecules in bacterial cells 
25-
27
. Our goal is to characterize the properties of the persister cells to understand how 
electrical field and currents could be applied towards impairing their defense 
mechanisms, and reducing drug tolerance. Recently, we have developed novel systems to 
control antibiotic-resistant bacterial subpopulation, known as persister cells, with weak 
electrochemical currents, a phenomenon that we called ECCP. We have demonstrated 
that the viability of persister cells following treatment with 70 µA/cm
2
 DC using SS 304 
electrodes for 1 h was reduced by ~2 logs compared to the untreated control. Synergistic 
effects were recorded when 1.5 µg/mL Tob was supplied to the treatment with 70 
µA/cm
2
 DC using SS 304. For example, around 5 logs of killing of the persisters were 
achieved after 60 min of co-treatment with 70 µA/cm
2
 DC using SS 304 and 1.5 µg/mL 
Tob
11
. Similarly, the treatments were effective on biofilm-associated persister cells. The 
synergy between DC and some antibiotics during ECCP revealed that the movement of 
some ions could have a direct impact on the cells. These findings led us to hypothesize 
and test several possible mechanisms to explain the killing of the persister cells with 
electrochemical treatments.  
  
In this study, we expand our understanding of the electrophysiology of persisters 
to their response to electrochemical stresses generated by carbon or SS-304 mediated DC 
treatments and antibiotics. Firstly, we found that DC alone could reduce persistence in 
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PAO1 cultures and alter the defense system of the persister cells against certain 
antibiotics. The sequential DC-Tob treatments provided new evidence that DC sensitizes 
persister cells to antibiotics. For instance, 92.5% of the persisters that tolerate Cip-
treatment (200 µg/mL Cip) become susceptible to the same concentration of Cip 
following a preliminary DC treatment using carbon electrodes. Moreover, all the 
persisters could be eradicated with 1.5 µg/mL Tob after the electrochemical sensitization 
using carbon electrodes. Such susceptibility of the persister cells to Tob remains constant 
even 30 min after the treatment, indicating that DC using carbon could engender 
permanent damage to the cellular functions of the persister cells. The discoveries that 
synergy and complete killing were achieved in sequential treatments of DC using carbon 
and Tob suggest that, in this condition, the antibiotics became more available to the cells 
or were more effective in reducing the viability of the persisters. This could elucidate our 
previous understanding of ECCP, in which no clear synergy was found during co-
treatments of the PAO1 persister cells with DC using carbon and Tob 
11
. Thus, it appears 
that DC using carbon electrodes could increase the permeability of the persister cells and 
facilitate the transportation of toxic materials (e.g. reactive oxygen species or ROS, 
antibiotics) within the cells only if the bactericides are not denatured by some adverse 
electrochemical reactions.  
  
To prove that transport and accumulation of charged elements within PAO1 cells 
could disrupt the membrane functions of the cells, we sought electrochemical conditions 
to investigate the ability of PAO1 cells to uptake extracellular electrode materials. The 
SEM-EDS analysis of PAO1 cells indicated that DC treatments enable the interaction 
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between metal ions and cells, with subsequent effects varying upon the physiological 
states of the cells (intact vs. treated cells). The accumulation of Fe, and Cr, in particular, 
was observed for the cells treated with SS 304-mediated DC, and appeared to change the 
surface charge of the PAO1 cells. Like many Gram-negative bacteria, PAO1 have a net 
negative charge due to negatively charged molecules such as alginate, and 
phosphorylated polysaccharides, which are present on the outer membrane of the cells 
28
. 
The presence of the metal ions decreased the surface charge of the untreated cell, which 
is consistent with report suggesting that increase of the ionic strength is inversely 
proportional to change in the bacterial zeta potential and electrophoretic mobility 
19
. 
Because the bacterial cell membrane is exposed to the surrounding environment and thus 
experiences the flows of ions during the electrochemical treatments, it was of interest to 
understand how the mode of transportation and the accumulation of extracellular 
materials impair the ability of the cells to control their surface properties, including the 
surface charge. Our experimental results reveal that the surface charge of the cells varies 
not only as function of ionic strength of the cell surrounding, but also as a function of the 
cell physiology. It was found that PAO1 cells experiencing DC treatment were more 
negatively charged than the untreated cells resuspended in the same ionic solution. One 
explanation for this observation could be the fact that the electrically-induced flow of SS 
304-associated ions might denature the chemical configuration of the cell membrane, 
which in turn reduced the level of interaction between the cells and the metal ions. The 
chemical alteration of the cell surface was reported to have variable disruptive effects on 
the surface charge of PAO1 
29
. In contrast to untreated cells exposed to SS 304 released 
ions, the cells resuspended in carbon electrolytes maintained the same surface charge as 
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the untreated PAO1 cells. Similarly, the surface charge of the cells treated with DC using 
carbon electrodes remained unchanged. Although the cells experienced the 70 μA/cm2 
DC current flow, they did not accumulate extracellular carbon. Instead, the carbon-treated 
cells appeared to accumulate intracellular materials. The polar compartmentalization of 
cellular materials might indicate that the electrical field generated by the treatment may 
cause a certain alignment of charged molecules (intracellular proteins, or DNA) and 
result in bacteriostatic effects 
30
, which need to be further studied. With no doubt, such 
change might affect the physiological properties the cells. 
 
The membrane functions were further impaired in that, the electrochemical 
currents generated via carbon electrodes increased their permeability and resulted in the 
hardening of the cell membrane. Although fixed with 2.5% gluteraldehyde, the stiffness 
of the untreated PAO1 cells was comparable to bacterial membrane stiffness reported. 
Eaton et al. 
31
 reported a value of 0.221 GPa for Escherichia coli cells, which were also 
air-dried on a solid substrate, but without previous treatment with gluteraldehyde. After 
DC treatment using carbon electrodes, the elasticity of the cell membrane of PAO1, in 
our experimental condition, became about 8 times stiffer than the 0.39 GPa of the 
untreated cells. This change in the membrane properties may suggest that mechanical 
properties of the cell membrane were impaired. 
  
Physical damage of the PAO1 cell membrane was not only induced by DC using 
carbon but DC treatment using SS 304 also affected the membrane configuration of 
PAO1. In response to the electrochemical stress, the cells secreted various proteins. 
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During the treatments, the cells lost their membrane integrity, resulting in the separation 
of the outer membrane from the inner membrane, and finally in cell lysis. Consistently, 
these morphological changes corroborated with the effects of DC on the mechanical 
properties of the PAO1 cells. Compared to the carbon-treated cells that harden under DC 
treatment, PAO1 cells treated with DC using SS 304 experienced greater physical 
deformation represented by large indent and major decrease in the stiffness of the cell 
membrane. Similar effects of the metal ion on the stiffness of bacterial cells were 
previously reported. Kumar et al. 
32
 described that the membrane elasticity of Gram-
positive Brevibacterium casei (original Young’s Modulus=0.769 GPa) decreases as a 
results of 0-72 h incubation in Co
2+
 solution, attributing the effects to biochemical 
interactions between the cell membrane components and the cations. Hence, the change 
in the membrane properties of the cells could affect the physiological response of the 
persister to DC and antibiotic treatments. 
 
5.6. CONCLUSIONS 
Overall, our findings reveal that the electrochemical treatment of bacterial cells 
disrupts the membrane properties of the cells. Depending on the electrode material, 
various effects were recorded. While treatment with SS 304 was more effective in 
synergy with antibiotics Tob, the sequential treatment using carbon and Tob resulted in 
the highest killing of the persister cells. Our data provide strong evidence that the DC 
affect the cellular and intracellular properties of the cells. Both the membrane activity and 
the intracellular organization of the cells were altered due to the DC treatments. This 
technology demonstrates that the activity of DC on the persister cells must be link to 
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physical damage. However, because the persisters maintain a certain level of metabolic 
activity, appropriate antibiotic should be used to enhance the efficacy of the treatment. 
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FIGURE CAPTIONS 
Figure 5.1. Sensitization of P. aeruginosa PAO1 persister cells by DC treatment. 
Stationary phase cells of P. aeruginosa PAO1 (OD600 of 0.9) were treated with 
70 µA/cm
2 
DC for 1 h using Carbon and SS 304 electrodes. After the DC 
treatment, the cells were exposed to ciprofloxacin (Cip) for 3.5 h to isolate the 
persister cells. The viable (regular and persister) cells were quantified by 
counting CFUs. The means and standard deviations are shown. (* p≤0.05,  and 
** p≤0.01) 
Figure 5.2. Sequential treatment of P. aeruginosa PAO1 persister cells using 70 µA/cm
2 
DC followed with antibiotics. The persister cells were treated for 1 h with DC 
using carbon and SS 304 electrodes. Subsequently to the DC treatment, the cells 
were exposed to antibiotics, including 1.5 µg/mL Tob, 60 µg/mL Kan, and 60 
µg/mL Spec immediately, 15 and 30 min after the treatment for 1 h. The viable 
cells were quantified by CFUs count. Three replicates were tested for each 
condition. The means and standard deviations are shown. 
Figure 5.3. Recovery of P. aeruginosa PAO1 persister cells following treatment with 70 
µA/cm
2 
DC. The persister cells were treated for 1 h using carbon (A) and SS 
304 (B) electrodes. Subsequently to the DC treatment, the cells were 
resuspended in LB medium with  or without antibiotics, including 1.5 µg/mL 
Tob, 60 µg/mL Kan, and 60 µg/mL Spec. The growth curve of the cell was 
recorded by measuring OD600 using a microplate reader. The means and 
standard deviations are shown. 
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Figure 5.4. Permeability of P. aeruginosa PAO1 to Propidium Iodide (PI) following DC 
treatments. The cells were treated with 70 µA/cm
2 
DC using carbon or SS 304 
electrodes for 1 h. After the treatment, DC treated cells, as well as the untreated 
control cells were exposed to PI for 15 min.  
Figure 5.5. Representative TEM images of planktonic P. aeruginosa PAO1 cells control 
(A) vs. cells treated with 70 µA/cm
2
 DC. (B) DC using carbon electrodes for 1 h 
and the cells were stained with vanadium oxide (Top) vs. uranyl acetate 
(bottom). Intracellular compartmentalization occurred after DC for 1 h. (C) DC 
using SS 304 electrodes for 1 h was performed and the cells were briefly stained 
with vanadium oxide. The treatment resulted in cells damage and in secretion of 
outer membrane vesicles (B).   
Figure 5.6. Representative TEM images of untreated planktonic P. aeruginosa PAO1 
cell. The cells were embedded in resin, stained with uranyl acetate and lead 
citrate. To performed TEM the cells were sectioned in 80 nm thin slides.  (A) 
Untreated control P. aeruginosa PAO1 cells. PAO1 cells treated with 70 
µA/cm
2
 DC using carbon electrodes (B1) for 20 in resulted in initiation dark 
compartment within the cells. (B2) The accumulation increased after 40 min 
and (B3) DC treatment for 60 min resulted in the misshaping of the cell 
membrane. In all the cases, no major protein secretion was observed. The cells 
were treated with 70 µA/cm
2
 DC using SS 304 electrodes (C1) for 20 min 
resulting in the protein secretion around the cells membrane, and (C2) Bulging 
of the cell membrane occurred at 40 min of the DC treatment; (C3) At 60 min of 
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the treatment, cells with a loose cells membrane were observed. Protein 
secretion became more significant with increasing treatment time.  
Figure 5.7. Effects of DC treatment on the cellular accumulation of metal cations by P. 
aeruginosa PAO1 cells. Stationary phase cells were treated with 70 µA/cm
2 
DC 
using carbon or SS 304 electrodes for 1 h. SEM-EDS analysis was performed to 
quantify the relative cellular concentration of the metal or organic elements. At 
least four replicates were tested for each condition. The means and standard 
errors are shown. (* p≤0.05, and ** p≤0.01) 
Figure 5.8. Effects of DC on the surface charge of P. aeruginosa PAO1 cells. Stationary 
l phase cells were treated with 70 µA/cm
2 
DC using carbon and SS 304 for 1 h 
or were resuspended in electrolytes generated for the DC treatments. The 
samples were resuspended in a solution of 10 μM of NaCl and the zeta-potential 
of the cells was measured. (* p≤0.05, and ** p≤0.01) 
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Figure 5.8 
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Table 5.1 
Mechanical properties of stationary phase cells of P. aeruginosa showing  
the effects of treatments with 70 µA/cm
2
 DC using SS 304 or carbon electrodes. 
 
  
Untreated PAO1 
(control) 
PAO1 treated with DC/ 
SS 304 
PAO1 treated with 
DC/Carbon 
  Average ± SD Average ± SD Average ± SD 
Maximum indent (nm) 28.9 ± 3.6 36.0 ± 14.4 11.9 ± 0.5 
Maximum Load (nN) 398.9 ± 78.6 376.1 ± 8.0 391.8 ± 16.6 
Area in contact with Samples (nm²) 3536.5 ± 717.3 5712.4 ± 4551.7 1044.5 ± 46.5 
Slope of linear range (nN/nm) 32.1 ± 1.1 32.9 ± 12.1 135.8 ± 67.8 
Modulus (GPa or nN/nm²) 0.39 ± 0.05 0.36 ± 0.17 3.0 ± 1.5 
Hardness (GPa or nN/nm²) 0.11 ± 0.01 0.09 ± 0.04 0.38 ± 0.0 
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CHAPTER 6 
 EFFECTS OF LOW-LEVEL ELECTRIC CURRENT ON GENE 
EXPRESSION OF PEUDOMONAS AERUGINOSA PERISTER CELLS 
 
 
 
 
 
 
 
 
 
The DNA microarray analysis described in this Chapter was collaborative work 
performed with Marcus Jones. Laura M Shepenger contributed to the testing of P. 
aeruginosa PAO1 mutants with antibiotics and DC. 
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6.1. ABSTRACT 
 
Electrochemical control of antibiotic-tolerant bacteria presents a potential 
opportunity to eradicate bacterial infections involving biofilms and persister cells. In 
Chapter 5, it was demonstrated that Pseudomonas aeruginosa PAO1 cells respond 
differently to electrochemical treatments mediated with various electrode materials. For 
instance, direct current (DC) treatment of PAO1 using carbon electrodes resulted in 
intracellular accumulation of proteins, while the DC treatment using stainless steel (SS) 
304 caused cell lysis and release of intracellular proteins. To understand these differences 
at the genetic level and correlate the results with those from electrochemical treatments of 
the persister cells, DNA microarray analysis was conducted on P. aeruginosa PAO1 
persister cells.  The findings from this study revealed that DC treatments have profound 
effects on the physiology of PAO1 persister cells. For instance, genes involved in pyocin-
related functions and SOS response were induced by the DC treatments with carbon and 
SS304, respectively, and genes for antibiotic tolerance were differentially expressed.  To 
corroborate the results, ten mutants were tested with the same electrochemical treatments. 
The results demonstrated that pqsB, pvcA and PA1897 may contribute to the response of 
PAO1 to DC treatment.  
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6.2. INTRODUCTION 
The metabolic versatility of Pseudomonas aeruginosa provides this opportunistic 
pathogen with a remarkable level of adaptability to survive in different environments, and 
causes chronic infections in patients with compromised immune systems such as those 
associated with medical implants, cystic fibrosis and burns. . The ability of P. aeruginosa 
to form bacterial biofilms, which embed sub-population of persister cells, creates an 
increasing challenge to curing P. aeruginosa infections with conventional antibiotics  
 
 Since antibiotics target biological processes such as DNA, protein, and cell wall 
synthesis, alternative approaches that target the physical properties of microorganisms 
have good potential to eradicate antibiotic-resistant bacterial infections. The finding that 
bacterial biofilms could be eliminated through synergistic effects with DC and antibiotics 
has led to the testing of the bioelectric effects on bacterial cells in vivo
1-3
. Our study 
conducted on the regular and persister cells of P. aeruginosa PAO1 demonstrated that the 
response of the cells is dependent upon the type of electrode material used to mediate the 
DC treatment. As shown in Chapter 3, DC treatment using SS304 led to the killing of 
PAO1 persister cells by 98% and 5 logs through synergy with tobramycin
4
. However, the 
same level of DC with carbon electrodes was less effective in killing PAO1 persister cells 
and the co-treatment with DC and Tob did not exhibit synergistic effects. Interestingly, 
complete eradication of the PAO1 persister cells was achieved, when Tob treatment was 
performed after the DC treatment. These findings corroborated the data reported in 
Chapter 5 that carbon and SS304 electrodes affected the cell morphology differently, 
resulting in intracellular accumulation of protein and cell lysis, respectively. We thus 
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hypothesize that electrochemical killing of P. aeruginosa using carbon and SS304 
electrodes is based on different mechanisms, which could be further investigated through 
analysis of the transcriptomes of PAO1 persister cells. 
 
 Chang et al. 
5
 reported that P. aeruginosa  responds to oxidative stress with 
induction of pyocin genes, and downregulation of intracellular transport genes, such as 
those controlling iron uptake.   Also, it is well known that aminoglycoside uptake can be 
affected by changes in the membrane potential of bacteria cells
6,7
. This inspired us to 
investigate if DC treatment may influence the antibiotic uptake by P. aeruginosa and the 
antibiotic susceptibility of treated cells.  In this chapter, DNA microarrays were used to 
investigate the response of the PAO1 persister cells to DC treatments. The transcriptional 
profiles of the cells before and after the treatment with both carbon and SS304 electrodes 
were compared to identity the genes involved in response to each treatment.  
 
6.3. MATERIALS AND METHODS 
6.3.1. Bacterial strain and growth media  
The wild-type P. aeruginosa PAO1 was cultured in Luria-Bertani (LB) medium
8
 
containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Each overnight culture 
was incubated at 37°C with shaking at 200 rpm. PAO1 mutants carrying ISlacZ/hah or 
ISphoA/hah were acquired from the Pseudomonas aeruginosa PAO1 transposon mutant 
library (UW-Genome Sciences , University of Washington, WA, USA) and cultured in 
LB medium with or without 10 μg/mL tetracycline (Tet). The mutants PW4389 
(PA1939-G06::ISlacZ/hah), PW10231 (PA5461-A02::ISlacZ/hah), PW2800 (pqsB-
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B05::ISlacZ/hah), PW8462 (PA4430-C09::ISphoA/hah), PW4830 (pvcA-
F05::ISlacZ/hah),  PW4567 (fusA2-F06::ISlacZ/hah), PW7877 (oprG-A04::ISphoA/hah), 
PW6348 (glk-C11::ISphoA/hah), PW3811 (aer-B08::ISlacZ/hah), and PW4324 
(PA1897-B09::ISphoA/hah)
9
 were grown in LB with 10 μg/mL tetracycline (Tet).  
 
6.3.2. Colony Forming Units (CFUs) 
The colony forming units (CFUs) were counted to quantify the number of viable P. 
aeruginosa PAO1 cells. Briefly 10 µL of each sample was diluted in a 10× series using 
0.85% NaCl solution and spread on LB agar plates (1.5% agar). The CFUs were counted 
the next day after incubation overnight at 37°C.  
 
6.3.3. DC treatment of persister cells 
The PAO1 persister cells were isolated by treating the stationary phase cultures for 3.5 h 
with 200 µg/mL Cip, as described in Chapter 3. The harvested cells were washed twice 
with 0.85% NaCl solution, resuspended in 0.85% NaCl solution and treated with 70 
µA/cm
2
 DC for 20, 40 or 60 min. To deliver the DC, an electrochemical cell was 
constructed by inserting two SS304 or two carbon electrodes along the opposite sides of a 
plastic cuvette (Thermo Fisher Scientific, Pittsburg, PA) as shown in Figure 4.1A. A 
silver wire (0.015” diameter, A-M Systems, Sequim, WA) was placed in bleach for 30 
min to generate an Ag/AgCl reference electrode. The reference electrode was then placed 
in the cuvette. DC was generated using a potentiostat (Potentiostat WaveNow, Pine 
Research Instrumentation, Raleigh, NC) in a 3-electrodes configuration. Using the 
AfterMath software (Potentiostat WaveNow, Pine Research Instrumentation, Raleigh, 
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NC), a galvanostatic mode was selected to monitor the DC level for 1 h. During DC 
treatments of the PAO1 mutants, 100 µL of sample was taken every 20 min to evaluate 
the viability of bacterial cells by counting CFU.  
 
6.3.4. DNA microarray analysis 
In order to understand the effects of DC on PAO1 persister cells at the genetic level, 
DNA microarray analysis was performed to determine the transcriptional profiles of the 
persister cells after various levels of DC treatment. Seven samples of PAO1 persister 
cells were isolated from overnight cultures (50 mL each), as described above. The cells 
were resuspended in 3 mL 0.85% NaCl and treated with 70 µA/cm
2
 DC. Both carbon and 
SS304 electrodes were tested for 20 min and 40 min treatments. A DC-free sample was 
used as control. Immediately after each treatment, the cell pellet was collected by 
centrifugation at 15,000 g for 2.5 min at 4 ºC, frozen in dry-ice immediately and stored at 
-80°C until RNA extraction. The total RNA was extracted from the cells using RNeasy 
Mini Kit (Qiagen) as described previously
10
, and sent to J. Craig Venter Institute for 
DNA microarray analysis.  
 
6.3.5. Q-PCR analysis  
To confirm the results of the microarray analysis, 10 representative genes including 
PA0647, PA4430, PA4614, PA0166, pscF (for DC treatment using SS304), PA1032, 
PA4067, PA0633, PA0640, pscF (for DC treatment using carbon) and the housekeeping 
gene pbpA (penicillin-binding protein 2) were selected to perform quantitative PCR 
(qPCR). Corresponding sets of primers (forward and reverse) were designed for the 
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selected genes (Table 1). The gene expression profile of PAO1 persister cells treated with 
70 µA/cm
2
 DC for 20 min or 40 min using carbon or SS304 electrodes was compared to 
that of the untreated control sample. The iScript cDNA synthesis kit (Bio-Rad, Hercules, 
CA, USA) was used to synthesize cDNA templates based on 200 ng total RNA. 
Following the manufacturer’s protocol, primer mix (containing the forward and reverse 
primers) and Syber green mix (including the Syber green dye and cDNA templates) were 
prepared to quantify the relative expression ratios of the gene of interest by running 
qPCR using a Eppendorf Realplex Mastercycler (Eppendorf North America, Inc., 
Westbury, NY). 
 
6.3.6. Susceptibility of P. aeruginosa PAO1and selected mutants to tobramycin 
To understand the mechanism of ECCP, the function of a set of PAO1 genes identified 
from microarray study was investigated under the electrochemical treatment mediated 
using carbon and SS304. Mutants of PA1939, PA5461, pqsB, PA4430, pvcA, fusA2, oprG, 
glk, aer, and PA1897 were acquired from the Pseudomonas aeruginosa PAO1 transposon 
mutant library (UW Genome Sciences) 
9
 to study the role of the corresponding genes in 
the response of the P. aeruginosa persister cells to the treatment with 70 µA/cm
2
 DC. To 
evaluate the effects of the mutants on the susceptibility of PAO1 to Tob, the mutants 
were grown overnight in LB supplemented with 10 μg/mL Tet. Then, the cells were sub-
cultured at an initial OD600 of 0.05 in 200 μL LB contained in 96 well plates (Costar ® 
No. 9017, Corning, NY) in the presence or absence of 1.5 μg/mL Tob. The wild type 
PAO1 was also grown in a 96 well-plate and all the samples were tested with 8 replicates 
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at 37 °C for 7h. Growth curves were recorded by measuring OD600 every hour using an 
ELx808 Absorbance Microplate Reader (Biotek, Winooski, VT).  
 
6.3.7. Effects of gene mutation on persister formation 
Previous work
11
 has demonstrated that P. aeruginosa persisters can be isolated by lysing 
the regular cells with 25 µg/mL ciprofloxacin (Cip) for 3.5 h. In order to determine the 
sufficient Cip concentration for our strain, P. aeruginosa PAO1 and mutant cells were 
challenged with various concentrations of Cip (0 - 200 µg/mL) for 3.5 h and the killing 
was evaluated by counting CFUs of surviving cells. Briefly, the cells were cultured in LB 
medium over night at 37°C. Then the cells were collected by centrifugation (Sorvall 
Legend RT+, Thermo scientific, Asheville, NC) at 8,000 rpm for 10 min at room 
temperature, and washed twice with 0.85% NaCl solution before being treated with 
different concentrations of Cip for 3.5 h at 37°C. After treatment, the cells were washed 
three times with 0.85% of NaCl solution to remove residual Cip and the debris of lysed 
cells. The number of viable persister cells was then quantified by counting CFU as 
described above. Two replicates were tested for each condition. 
 
6.3.8. Effects of DC on PAO1 mutants 
Based on the transcriptional profiles of the DC treated PAO1 persister cells, the mutants 
of PA1939, PA5461, pqsB, PA4430, pvcA were selected to further study the function of 
the corresponding genes in DC treatments mediated with SS304; while mutants of fusA2, 
oprG, glk, aer, and PA1897 were tested with DCs generated with carbon electrodes. The 
mutants were cultured overnight in LB medium supplemented with 10 μg/mL Tet. The 
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persister cells were isolated with 200 μg/mL Cip and treated with 70 µA/cm2 DC for 1 h, 
as described above. During the treatment, 100 µL of sample was taken every 20 min to 
evaluate the viability of bacterial cells by counting CFU.  
 
6.3.7. Statistical analysis 
SAS Software was used to conduct t-test and one-way ANOVA analyses. Differences 
with p < 0.05 were considered as statistically significant. 
 
6.4. RESULTS 
6.4.1. Genes that were consistently changed by carbon and SS304 mediated 
treatments  
To understand what genes and pathways in PAO1 persister cells are affected by DC, 
persister cells harvested from 50 mL cultures of PAO1 were treated with 70 µA/cm
2
 DC 
using carbon or SS304 electrodes for 20 min and 40 min. The total RNA was isolated for 
microarray analysis, and the transcriptional profiles were validated with qPCR analysis of 
10 representative genes (Table 1). Gene expression with a 2 fold or higher change ratio 
was considered significant. As shown in Table 2, the DC treatment resulted in the 
expression of a common set of genes induced or repressed by the electrochemical 
currents generated by carbon and SS304 electrodes. For instance, genes including 
PA4623, PA4140, PA2756, PA2484, PA2313, PA09075 (“hypothetical, unclassified, 
unknown”), PA0616, PA0639, PA0644 (“related to phage, transposon, or plasmid”), and 
rpsP, glk, PA0206, PA4786 involved in “Translation, post-translational modification, 
degradation”, “Carbon compound catabolism”, “Transport of small molecules”, and 
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“Putative enzymes”, respectively, were commonly induced in DC treatments mediated 
with both carbon and SS304 electrodes.  The genes that were repressed under all 
conditions include PA0317, PA4319, PA4347, PA4894 (“hypothetical, unclassified, 
unknown”), panB, PA2324, pscF, PA1600 and PA0322.  The five latter genes are 
involved in “Biosynthesis of cofactors, prosthetic groups and carriers”, “Putative 
enzymes”, “Protein secretion/export apparatus”, “Energy metabolism”, and “Transport of 
small molecules”, respectively.  
 
6.4.2. Effects of carbon electrode-mediated DC on gene expression in PAO1 
persister cells 
Treatment with 70 µA/cm
2
 DC for 20 min using carbon electrodes induced 51 genes and 
repressed 32 genes consistently in duplicated experiments (Fig. 6.1A). In comparison, the 
same treatment condition for 40 min induced 139 genes and repressed 47 genes (Fig. 
6.1B). A total of 23 genes were induced by both 20 min and 40 min treatments, including 
ribH (involved in the “biosynthesis of cofactors, prosthetic groups and carriers”), glk 
(involved in “carbon compound catabolism”), PA4010, PA0612, PA1042, PA1913, 
PA1967, PA2613, PA3205, and PA3320 (all of “hypothetical, unclassified, unknown” 
functions), PA1897 and oprG (encoding “membrane proteins”), PA1470 (encoding for a 
“putative enzyme”), PA0617, PA0627, PA0628, PA0629, PA0633, and PA0636 (“pyocin-
related genes”), fusA1 and fusA2 (elongation factors involved in “translation, post-
translational modification, and degradation”) and fruK and ccmA (involved in the 
“transport of small molecules”).  
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Our findings also suggest that DC treatment using carbon electrodes may affect 
multi-drug resistance, and pyocin-related functions and biosynthesis in PAO1 cells. For 
example, mexA, OprM, OprG, PA1032 and PA4375, which are involved in antibiotics 
resistance and bacterial efflux systems, were induced by the 40 min DC treatment using 
carbon. Strikingly, 17 out of 18 phage-related genes that were induced by 40 min DC 
treatment using carbon electrodes are known to be involved in pyocin production, which 
include PA0616, PA0617, PA0619, PA0622, PA0623, PA0624, PA0626, PA0627, 
PA0628, PA0629, PA0633, PA0636, PA0637, PA0638, PA0639, PA0640, and PA0644. 
Finally, the induction of 13 genes (3 genes at 20 min, 11 at 40 min and 2 at both 
conditions) involved in ‘translation, post-translational modification, and degradation’ 
suggests that DC treatment may affect the biosynthesis in treated cells. These genes 
include lexA (encoding for LexA repressor induced by 1.9 fold at 40 min), the ribosomal 
genes rpsB, rpsL, rpsO, rpsP, rpsS, and fusA1, and fusA2 (encoding for elongation 
factors). Also, three genes for DNA repair were repressed, including PA2138, ogt (at 20 
min) and recR (at 40 min). Energy metabolism related genes such as cyoD, PA1600, 
PA0510 (at 20 min), ccmH, nirJ, PA2716 (at 40 min), together with some genes encoding 
putative enzymes associated with oxido-reduction (PA0237, PA4621, PA5327) were also 
repressed. The downregulation of PA1600, cyoD and ccmH (which encode for 
cytochromes) suggest that DC might also affect cell respiration through oxido-reduction 
reactions and therefore the membrane functions of persister cells.  
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6.4.3. Effects of SS304-mediated DC on gene expression in PAO1 persister cells 
Compared to the data of PAO1 cells treated with carbon electrodes, DC treatments of 
PAO1 persister cells using SS304 electrodes affected the physiological status of the 
persisters to a greater extent. A total of 250 genes were induced and 244 genes were 
repressed by the SS-mediated DC treatment for 20 min (Fig. 6.1A); while 135 genes were 
induced and a total of 95 genes were repressed by DC treatments using SS304 for 40 min 
in duplicated experiments (Fig. 6.1B). Overall, 74 genes and 35 genes were commonly 
induced and repressed, respectively, by both 20 min and 40 min DC treatments using 
SS304 (See supplementary data-Appendix II). The top 10 induced genes at both 
conditions include sdhD (“energy metabolism”), PA1939, PA5461, PA1057, PA1343 
(“hypothetical, unclassified, unknown”), pqsB (“biosynthesis of cofactors, prosthetic 
groups and carriers”), secE (“protein secretion/export apparatus”), pvcA (“secreted 
factors, toxins, enzymes, alginate”), PA0810 (“carbon compound catabolism”), and leuA 
(“amino acid biosynthesis and metabolism”). The 10 most repressed genes by SS304-
mediated DC treatments include cysH (“amino acid biosynthesis and metabolism”), 
PA2768 and PA1972 (“hypothetical, unclassified, unknown”), pscQ and pscF (“protein 
secretion/export apparatus”), PA3630 (“transcriptional regulators”), PA0345 (“membrane 
proteins”), lasB (“translation, post-translational modification, degradation”), PA0600 
(“two-component regulatory systems”), and PA0240 (“transport of small molecules”).  
 
Some pathways, including protein secretion and export apparatus, energy-related 
functions, and SOS response, were among the features of the SS-mediated DC treatment, 
along with the antibiotic resistance functions, which were downregulated. For instance, 
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genes involved in “transport of small molecules” (23 genes), “energy metabolism” (14 
genes), “transcriptional regulators” (13 genes), “biosynthesis of cofactors, prosthetic 
groups and carriers” (12 genes) and “putative enzymes” (11 genes) are among the most 
represented groups of genes induced by SS304 mediated DC for 20 min. The most 
significant functions of the repressed genes include “transport of small molecules” (26 
genes), “transcriptional regulators” (25 genes), and “putative enzymes” (24 genes) groups. 
Seven genes involved in “energy metabolism”, including snr1, cycH, PA2165, nirN, 
PA0509, PA0521, PA1600, and PA2417, were repressed by 20 min DC treatment using 
SS304. DC treatment using SS304 for 40 min resulted in the induction of fewer genes 
compared to carbon, including 11 genes for “transport of small molecules” and 
“transcriptional regulators”, respectively. The most representative categories of genes 
repressed by 40 min of SS304 treatment are also involved in “transport of small 
molecules” (10 genes) and “transcriptional regulators” (10 genes). Among the “transport 
of small molecules” genes repressed under both conditions of DC using SS304, 5 are 
identified as probable major facilitator superfamily (MFS) genes and 9 are related to the 
ATP-binding cassette (ABC) transporters.  These two major types of transporters regulate 
bacterial response to chemiosmotic ion gradients and the cross-membrane transport of 
large molecules, including antibiotics 
12,13
. ABC transporters are required when energy is 
needed to perform cellular functions such as DNA repair 
14
. Under our conditions, 6 
genes involved in the translation or the repair of DNA were also found induced at 20 min 
or 40 min, which are ruvB and ruvC (encoding for holliday junction enzymes), uvrB 
(encoding for excinuclease ABC subunit B), ihf (encoding for integration host factor beta 
unit), gyrA (encoding for DNA gyrase subunit A), and PA5348 (encoding a probable 
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DNA-binding protein). The induction of these genes by SS304-mediated DC suggests 
that the treatment might cause DNA damage. Moreover, genes encoding “protein 
secretion/export apparatus” were repressed by SS304-mediated DC treatment for 20 min 
(hasE, pscK, pcrV), 40 min (xcpX), and in both conditions (PA2673, pcrG, pscF, pscQ), 
or induced at 20 min (popD, secE, SecG) and 40 min (xcpS, PA3404, secE). Finally, DC 
treatment using SS304 induced 24 genes involved in synthesis of outer membrane 
vesicles (OMV) (see Table 3), which indicates potential changes in membrane integrity 
and functions.  
 
6.4.4. Susceptibility of selected P. aeruginosa mutants to antibiotics including Tob 
and Cip 
The analysis of the transcriptional profiles of PAO1 persister cells before and after the 
DC treatment performed with carbon or SS304 electrodes revealed that some genes may 
be important to the response of the persisters to the electrochemical treatments. Based on 
the microarray analysis, a total of 10 genes that were highly induced by the DC treatment 
using carbon and SS304 electrodes were selected for further investigation (Table 4). 
These strains have mutations in PA1939, PA5461, pqsB, PA4430 and pvcA (induced by 
SS304-mediated treatment) as well as fusA2, oprG, glk, aer and PA1897 (induced by 
carbon electrode mediated DC).  
  
To determine if there is any difference in antibiotic susceptibility among these 
mutants, the cells were grown in LB medium in the presence or absence of 1.5 μg/mL 
Tob for 7 h.  As shown in Fig. 6.2A, most mutants have normal growth except that the 
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mutant of oprG grew slowly in LB medium, compared to the wild-type and the other 
mutants. However, the growth of all the mutant strains in the presence of 1.5 μg/mL Tob 
was similar or slightly higher than the growth of the wild-type PAO1 (Fig. 6.2B). To 
further test the susceptibility of the mutants to antibiotics, all the strains were exposed to 
increasing concentration of Cip. The results of this test are shown in Fig. 6.3 
demonstrating that the concentration of 200 μg/mL Cip was also appropriate for the 
isolation of persister cells from these mutant strains. However, the exact number of 
persisters isolated varied depending on the mutated genes. The number of persisters 
within stationary culture of mutants including pqsB, fusA2, PA4430, glk, and oprG 
represented 1% of the total cells found within the stationary cultures, which was similar 
to the level of persister cells in the wild-type PAO1
4
. The number of persister cells in 
stationary cultures of pvcA, PA1939, PA5461, and aer mutants represented between 0.1 
to 1% of the total population. However, the stationary cultures of mutant of PA1897 
harbored the lowest number of persisters, representing only 0.01% of the overall 
population. 
 
6.4.5. Effects of DC on the persister cells of selected mutants 
To evaluate the roles of the genes that were differentially expressed to electrochemical 
treatments, the selected mutant strains were cultured and the persister populations were 
isolated as described in the Method section. The cells were washed with 0.85% NaCl 
solution and resuspended in the same at OD600 of 0.8 to perform DC treatments. Mutants 
including PA1939, PA5461, pqsB, PA4430, and pvcA were treated with 70 μA/cm2 DC 
using SS304 electrodes, while the remaining mutants (fusA2, oprG, glk, aer, and PA1897) 
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were treated with 70 μA/cm2 DC using carbon electrodes for 1 h. The response of the 
mutants to the electrochemical treatments demonstrated that some gene might be very 
important to PAO1 persisters. As shown in Fig. 6.4A, DC treatment using carbon 
electrodes resulted in more killing of the persister cells of PA1897 mutant. Compared to 
the wild-type PAO1, the persisters of mutant of PA1897 were killed by 1.7 log after DC 
for 60 min (vs. 1.1 log for the wild type, one-way ANOVA, p<0.0001), suggesting that 
this mutation may affect the resistance of the P. aeruginosa cells to the DC treatment. 
The DC treatment did not significantly affect the viability of mutants of oprG (Two-way 
ANOVA, p=0.8) and aer (one-way ANOVA, p=0.5. Also mutants of fusA2 (one-way 
ANOVA, p=0.001) and glk (one-way ANOVA, p=0.02) were less susceptible to DC 
treatment compared to the wild type. This suggests that there are redundancies in the 
functions of the genes involved in the response of PAO1 persisters to DC treatment. 
 
DC treatment using SS304 highlighted more genetic functions, which could be 
interesting for the persister control using electrochemical treatments (Fig. 6.4B). For 
instance, while the persister cells of wild-type PAO1 were killed by 1.6 log with 70 
μA/cm2 DC using SS304 electrodes, the persisters collected from the mutants of pqsB, 
pvcA and PA4430 were killed by 2.8 logs (one-way ANOVA, p<0.0001), 2.8 logs (one-
way ANOVA, p<0.0001) and 2.1 logs (one-way ANOVA, p=0.04), respectively. These 
results suggest that psqB, pvcA and PA4430 might constitute important targets of the 
electrochemical treatment. No clear difference was found in the killing effect of the DC 
treatment of the persisters of PAO1 vs. those of mutant of PA5461 (one-way ANOVA, 
p=0.6). Interestingly, deletion of PA1939 rendered the persister cells less susceptible to 
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the treatment of 70 μA/cm2 DC using SS304. These mutants were killed 1 log less than 
the wild type PAO1 (one-way ANOVA, p<0.0001). 
 
6.5. DISCUSSION 
The electrophysiological properties of the persister cells were investigated using DNA 
microarrays. Under our experimental condition, DC treatments were performed for 20 
min and 40 min only, since strong killing effects were observed in the 1 h treatments 
4
. 
The differentially expressed genes provide important information for understanding the 
effects of DC on persister cells. A common feature of the DC treatment using both carbon 
and SS304 is the generation of ROS due to the oxido-reduction reactions occurring at the 
electrodes. Oxygen radicals generated through the electrolysis of water, or Fenton 
reaction in the presence of Fe, has been widely reported as a cause of DNA damage 
15,16
 
17
. The DC treatment in our system provides an exogenous source of Fe, which may 
increase the concentration of free Fe ions within the cells, and results in more oxidative 
stress as previously reported 
18
. Our microarray data analysis confirmed that SOS 
response to oxidative stress was more prevalent in DC treatments performed with SS304, 
compared to that performed with carbon electrodes. Some more genes involved in the 
DNA repair were induced by the SS mediated treatments. The induction of lexA, a SOS 
regulon repressor of DNA damage, escalated from 2 to 6-fold with the 20 min and 40 min 
treatments using SS304 (Table 3). DC treatment using SS304 also induced the lexA gene 
3 times more than the treatment using carbon electrodes (at 40 min). The finding that 17 
pyocin-related genes were induced by the treatment with DC using carbon electrodes 
confirmed that pyocin production may be a result of oxidative stress in persister cells
5
. 
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The DC treatments stimulated variable responses associated with drug resistance. 
Previously, we discovered that the co-treatment of the persister cells with antibiotics and 
DC using carbon electrodes did not show any synergistic killing activity
4
. However, 
synergistic effects were achieved during sequential treatment with DC for 1 h, followed 
with 1.5 μg/mL Tob for 1 h. The microarray analysis of cells treatment with carbon 
electrodes showed that the genes associated with drug resistance were affected during the 
treatment. For instance, mexA and oprM that encode efflux systems involved in multidrug 
resistance were induced by 40 min treatment with DC using carbon electrodes. Thus we 
hypothesize that such synergistic effects from sequential treatment with DC and Tob may 
be partially caused by the effect of DC and its electrochemical byproducts on membrane 
functions of the cells. Similarly, DC treatment using SS304 also affected genes associated 
with antibiotic resistance. For instance many genes associated with protein secretion and 
export apparatus, transport of small molecules, and energy metabolism were either 
induced or repressed. Several genes involved in response to antibiotics were repressed at 
20 min by the DC treatment using SS304, such as PA1129, PA1237 and PA2018. It will 
be interesting to further investigate if such effects contribute to the synergistic killing 
during co-treatment with DC and Tob. 
 
The test of selected mutants with DC treatment has revealed that some genes are 
indeed involved in bacterial response to DC. For instance, the increased sensitivity of 
PA1897 to DC suggests that a hypothetical protein encoded by this gene may contribute 
to the response of persister cells to electrochemical current mediated with carbon 
electrodes. It was also discovered that some mutations led to an altered level of 
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persistence. This finding suggests that some genes involved in persister formation may 
also be involved in response to electrochemical stresses. Interestingly, mutation of fusA 
and glk genes, encoding for elongation factor G and glucokinase, respectively, rendered 
the persister cells less susceptible to DC. Further studies on gene regulation are required 
to better understand the functions of these genes and their roles in bacterial response to 
DC. 
 
6.6. CONCLUSIONS 
In this study, the response of the P. aeruginosa PAO1persister cells to the DC treatments 
were investigated to understand the differences in persister killing by DC mediated with 
carbon vs. SS304 electrodes. The results revealed that pyocin production and SOS 
response were induced by DC treatments using carbon and SS304, respectively. The 
microarray results were validated by qPCR. Furthermore, some mutants of selected genes 
exhibited altered susceptibility to DC treatment. Overall, this study provided additional 
information for understanding the mechanism of ECCP and for designing more effective 
controls. 
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FIGURE CAPTIONS 
Figure 6.1. Transcriptional profile of P. aeruginosa PAO1 persister cells treated with 70 
µA/cm
2 
DC using carbon or SS304 electrodes for (A) 20 min, and (B) 40 min. 
 
Figure 6.2. Growth curves of the wild-type P. aeruginosa PAO1 and mutants in LB 
medium in the absence (A) or presence (B) of 1.5 μg/mL Tob.  
 
Figure 6.3. Viability of P. aeruginosa PAO1 and mutants after a 3.5-h treatment of 
planktonic stationary cultures with different concentrations of Cip.  
 
Figure 6.4. Effects of DC treatment of cultures of P. aeruginosa PAO1 and mutants of 
planktonic persister cells in stationary phase. The persister cells were treated 
with 70 µA/cm
2
 DC for 1 h using carbon (A) or SS304 (B) electrodes.  
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Figure 6.3 
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Table 6.1 
Comparison of transcriptional profile of selected genes expressed during  
DC treatment mediated with carbon and SS304 for 20 and 40 min using DNA microarray and q-PCR analysis 
Target Forward primer (5'-3') Reverse primer (5'-3') Fold change in mRNA level  
   
Microarray Quantitative PCR 
   20 min 40 min 20 min 40 min 
Housekeeping gene 
    pbpA CCACAAATAGTCCCCAGTCCC TTGCGGTCGAAGATGATCCC 
    DC using SS304 
    PA0647 GAGATTCGATAGCCGTCTCGG TCGATCACTTGGGCAACTCC 3.2 2.3 38.1 21.5 
PA4430 CTTCGAGATGGCCAACCAGT GTAGCCGAGGATCACGAAGG 3.1 16.9 1.3 12.9 
PA4614 GAGTCGACTTCTCCGACCTG TCACGACTTGTTCTGCTGGG 2.0 2.3 2.7 11.2 
PA0166 GGTGGCGCTGATCTACCTG GATATAGATCCCGACGTGCCG -2.4 -2.0 -2.4 -1.3 
pscF GGCATTCTTTCGCAGCTCAC ACCGACCACTTGTTGATCTTGT -3.1 -2.4 -3.2 -8.0 
DC using carbon 
    PA1032 ACGTTAGCTTCCCGTTCCAG AGATCAGTTCGATCCCGTGC 1.8 3.5 6.8 31.6 
PA4067 AGCATGAAGCTGCAGGACTC CGCGACAGTCTACGACTCAG 4.5 2.4 1.4 2.8 
PA0633 CAGATCTACGCCCTGGTTCC TCGTCTCGCCATCTTTCTCG 2.4 2.8 1.2 17.2 
PA0640 CGACATATTCAAGCGAGCCG AGGTCAGCCCTTTCGATTCC 2.6 1.7 1.9 2.4 
pscF GGCATTCTTTCGCAGCTCAC ACCGACCACTTGTTGATCTTGT -2.5 -1.4 -1.4 -1.7 
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Table 6.2 
List of genes common to the DC treatments using carbon and SS304 electrodes 
    carbon SS304 
genes   
20 
min 
40 
min 
20 
min 
40 
min 
Common genes induced 
PA4786 short-chain dehydrogenase 1.1 3.5 2.2 1.0 
PA4623 hypothetical protein 1.0 3.4 1.4 2.1 
PA4140 hypothetical protein 1.6 2.1 3.1 2.9 
rpsP 30S ribosomal protein S16 1.3 2.8 3.0 2.4 
glk glucokinase 3.2 8.5 3.7 0.9 
lexA LexA repressor 1.5 1.9 1.8 6.0 
PA2756 hypothetical protein 0.6 6.6 2.3 5.9 
PA2484 hypothetical protein 2.6 1.3 1.3 2.9 
PA2313 hypothetical protein 1.0 4.3 1.0 2.0 
PA0907 hypothetical protein 0.9 2.8 4.8 1.0 
PA0644 hypothetical protein 0.9 2.0 1.8 2.1 
PA0639 hypothetical protein 1.4 2.2 2.0 2.1 
PA0616 hypothetical protein 0.7 2.5 2.2 2.0 
PA0206 
probable ATP-binding component of ABC 
transporter 1.1 7.3 3.0 1.8 
Common genes repressed 
PA4894 hypothetical protein -1.2 -2.8 -1.8 -2.2 
panB 
3-methyl-2-oxobutanoate 
hydroxymethyltransferase -1.0 -2.0 -2.0 -1.1 
PA4347 hypothetical protein -1.3 -2.1 -2.3 -2.3 
PA4319 hypothetical protein -2.1 -0.6 -2.5 -0.9 
PA2324 hypothetical protein -2.8 -1.5 -3.0 -1.4 
pscF type III export protein PscF -2.5 -1.4 -3.1 -2.4 
PA1600 probable cytochrome c -2.3 -0.9 -2.2 -1.6 
PA0322 probable transporter -2.5 -1.7 -1.3 -2.7 
PA0317 hypothetical protein -1.0 -2.0 -1.5 -2.3 
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Table 6.3 
List of genes for outer membrane vesicle regulation after 70 µA/cm
2
 DC using SS304 
electrodes 
    fold change 
gene description 20 min 40 min 
PA4623 hypothetical protein 1.36 2.14 
PA1526 probable transcriptional regulator 2.98 6.43 
PA0647 hypothetical protein 3.21 2.32 
PA4638 hypothetical protein 3.04 0.79 
PA2885 probable transcriptional regulator 2.08 1.17 
PA4451 hypothetical protein 2.44 3.86 
PA0631 hypothetical protein 2.27 1.72 
PA0648 hypothetical protein 1.24 2.25 
xylZ 
toluate 1,2-dioxygenase electron transfer 
component 1.39 2.28 
PA2479 probable two-component response regulator 3.20 2.98 
PA2135 probable transporter 2.53 5.12 
hepA ATP-dependent helicase HepA 2.95 2.38 
PA1895 hypothetical protein 1.91 2.49 
PA3330 probable short chain dehydrogenase 2.94 1.41 
PA0368 hypothetical protein 3.77 2.04 
rpsI 30S ribosomal protein S9 3.04 1.95 
PA4372 hypothetical protein 2.27 2.11 
PA3517 probable lyase 2.17 2.39 
PA0616 hypothetical protein 2.22 2.02 
PA0206 
probable ATP-binding component of ABC 
transporter 3.02 1.79 
PA5380 probable transcriptional regulator 3.36 1.12 
PA0779 probable ATP-dependent protease 1.50 3.27 
PA1504 probable transcriptional regulator 0.59 3.95 
PA0308 hypothetical protein 2.69 1.76 
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Table 6.4 
List of mutants selected to study the gene function under DC treatments 
 
      Fold Change 
Condition Gene Description 
20 
min 
40 
min 
DC using 
SS304 
electrode 
pqsB 
beta-keto-acyl-acyl-carrier protein synthase-like 
protein 7.0 2.1 
pvcA pyoverdine biosynthesis protein PvcA 6.2 2.4 
PA1939 hypothetical protein 10.5 3.5 
PA4430 probable cytochrome b 3.1 16.9 
PA5461 hypothetical protein 9.7 12.5 
DC using 
carbon 
electrode 
aer aerotaxis receptor Aer 1.5 4.0 
glk glucokinase 3.2 8.5 
fusA2 elongation factor G 4.7 6.1 
oprG Outer membrane protein OprG precursor 4.5 2.4 
PA1897 hypothetical protein 2.3 4.1 
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CHAPTER 7 
PROBING THE SYNERGY BETWEEN TOBRAMYCIN AND 
CHROMIUM (III) IN THE ELECTROCHEMICAL TREATMENTS 
OF BACTERIAL CELLS 
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7.1. ABSTRACT 
The ability of the aminoglycosides to eliminate antibiotic-resistant bacteria can be 
enhanced by means of several physicals factors. For example, tobramycin (Tob) 
exhibited synergistic killing effects with direct currents (DC) in the electrochemical 
control of bacterial cells. As described in Chapter 3, the treatment of Pseudomonas 
aeruginosa persister cells with 70 μA/cm2 DC mediated with stainless steel 304 and 1.5 
μg/mL Tob resulted in 5-log reduction of the persister cell viability vs. 2-log in the 
absence of this antibiotic, and killing by Tob alone. Supplementation of the metal ions, 
e.g. Ni
2+
, Cr
2+
 and Fe
2+
, to carbon-mediated DC treatment was also found to increase 
persister killing in the presence of Tob, leading to our hypothesis that the interactions 
between Tob and metal ions could contribute to the synergy. To better understand these 
interactions and their effects on the cells, the electrochemical properties of the 
aminoglycosides, including Tob and a similar molecule, kanamycin (Kan), were 
investigated. The results of Nuclear Magnetic Resonance (NMR) analysis demonstrated 
that, unlike Kan, increase in the concentration of Cr
3+
 caused a shift in the HSQC peak of 
Tob, suggesting the formation Cr
III
(Tob) complexes under DC treatment. The stability of 
the complexes was further studied using UV-visible spectroscopy and cyclic voltammetry, 
which demonstrated that the configuration of the Cr
III
(Tob) complexes under the 
electrochemical treatment conditions could enhance the affinity between the complexes 
and negatively charged cellular components such as DNA or RNA. These findings are 
helpful for developing more effective approaches for improving the bioactivity of 
aminoglycosides and treat antibiotic-resistant bacteria more effectively. 
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7.2. INTRODUCTION 
The transport of aminoglycoside antibiotics across bacterial membranes consisting of 
lipid bilayers and complex transmembrane porins and channels is an energy-demanding 
process. This process is affected by many factors such the membrane potential of targeted 
cells, ionic strength and pH of the medium for treatment, and the electrochemical 
gradient of compounds in the vicinity of the cells
1
. Upon entering the cells, 
aminoglycosides bind to the ribosomal RNA
2,3
. Such interactions interrupt the function of 
the translational machinery, leading to protein mistranslation, SOS response and 
eventually cell death 
4
. Thus, the bactericidal effects of aminoglycosides are dependent 
upon their strong affinity with the cellular targets, which could be affected not only by 
the structure of the antibiotic itself but also by external physicochemical factors that can 
affect the transport of aminoglycosides. 
  
In contrast to other aminoglycosides such as gentamycin (Gen), amikacin (Amk), 
streptomycin (Strep) and kanamycin (Kan), Tob has an excellent bioactivity in the 
treatment of bacterial infections. In vitro and in vivo models of infections have 
demonstrated that Tob is very effective in killing multidrug-resistant pathogens including 
P. aeruginosa, Staphylococcus aureus and some Enterobacteriaceae. Tob differs 
structurally from Kan in that the later compound possesses an additional hydroxyl (OH) 
group (Fig. 7.1). This slight modification is believed to lower the basicity of Kan, 
weakening its electrostatic interaction with 16S ribosomal RNA, and consequently 
contributing to its low bioactivity
3
. In addition to these electrostatic considerations 
inherent to the antibiotics, the affinity between an aminoglycosides and its cellular target 
 184 
could also be affected by the ionic strength of the solution 
5
.Interactions between 
positively charged ions and aminoglycosides have been documented. Specifically, the 
susceptibility of P. aeruginosa to Strep, Gen, Amk and Tob decreased when the cells 
were grown on Mueller-Hinton Agar containing divalent cations such as Mg
2+
 or Ca
2+
 
6-9
. 
However, some reports present clear evidence that longer exposure of bacteria to metal 
cations alone including Co
2+
, Ni
2+
, Cu
2+
, Zn
2+
, Al
3+
 and Pb
2+
 in the mM range could 
reduce the number of viable P. aeruginosa cells by 3 logs 
10
. Interestingly, in a model of 
cystic fibrosis on epithelial cells, the bioactivity of Tobramycin against P. aeruginosa 
biofilm was found enhanced with the supplementation of iron chelators including 
deferoxamine and deferasirox 
11
, suggesting some rather synergistic effects between Tob 
and Fe.  
 
The synergistic killing of bacterial biofilm with DC, aminoglycosides and metal 
ions is a well-known phenomenon, referred to as bioelectric effects
12-14
. Recently, we 
have demonstrated synergistic killing of P. aeruginosa PAO1 persister cells can be 
achieved with low-level DC and 1.5 μg/mL Tob using SS 304 electrodes containing Fe, 
Cr, Mn an Ni. However, no synergy was found when Tob was added subsequently to the 
DC treated PAO1 persister cells. Also, the supplementation of 0.1 μM Ni2+, 0.27 μM  
Cr
3+, or 0.82 μM Fe2+ to the carbon mediated-DC treatment in the presence of 1.5 μg/mL 
Tob improved the killing of persister cells by 84.5 ± 1.2%, 38.1 ± 5.7%, and 20 ± 7.4%, 
respectively, compared to the treatment without ion supplementation. These findings led 
us to hypothesize that possible interaction between the SS-released metal cations and Tob 
could be beneficial to the control of bacterial persister cells, which could guide the design 
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of new therapeutics. Thus, the study in this chapter aims to characterize the 
electrochemical properties of Tob and metal cations, and their synergistic activities in 
killing P. aeruginosa cells.  
 
7.3. MATERIALS AND METHODS 
7.3.1. Chemicals and reagents 
Nickel (II) Chloride (NiCl2), Chromium (II) Chloride (CrCl2), Chromium (VI) oxide 
(CrO3), Chromium (III) chloride hexahydrate (CrCl3.6H2O) were purchased from Acros 
Organics (Thermo Fisher Scientific, Waltham, MA). Iron (II) chloride tetrahydrate 
(FeCl2.4H2O) was purchased from Sigma-Aldrich (St. Louis, MO). Ferric chloride 
anhydrous (FeCl3) and Manganese Chloride (MnCl2(H2O)x) were purchased from Fisher 
scientific (Waltham, MA). Tobramycin was purchased from TCI America (Portland, OR). 
Stock solutions for these chemicals were prepared with Milli-Q water. 
 
7.3.2. Electrochemical treatments  
To investigate the interaction between metal ions and aminoglycosides including Tob and 
Kan, an electrochemical cell as described in chapter 3 was constructed using TGON 805, 
a carbon-based material, as working and counter electrodes. An Ag/AgCl electrode was 
used as a reference electrode. Tob and Kan was diluted in Milli-Q water at the 
concentration of 9 mM and was supplemented with 10 μM Fe2+, Fe3+, Cr2+, Cr3+, Cr6+, 
Mn
2+
, or Ni
2+. Three milliliters of each mixture were treated with 70 μA/cm2 DC for 1 h 
using TGON 805, and the untreated sample was used as a control. After DC was 
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performed, both the untreated samples and the DC-treated samples were stored one ice 
till NMR was performed.  
 
7.3.3. Effects of Tob and Cr
3+
 on PAO1 without DC 
As mentioned in Chapter 3, we found that supplementation of Cr
3+
 to DC treatment of 
PAO1 mediated with carbon electrodes and in the presence of 1.5 μg/mL Tob resulted in 
improved killing of the persister cells. To understand if Cr
III
(Tob) complexes exhibit 
agonist or antagonist effects outside of the electric field, the wild-type P. aeruginosa 
PAO1 was cultured overnight in 25 mL Luria-Bertani (LB) medium 
15
 containing 10 g/L 
tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Each overnight culture was incubated at 
37°C with shaking at 200 rpm. The next day, the cells were sub-cultured at an initial 
OD600 of 0.05 in 200 μL LB contained in 96 well plates (Costar ® No. 9017, Corning, 
NY) in the presence or absence of 3.2 μM of Tob (~1.5 μg/mL Tob), 3.2μM Cr3+ in the 
presence of 3.2 μM Tob, and 3.2 μM CrIII(Tob), the DC-treated Cr3+-Tob mixture 
generated under electrochemical condition described above. PAO1 without treatment was 
used as a control and all the samples were grown with 8 replicates at 37 °C for 7h. 
Growth curves were recorded by measuring OD600 every hour using the ELx808 
Absorbance Microplate Reader (Biotek, Winooski, VT).  
 
7.3.4. Nuclear magnetic resonance spectroscopy 
Sensitivity-enhanced 
1 h
-
13
C HSQC-NMR experiment was performed on DC-free or DC-
treated ion-aminoglycoside mixtures using the Bruker Avance 500 MHz NMR (Bruker 
BioSpin Corporation, Billerica, MA). All experiments were conducted using a Bruker 5 
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mm QXI gradient probe at 25 ºC, with a 2 s relaxation delay. The delay for the INEPT 
transfer was determined based on the coupling constant of 155 Hz. The samples were 
scanned 32 times with a proton sweep width of 4005.4 Hz (equivalent to 8 ppm) and the 
carbon sweep width was 22638.2 Hz (equivalent to 180 ppm). To establish the 
heteronuclear correlation, 1024 points were collected for proton and 256 points for 
carbon, and the spectra were processed with 1024 points in both dimensions. 
 
7.3.5. UV-Vis Spectroscopy 
To study electrochemical properties of Cr
III
(Tob) complexes, solutions of 15 mM Cr
3+
 
solutions were prepared by dissolving 4.096 g CrCl3.6H2O in 1 L Milli-Q water.  
Cr
III
(Tob) complexes were formed by adding 7.2 g/L, 14.4 g/L or 21.6 g/L Tob to 15 mM 
Cr
3+
 solutions, resulting to a molar Tob:Cr
3+
 ratio of 1:1, 2:1 and 3:1, respectively (state 
final concentrations 15mM Tob and 15 µM Cr
3+
, 30 mM Tob and 15 µM Cr
3+
 for the 2:1, 
and 45 mM Tob and 15 µM Cr
3+
 for 3:1 mixtures. The cell path length was 1 cm). The 
pH of the solutions was adjusted to 1, 2, 4, 6, 8 and 10 using 12N HCl or 10N NaOH. To 
induce the deprotonation of Tob (Isoelectric point Ip=11.11) and the formation of 
Cr
III
(Tob) complex, the pH was also adjusted to 12. Using the Evolution
TM
 201-UV-
Visible Spectrophotometer (ThermoFisher Scientific, Waltham, MA), UV-visible spectra 
were recorded immediately after mixing the Tob and Cr
3+
 solutions, and 2.5 h later to 
evaluate the shift in the absorbance peaks. 
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7.3.6. Cyclic Voltammetry (CV) 
To evaluate the stability of the interaction between the aminoglycosides and ions, cyclic 
voltammetry was performed. A working gold electrode was used as the inert electrode to 
study the reversibility of the binding between Tob and Cr
3+
. TGON 805 and Ag/AgCl 
electrodes were used as counter and reference electrodes, respectively. First, the redox 
behavior of reference solution containing 15 mM Iron (II) ammonia sulfate 
((NH4)2Fe(SO4)2·6H2O), 15 mM Iron (III) chloride (FeCl
3
), and 15 mM CrCl3.6H2O were 
evaluated. A sweep voltage was applied at a scan rate of 100 mV/s between -1 V and 1 V, 
and a cyclic voltammogram was recorded. To evaluate the redox properties of the Tob- 
Cr
3+ 
complexes, the cyclic voltammograms of Tob alone, and complexes formed between 
15 mM Tob and 15 mM Cr
3+
 were recorded following the same procedure. 
  
7.4. RESULTS 
7.4.1. Antagonist effects of Tob and Cr
3+
 on the cells in absence of DC 
The interaction between Tob and Cr
3+
 have been shown to contribute to the killing of 
PAO1 persister cells under DC conditions in chapter 3 
16
.  To better understand the 
effects of the interaction between Tob and Cr
3+
, and the role of such interaction in the 
synergistic killing of the PAO1 cells, the bioactivity of the complexes were investigated 
outside of an electric field. A subculture of PAO1 was grown in LB in the presence or 
absence of Tob, and mixtures of Tob and Cr
3+
 (molar ratio of 3.2 μM: 3.2 μM) pre-
treated with or without 70 μA/cm2 DC using TGON 805. As shown in Fig. 7.2, the 
growth curve of the PAO1 cells demonstrated that the presence of Cr
3+
 affected the 
bioactivity of Tob. The cell density of PAO1 reached OD600 of 0.4 after 4 h of incubation 
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at 37º C with 3.2 μM Tob alone. However, compared to the growth with 3.2 μM (1.5 
μg/mL) Tob alone, the inhibitory activity of Tob on PAO1 cells was lost in the presence 
Cr
3+. The growth of PAO1 in the presence of 3.2 μM Tob and 3.2 μM Cr3+ (Tob/Cr3+), or 
3.2 μM CrIII(Tob) or Tob-Cr3+ complex generated electrochemically was similar to that of 
PAO1 cells culture in LB alone. All the cultures reached OD600 of 1 after 7 h of growth. 
 
7.4.2. Formation of Cr
III
(Tob) under DC treatment.  
To evaluate if electrochemical treatments facilitate the interaction between the 
aminoglycosides and metal ions, 10 µM of the metal ions were supplemented to 9 mM 
Tob or Kan in Milli-Q water and the mixtures were treated with 70 μA/cm2 DC using 
TGON 805 electrodes. As shown in Fig 7.3, no chemical shift was observed in the NMR-
HSQC spectra of Tob treated with DC compared to the untreated samples, suggesting that 
DC treatment in the presence of Ni
2+
, Fe
3+
, Fe
2+
, Cr
2+
, Cr
6+
 and Mn
2+
 did not induce any 
structural change to Tob or Kan. However, DC treatment of Tob-Cr
3+
 mixtures followed 
by analysis using 
1
H-
13
C HSQC-NMR showed changes in the chemical shifts of both 
1
H 
and 
13
C resonances of Tob as a function of the concentration of Cr
3+
 initially added to the 
system. Since the peaks in the 2D NMR spectrum are well defined and are not greatly 
shifted relative to the free antibiotic, they cannot be due to direct binding of mononuclear 
Cr
3+
 to Tob. Chromium (III) has a 3d
3
 electronic configuration with S = 3/2 in an 
octahedral crystal field (Table 2). This property of the ion produces long spin-lattice 
relaxation times for protons on attached ligands causing resonances to be highly shifted 
and broad effectively rendering them unobservable in the NMR spectrum 
17
. Since 
combining more than one Cr
3+
 ion to form di or polynuclear complexes can reduce the 
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effective electronic spin of the system through anti-ferromagnetic coupling mechanisms, 
it is possible that the chromium species produced upon the application of DC current is a 
polynuclear complex low net spin leading to narrow and only modestly shifted 
1 h
 and 
13
C 
resonances 
18-20
. Clearly additional work will be needed to identify the structure of this 
complex and how it is produced in the presence of the electric field. As shown in Fig. 7.4, 
the increase in the concentration of Cr
3+
 correlates with the shift of the peaks, confirming 
that Cr
III
(Tob)  complex formation occurred under DC treatment. Six major H chemical 
shifts were recorded and the relative value of the shift in comparison to the DC-free 
sample is reported in Table 1. The most significant H chemical shifts (shift 4 and 5) were 
generated by the hydrogen of the -CH2- bound group to the primary amine group (-CH2-
NH2). While the positions of peaks 4 and 5 for the DC-free control sample made of 9 mM 
Tob and 10 μM CrIII were located at 3.069 ppm and 2.812 ppm respectively, they shifted 
to 3.193 ppm and 2.939 ppm, respectively, after DC treatment. 
 
7.4.3. Interaction between Tob and Cr
3+
.  
The strength of interaction between Tob and Cr
3+
 was further investigated using UV-
visible spectroscopy. Tob and Cr
3+
 were mixed at equal concentration of 15 mM and the 
pH of the mixtures was adjusted to 1-12 using HCl to observe the interaction in acidic pH 
or NaOH to induce the deprotonation of Tob and facilitate its binding to Cr
3+
. As shown 
in Fig 7.5, the UV-Vis spectra of the samples, which were acquired immediately after 
samples were mixed, show that representative sifts occurred at pH lower than 6 and great 
than 10, and the sample precipitated at pH between 6 and 10.  However, to insure that 
complex formation occur, the rest of the experiment was conducted at pH 12, to insure 
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deprotonation of Tob (Ip=11.11). The samples were mixed and collected after 
equilibrium was reached, which occurred after 2.5 h. As shown in Fig. 7.5, the solution of 
CrCl3.6H2O exhibits 3 peaks, which are located at 300.02 nm, 425.27 nm and 588.87 nm, 
with a respective intensity of 0.539, 0.416 and 0.357, respectively. However, the gradual 
addition of Tob to Cr
3+
 solutions at pH 12 resulted in increase in the absorbance energy, 
broadening of the absorbance band and chemical shift (Fig. 7.6). The mixture of Tob and 
Cr
3+
 at a ratio of 1:1 generated peaks at 298.89 nm, 423.16 nm and 588.7 nm. The 2:1 
Cr
III
(Tob)  mixture further increased the shift in the absorbance band, resulting in peaks 
at 289.99 nm, 422.05 nm and 585.48 nm. Finally, the addition of the third volume of Tob 
to the Cr
3+
 solution resulted on absorbance peak at 289.56 nm, 421.23 nm and 584.75 nm. 
The shift intensity of the peak under this condition was 0.35, 0457 and 0.385, 
respectively.  These results suggested that the binding of Tob to Cr
3+
 might increase the 
energy state of Cr
3+
.  
 
To further evaluate the stability of the Cr
III
(Tob) complexes, CV experiments 
using a working gold electrode were performed and compared to other metal-ligand 
complexes involving amine groups. Thus, (NH4)2Fe(SO4)2·6H2O was used as a control 
solution. Other solutions including metal cation solutions (FeCl3, CrCl3.6H2O) and Tob, 
were also used as references. The cyclic voltammogram for the solutions of FeCl3 is 
shown in Fig. 7.7A, and demonstrated that Fe
3+
 is oxidized reversibly and reduced with 
peaks 490.95 mV and 310.3 mV. Similarly, the redox behavior of (NH4)2Fe(SO4)2·6H2O 
showed that Fe
2+
 was oxidized and reduced at working electrode potentials of 580.42 mV 
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and  -63.84 mV, respectively, suggesting a reversible reactions between Fe
2+
 and its 
amine or sulfate ligand.  
 
The cyclic voltammetric response of CrCl3.6H2O demonstrated that no electron 
was generated from Cr
3+
, corroborating with the absence of the oxidation peak. Instead, a 
reduction peak was recorded at 536.22 mV. Also, the cyclic voltammogram of Tob 
illustrated in Fig. 7.7B supports that the antibiotic did not lose electron over the range of -
0.5 V to 0.75 V. The CV plot of the mixture of Tob and Cr
3+
 at pH 5.8 (Fig. 7.7C) 
showed that the complex was not oxidized nor reduced over the voltage range tested, 
suggesting a stable interaction at pH 5.8. Similarly, the redox properties of the Cr
III
(Tob) 
complexes was tested at pH 12, and showed that the complexes did not oxidize (Fig. 
7.7D). However, a reduction peak became more apparent with the increase in the amount 
of Tob in the solutions (Fig. 7.7D), suggesting a loss of stability with the increase of Tob. 
 
7.5. DISCUSSION 
The electrical enhancement of antibiotic activity in killing cell associated with bacterial 
biofilms is well-known phenomena known to as bioelectric effects
12,14,21
. Recently, this 
finding has inspired our study on the persister cells’ response to electrochemical stress 
and led to the conclusion that similar technology could be employed to target recalcitrant 
bacterial infections associated with biofilms and persister cells, a phenomenon we named 
ECCP or electrochemical control of bacterial persister cells
16
. This interesting discovery 
led to hypothesize that the DC contributes to the electrochemical disruption of the 
membrane of the persister cells and facilitates the transport of the antibiotics through 
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interaction with electrochemical byproducts. Because electrochemical treatment mediated 
with SS304 electrodes generates metal cations including Fe, Cr, Mn, and Ni ions with 
various oxidation states, we proposed that the synergistic effects of the antibiotic Tob and 
DC in killing persister cells occurred in combination with the metal cations. This 
hypothesis was verified during the treatment of PAO1 persisters with 70 μA/cm2 DC 
using carbon electrodes in the presence of Tob and Ni
2+
, Cr
3+
 or Fe
2+
 (Chapter 3).  
 
In this Chapter, the interaction between Tob and the metal cations was further 
investigated. Different metal cations formed with SS-released elements were treated with 
DC in the presence of Tob to induce the interactions such as those occurring under the 
conditions of ECCP. Using NMR analysis, it was found that the interaction between Cr
3+
 
and Tob caused by DC resulted in H chemical shifts, suggesting that DC might induce 
structural change in Tob, which could be relevant to the synergy. The 
1
H-
13
C chemical 
shifts were analyzed based on previous study 
22
. It occurred that Cr
3+
 may bind to the free 
primary methylamine group (-CH2-NH2) or to a free primary amine of the cyclohexane 
group of Tob. 
 
To understand the roles of interaction between Tob and the SS-released cations in 
the synergistic control of the P. aeruginosa cells, PAO1 cells were grown in LB medium 
in the presence or absence of the Tob and the Cr
3+
. The results of this test confirmed that 
the interactions between Tob and Cr
3+
 still occurred without DC. However outside of the 
electrical field, such interactions were detrimental, as the bioactivity of Tob was found 
lower compared to Tob alone without Cr
3+
.  To further understand between Tob and Cr
3+
, 
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additional tests were performed to determine the electrochemical properties of the 
complex. First, the ability of Tob and Cr
3+
 to form conjugated species was evaluated over 
a range of pH varying from 1 to12. The UV-visible spectra show clearly that Cr
3+
 and 
Tob interact at pH lower than 6 and higher than 10, which might explain the finding that 
Cr
3+
 interfered with the bioactivity of Tob during the growth in LB solution. In effect, the 
redox properties of Cr
III
(Tob) at a 1: 1 molar ratio and at pH of 5.8 also showed no redox 
properties, suggesting the formation of stable complexes. 
 
To further investigate the nature of the interactions, the mixed solution of Tob and 
Cr
3+
 were adjusted to pH 12 to induce deprotonation, as DC treatment using carbon 
electrode induced local pH change. Thus, Cr
III
(Tob)  complexes were formed at different 
molar ratio to study the electrochemical properties of the complexes. The cyclic 
voltammetric response of the complexes to forward and reverse voltage scan ranging 
from -500 to 600 mV demonstrated that the complex was not oxidized, and was stable, 
unless more Tob molecules were interaction with Cr
3+
 (e.g. Tob:Cr
3+
 mixture with a 
molar ratio of 3:1). Then, a reduction peak, similar to that of Tob alone, was observed, 
suggesting that Cr
3+
 could become less stable with increasing interactions with Tob 
molecules. The UV-visible spectra of the complexes showed an increase in shift with the 
increase in Tob concentration. In addition, a third absorbance peak was recorded at 
~290nm, which suggests that Cr
3+
 might display a hydration isomery comparable to 
[Cr(H2O)6].Cl3 as reported by Barbier et al
23
.   
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The study of the electrochemical properties of Tob and Cr
3+
 could help 
understand the interaction between the aminoglycosides and the positively charged ions 
during the electrochemical control of bacterial cells. This interaction could be 
advantageous in the case of electrically induced disruption of the membrane functions. 
Thus, the movement of the complex under the DC condition may facilitate the transport 
of Tob and Cr
3+
, which could contribute to synergistic killing of bacterial cells. In effect, 
Cr
3+
 alone is known to cause oxidative damage of the DNA
24-26
. Due to its high 
electropositivity, Cr
3+
 interacts well with negatively charged molecules, including DNA 
27
. Hence, the binding of Cr
3+
 to Tob could increase the overall charge of Tob, which is 
positivily charged at pH below 11.11 (pI of Tob), and could favor the electrostatic 
binding interaction between the Cr
III
(Tob) complex and ribosomal RNA in the presence 
of DC. In the absence of DC, the Tob- Cr
3+
 interactions could exhibit adverse effects due 
to the binding of the complex to negatively-charged bacterial cells, and lead to the 
inability of Cr
III
(Tob) complex to cross the membrane barrier.  
 
7.6. CONCLUSIONS 
The interaction of Cr
3+
 and Tob was investigated in this study. The interaction between 
Cr
3+
 and Tob was hypothesized believe to contribute to the synergistic killing of PAO1 
cells during the electrochemical treatments. However, adverse effects were also recorded 
in the absence of DC, suggesting that the synergy between Cr(III) and Tob may be caused 
by electrically induced trans-membrane transport of Tob in the cells toward their 
negatively charged cellular target. However, DC treatment did not stimulate the 
formation of Cr
III
(Kan) complex. This finding demonstrates that the effectiveness of the 
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electrochemical treatment relies on the specific nature of the electrochemical agents 
exposed to the cells. 
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FIGURE CAPTIONS 
Figure 7.1. Structure of Tobramycin (A) and Kanamycin (B) 
 
 Figure 7.2. Growth curve of PAO1 in the presence or absence of Tob and Cr
III
. 
Tob/Cr3+ represent the growth in the presence of Tob and Cr
3+
, and [Tob-Cr
3+
] 
represents the growth in the presence of the DC-treated Tob-Cr
3+
 complex.The 
cells were subcultured at OD600 of 0.05 and the growth curve was recorded for 
7h. 
 
Figure 7.3. HSQC-NMR of a mixed solution of 9mM Tob and 10 µM Cr
3+
 (purple 
peaks), 9mM Tob and 50 µM Cr
3+
 (blue peaks), 9mM Tob and 100 µM Cr
3+
 
(green peaks) treated with 70 µA/cm
2
 DC using TGON vs. untreated control 
(red peaks).  δ F1 corresponds to δ 13C (in ppm) and δ F2 to δ 1H (in ppm). 
 
Figure 7.4. UV-visible spectra of Cr
III
(Tob) complexes at pH 1 to 12. The samples were 
allowed to reached equilibrium after 2.5h and the spectra were recorded. 
 
 Figure 7.5. UV-visible spectra of Cr
III
(Tob) complexes at pH 12. The samples were 
allowed to reached equilibrium after 2.5h and the spectra were recorded 
 
Figure 7.6. Cyclic voltammogram of (A) (NH4)2Fe(SO4)2·6H2O, FeCl3 and CrCl3.6H2O 
solutions, (B) Tobramycin and Cr
III
-Tob complexes at (C) pH 5.8 and (D) pH 12. 
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Figure 7.4 
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Table 7.1 : Relative value of the  H chemical shifts (in ppm) with the increasing 
concentration of Cr
3+
 and assignement of the H chemical shifts 
Peak 1 2 3 4 5 6 
Untreated control sample 5.2075 3.647 3.3446 3.0688 2.8122 2.9965 
DC_9mM Tob-10μM Cr3+ 5.219 3.6601 3.3564 3.0845 2.831 3.0035 
DC_9mM Tob-50μM Cr3+ 5.2423 3.678 3.3629 3.1063 2.8599 3.0147 
DC_9mM Tob-100 μM Cr3+ 5.2999 3.7288 3.3943 3.1926 2.9386 3.0595 
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Table 7.2 : Cristal field effects of Cr(III) 
  
4
A2 
(Ground 
State) State in the crystal field) 
    
 
pH 
4
T2(F) 
(nm) 
4
T2(F) 
(cm
-1
)   
4
T1(F) 
(nm) 
4
T1(F) 
(cm
-1
)   
4
T1(P) 
(nm) 
4
T1(P) 
cm
-1
) 
Cr(III) in 
water 1 590 16949   426 23474   300 33333 
 
2 636 15723 
 
444 22523 
 
295 33898 
 
4 634 15773 
 
444 22523 
 
289 34602 
 
12 600 16667 
 
434 23041 
 
300 33333 
Cr(III)/Tob 
1:1 1 577 17331   409 24450       
 
2 574 17422 
 
405 24691 
   
 
4 591 16920 
 
432 23148 
 
294 34014 
  12 582 17182   423 23641   292 34247 
          Average crystal field increases in the presence of Tob 
    Conclusion: The amino groups of Tob are binding to 
Cr(III) 
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CHAPTER 8 
SELECTIVE CONTROL OF P. AERUGINOSA CELLS BY 
ELECTROCHEMICAL TREATMENT OF CO-CULTURES INVOLVING 
HUMAN EPITHELIAL CELLS 
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8.1. ABSTRACT 
The implantation of artificial materials can encounter recurring complications due to 
surface colonization by multi-drug resistant microorganisms. The formation of microbial 
communities known as biofilms on contaminated biomaterials and the presence of 
biofilm associated persister cells present a great challenge for controlling device-
associated infections. As described in previous chapters, in vitro studies on Pseudomonas 
aeruginosa, a model of Gram-negative pathogen, have demonstrated that the 
electrochemical agents including direct current (DC) can improve the killing activities of 
antibiotics such as Tobramycin against the biofilm cells and persister cells. This approach 
holds to control potential chronic infections associated with implanted medical devices. 
To evaluate the safety of this technology and to help design in vivo studies, the effects of 
DC treatments on bacterial cells were further investigated in a co-culture model involving 
four human epithelial cell lines. The results show that 68.1% human cells can survive the 
treatment with 70 μA/cm2 DC using stainless steel (SS) 304 electrodes for 1 h, while 90% 
P. aeruginosa cells were eliminated in the co-culture with epithelial cells. An additional 
2-log killing of P. aeruginosa was achieved by augmenting the current density to 84 
μA/cm2 DC or through synergistic effects with Tob. 
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8.2. INTRODUCTION 
Infection with opportunistic pathogens is a major risk factor associated with implantation 
of medical devices, on medical equipment and devices has increased the risk of acquiring 
and developing chronic infections during or after major surgeries
1
, intubation procedure
2
, 
and treatment of burn patients
3
. In the last two decades, Pseudomonas aeruginosa has 
emerged as one of the leading nosocomial pathogens for which novel strategies of control 
are urgently needed
4-6
. Owing to inherent abilities such as efflux pumps, this Gram-
negative bacterium can extrude antibiotics that are commonly used to treat infection, or 
adopt a different lifestyle allowing it to colonize surfaces of tissues of biomaterials and 
develop sessile communities known as biofilms. The extracellular polymeric substances 
of biofilms provide the embedded cells with extra layers of protection against the host 
immune system and limit flow across the biofilms, rendering the diffusion of antibiotics. 
Consequently, P. aeruginosa can escape from the treatment of many antibiotics such as 
β-lactam7, fluoroquinolones8, carbapenems9 and aminoglycosides10,11, and cause to 
persistent infections. 
 
The mechanisms of antibiotic resistance rely on the ability of the cells to control 
membrane permeability, modify the cellular targets of antibiotics or enzymatically 
degrade antibiotic compounds. Given the rapid increase in antibiotic resistant infection, 
other approaches, such as those involving physical or electrochemical factors, are being 
pursued. Among these non-conventional methods, low direct currents (DCs), alternating 
currents (ACs), and electric fields have been proven to kill bacteria
12,13
. Recently, we 
reported that persister cells isolated from P. aeruginosa PAO1 can be effectively killed 
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(by about 2 logs) with low-level DC (70 μA/cm2). Also, synergistic effects were observed 
when persister cells were treated with DC and Tob together.  
 
Although the safety of such DC treatment has not been tested, certain electrical 
currents and potentials are known to be beneficial to mammalian cells and could promote 
the migration of macrophages, neutrophils
14
, fibroblasts
15
 and epithelial cells
16,17
 engaged 
in inflammatory response, and thus improve wound repair 
18-20
.  Thus, we hypothesize 
that selective killing of bacterial cells can be achieved by applying low-level DC to co-
cultures of mammalian and bacterial cells. In the study outlined in this chapter, different 
human epithelial cancer cell lines were utilized in a model of infection with PAO1 to test 
the efficacy of the DC treatment using SS 304 in killing bacterial cells and evaluate the 
cytotoxicity of this treatment. The effects of antibiotic (Tob) and electric currents on the 
viability of both bacterial and human cells were investigated.  
 
8.3. MATERIALS AND METHODS 
8.3.1. Bacterial cell and culture condition 
The wild-type P. aeruginosa PAO1 was cultured in Luria-Bertani (LB) medium
21
 
containing 10 g/L tryptone, 5 g/L yeast extract, and 10 g/L NaCl. Each overnight culture 
was incubated at 37°C with shaking at 200 rpm.  
 
8.3.2. Human cell lines and culture condition 
Human epithelial lung cancer cells CRL-5907 (NCI-H1944), CRL-5908 (NCI-H1975), 
CLR-5803 (NCI-H1299), and human epithelial breast cancer cell MDA-MB-231 
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(ATCC® HTB-26 ™) were generously provided by Dr. Jing An at SUNY Upstate 
Medical University. The epithelial cells were grown in RPMI medium supplemented with 
10% Fetal Bovine Serum (FBS) and 1% of Penicillin-Streptomycin-Glutamine (PSG).  
 
8.3.3. Effects of low-level DCs on human epithelial cells. 
To test the effects of DC on adherent cells, human epithelial cells (NCI-H1944) were 
grown for 8 days on collagen-coated 12 well-plate inserts in the presence of 2 mL of 
RPMI medium supplemented with 10% FBS and 1% PSG; and the medium was 
replenished after the fourth day of the culture. The cells attached on the insert were 
washed with Hank’s balanced salt solution (HBSS), and the insert was transferred to an 
electrochemical cell with of HBSS buffer to investigate the effects of electrochemical 
currents on mammalian cells. The electrochemical cell was constructed by inserting two 
flexible sheets of SS 304 in a well of a 12 well-plate, above and below the sample, 
respectively. An Ag/AgCl-reference electrode was prepared by dipping a silver wire into 
a solution of sodium hypochlorite for 30 min. All the electrodes were introduced in the 
well in the 3-configuration system, as depicted on Fig. 8.1. Using a potentiostat, Total 
DC level of 500 μA was delivered to the cells for 30 min. In this experiment, the cells 
were tested under three conditions: (1) The untreated control sample was exposed to 
HBSS solution only without DC treatment; (2) The sample treated using cathodic current 
had the cells exposed to the counter electrode while the working electrode was separated 
from the cells by the permeable membrane of the insert; (3) The sample treated using 
anodic current had the cells directly exposed to the working electrode. The viability of 
 217 
cells was evaluated by imaging after staining with Live/dead Cell-Mediated Cytotoxicity 
Kit (Life Technologies, NY).  
 
To test the effects of DC on suspended cells, human epithelial cells NCI-H1299, 
NCI-H1975 and ATCC® HTB-26 ™ were grown in a T-flask containing 25mL of RPMI 
supplemented with 10% FBS and 1% PSG. The cells were incubated for 4 days in the 
presence of 5% CO2 at 37 °C. To release the adherent cells in the suspension, the cells 
were treated with TE buffer containing 0.25% Trypsin and 0.53 mM EDTA. After re-
suspension in RPMI, the cells were washed and re-suspended in HBSS buffer to perform 
DC treatment. An electrochemical cell was constructed by inserting two SS 304 coupons 
along the opposite sides of a cuvette. An Ag/AgCl electrode was also inserted into the 
cuvette to establish the 3 electrodes system. To investigate the effects of electrochemical 
currents on epithelial cells, 70 µA/cm² DC was supplied to the cells for 1 h in the absence 
of antibiotic. Using the trypan blue exclusion method, the cell viability was evaluated 
every 20 min.  
 
8.3.4. Determination of Tob concentration for testing the synergy with DC 
To determine what concentration of Tob is appropriate for testing the synergy with DC in 
co-culture, NCI-H1299, and NCI-H1975 were allowed to adhere on the surface of a 12-
well plate after 4 days of incubation at 37°C in a 5% CO2 incubator. The medium was 
then decanted and the cells were washed with PBS buffer. The adherent mammalian cells 
were infected with PAO1 cells with a cell density at OD600 equals to 0.5. Concentrations 
of Tob varying from 0-120 μg/mL were used to treat the co-cultures for 1 h and 2h. The 
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cells were incubated at 37°C without shaking. To understand whether or not the 
adherence of the mammalian cells to surfaces affected the susceptibility of the bacterial 
cells to Tob, another experiment was performed, in which human epithelial cells NCI-
H1299, and NCI-H1975 were re-suspended in PBS buffer and infected with the same 
density of P. aeruginosa PAO1 cells (OD600= 0.5) in 24-well plate. Finally, the cells were 
treated with 0-120 μg/mL Tob for 1 and 2 h and were incubated at 37°C with shaking to 
prevent the adherence of the mammalian cells.  In both conditions, the viability of 
bacterial cells was determined by counting colony-forming unit (CFU). 
 
To test the effects of Tob on P. aeruginosa PAO1, NCI-H1299 cells re-suspended 
at a density of 1.5x10
5
 cells/mL were infected with PAO1 cells at OD600 of 0.15, resulting 
to a bacteria/NCI-H1299 ratio of 100-1000/1. The co-culture of NCI-H1299-PAO1 was 
treated with 3 µg/mL Tob (without DC) and compared with the Tob free co-culture 
controls. The viability of the mammalian cells during treatment was determined using 
trypan Blue exclusion assay. The number of viable bacterial cells was quantified by 
counting CFU. 
 
8.3.5. Effect of DC and Tob on the viability of P. aeruginosa PAO1 in co-cultures 
NCI-H1975 cells were collected after treatment of a 4-day culture with TE buffer and 
centrifugation at 1000 rpm for 3 min. The NCI-H1975 cells were then re-suspended in 
0.85% NaCl solution. Meanwhile, P. aeruginosa PAO1 cells were collected from an 
overnight culture and the cells were washed and re-suspended in 0.85% NaCl solution. 
Initially, NCI-H1975 cells were introduced in the electrochemical cell with P. aeruginosa 
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PAO1 cells at OD600 of 0.15. DC with a current density of 70 µA/cm
2
 DC was supplied 
for 1 h using SS 304 electrodes in the presence and absence of Tob to challenge the co-
culture of bacterial and human cells. The viability of human cells was investigated after 1 
h of DC treatment using Trypan Blue exclusion assay. The number of viable bacterial 
cells was quantified by counting CFU. 
 
8.4. RESULTS  
8.4.1. Effects of DC treatment on epithelial cells. 
Human epithelial cells NCI-H1944 were successfully grown on collagen-coated 12 well-
plate inserts. The cells were seeded for 8 days at a density of 60,000 cells/insert and 
treated with 500 μA of total DC for 30 min. The results revealed that less than 50% of the 
cells treated with the cathodic currents for 30 min were viable (Fig. 8.2). However, cells 
treated using anodic current were less affected than those treated with the cathodic 
current. To test if the low survival rate of the cells exposed to cathodic currents was the 
result of high current density delivered to each individual cell, the cell density was 
doubled to 1.3x10
5
 cells/insert in order to improve the confluence of the cells and 
therefore their tolerance of the current density. These cells were also treated with a total 
DC of 500 μA for 30 min using SS 304. As shown in Fig. 8.3, the treatment was slightly 
improved in that condition. The cells displayed a higher survival rate during the treatment 
administered using anodic currents. On the other hand, the viability of cells treated with 
cathodic currents was lower, and most dead cells were found near the center of insert. 
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To investigate the effects of electrochemical currents on suspended mammalian 
cells, planktonic suspensions of NCI-H1944 cells were treated with current levels ranging 
between 35 and 70 µA/cm² DC. Fig. 8.4A shows that the viability of the planktonic 
suspension of human epithelial cells was reduced by 26.8%, with 35 µA/cm² DC using 
SS 304. Similar level of killing was observed for all three conditions (one-way ANOVA, 
p =0.17). The viability of NCI-H1299, NCI-H1975 and ATCC® HTB-26 ™ cells tested 
with 500 µA or 70 µA/cm² DC for 1 h was also evaluated. Fig. 8.4B demonstrates that 
low-level DC treatment had cidal effects on the tested epithelial cancer cells. In particular, 
ATCC® HTB-26 ™ epithelial breast cells was severely affected by the treatment with 70 
µA/cm² DC, which resulted in the decrease of the cell viability by 69.0%. The NCI-
H1975 cells, which are epithelial cells derived from the lung cancer, were more resistant 
to 70 µA/cm² DC. Only 43.9% NCI-H1975 were eliminated by DC treatment. Among the 
epithelial cancer cells, NCI-H1299 tolerated the most the DC treatment. Only 35.7% of 
the cells were killed by the DC treatment (one-way ANOVA, p =0.057), suggesting that 
NCI-H1299 might have a greater resistance to the electrochemical currents. 
 
8.4.2. Effects of antibiotics on cell viability in a co-culture model 
To determine a concentration of Tob that has minor effects on the viability of bacterial 
cells in the co-culture model, suspensions of NCI-H1299 and NCI-H1975 were infected 
with P. aeruginosa PAO1 cells (OD600= 0.15) and treated with 0-120 µg/mL Tob. The 
viability of P. aeruginosa PAO1 cells in the co-cultures was significantly reduced by the 
antibiotic treatment after 1 h and 2 h, compared to the Tob free control sample. As shown 
in Fig. 8.5A, incubation of PAO1 with 120 μg/mL Tob reduced the number of viable 
 221 
PAO1 cells by 2 logs, while the cells incubated with the epithelial cells were killed by 3 
logs by Tob. Fig. 8.5B demonstrates that this difference increases overtime. After 2 h of 
(120 µg/mL) Tob treatment, the number of viable PAO1 cells incubated with the 
epithelial cells decreased by 4.5 logs (one way ANOVA, p <0.001 for all conditions). 
However, the survival of bacteria was not significantly affected by Tob with a 
concentration lower than 3 μg/mL. To determine if attachment of the mammalian cells 
affects the susceptibility of the bacterial cell to Tob, NCI-H1299 and NCI-H1975 were 
also tested by allowing these cells to adhere to the surface of a 12-well plate and were 
infected with P. aeruginosa PAO1 cells at OD600 equals to 0.15. The cells were incubated 
with Tob for 1 h. As shown in Fig. 8.6, PAO1 cells incubated with NCI-H1975 was more 
susceptible to the antibiotic treatment compared to those incubated with NCI-H1299 
(one-way ANOVA, p=0.001 for both conditions).  In the presence of 120 μg/mL Tob, the 
bacteria were killed by 5 logs when they were incubated with NCI-H1975. In contrast, 
the PAO1 cells in co-culture with NCI-H1299 were killed by 3 logs (one-way ANOVA, p 
=0.001 for both conditions). This finding suggests that both physiological state (attached 
vs. suspended) affect the interaction with bacteria and thus the efficacy of antibiotic 
treatments.  
  
To confirm that 3 μg/mL Tob alone has minimal effect on P. aeruginosa in our 
co-culture model, mixed suspension of PAO1 and NCI-H1299 cells was treated with 3 
µg/mL Tob (without DC) for 4 h and the cell viability was compared to that of the Tob-
free control. The viability of P. aeruginosa PAO1 cells was reduced by about 1 log after 
4 h treatment of the co-culture with 3 μg/mL Tob (Fig. 8.7A). On the other hand, the 
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viability of the NCI-H1299 cells did not decrease (Fig. 8.7B) even after 16 h treatment of 
the co-culture with 3 μg/mL Tob (t-test, p =0.901). These results indicate that Tob levels 
between 1.5 and 3 µg/mL are appropriate for testing the synergistic effects of DCs and 
antibiotics in the co-culture model. 
 
8.4.3. Viability of the bacterial cells during DC treatment. 
To evaluate the effects of electrochemical currents in a co-culture model, NCI-H1299 
cells prepared as described above were mixed with stationary phase PAO1 cells with an 
inoculation OD600 of 0.15. Then, 70 µA/cm
2
 DC was delivered to the co-cultures for 1 h 
in the presence and absence of 1.5 or  3μg/mL Tob. It was found that the viability of the 
NCI-H1299 cells was not significantly reduced (Fig. 8.8A). In contrast, 70 μA/cm2 DC 
treatment mediated with SS 304 electrodes killed PAO1 by more than 1 log and synergy 
was observed with increasing level of Tob (t-test, p <0.025 for all conditions, Fig. 8.8B). 
The killing was found to be dependent on both the concentration of Tob and the dose of 
DC delivered to the cells. Increasing Tob concentration from 3 to 12 and 30 μg/mL 
resulted in increased killing of PAO1 cells (Fig. 8.8B). Furthermore, by augmenting the 
current density from 70 μA/cm2 to 84 μA/cm2, the DC treatment became more effective 
in selective killing of PAO1 cells. One additional log killing was achieved by increasing 
DC level from 7 to 84 μA/cm2 (Fig. 8.8B). The results suggest that selective killing of the 
bacterial cells could be achieved by means of the electrochemical treatments. 
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8.5. DISCUSSION 
The bioactivity of the DC and electric fields on mammalian cells is well documented and 
has demonstrated that the cells react differently to various levels of currents
22
. In the 
medical field, low-level direct currents and electric fields has been utilized both to 
promote the growth of normal cells during wound healing
19,20,23
 and to eliminate tumor 
cell
24-27
, which is referred to as electrochemical cancer therapy (ECT). Because the 
electrophysiological properties of cancer cells is lower than that of normal cells
28
, it was 
beneficial for us to develop a model of infection with epithelial cancer cells to study the 
selectivity of the DC treatments, not only because the cancer cells are more susceptible to 
electrical treatments compared to normal cells, but also because they replicate faster 
compared to the normal epithelial cells, offering convenience for experiments. 
Furthermore, the cancer cells can be suspended allowing us to compare the killing in a 
well-mixed co-culture, to develop an in vitro model of bacterial infection with epithelial 
cells, four epithelial cell lines were used, including NCI-H1944, NCI-H1299, NCI-H1975, 
and ATCC® HTB-26 ™. The epithelial cancer cell lines were tested with 70 μA/cm2 DC 
using SS 304 electrodes to evaluate the cytotoxicity of the electrochemical treatments. 
The results show that the epithelial cells were more susceptible to the treatments when 
exposed to cathodic currents instead of anodic currents. The increase in cell density 
enhanced the tolerance of epithelial cells to anodic current, which may better represent 
the tissues with multiple layers and high density of mammalian cells. In addition, our 
results showed that these cell lines have different levels of tolerance to the 
electrochemical currents, and that NCI-H1299 withstood better the effects of DC than the 
other three cell lines tested. 
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After the initial tests, the co-cultures were used to simulate infections; it was 
found that PAO1 cells become more sensitive to Tob in the presence of epithelial cells, 
which may be due to the secretion of different factors by the human cells. The treatment 
of the mixed cultures revealed that the P. aeruginosa PAO1 cells were significantly killed 
after treatment with high level of antibiotic and long exposure to antibiotics. At 
concentration lower than 3 μg/mL Tob, however, no major killing effects were recorded. 
Therefore, the concentration of 3 μg/mL Tob was retained to test the synergy with 70 
μA/cm2 DC and Tob in killing bacteria in the mixed cultures. The results of the DC 
treatment revealed that DC was more effective in killing PAO1 cells compared to 
epithelial cells under the selected condition, and synergistic effects between DC and Tob 
were observed. The extent of the bacterial killing under this condition was about 3 logs, 
which is lower than the 5 logs achieved in the DC treatment of P. aeruginosa PAO1 cells 
using SS 304 electrodes and 1.5 μg/mL Tob in the absence of human cells. 
 
The mechanism of the selective killing of bacterial cells by the low-level currents 
is unknown. In Chapter 3, it was demonstrated that the metal ions released from SS 304 
(Fe, Cr, Ni and Mn) during the DC treatment play an important role in bacterial killing 
29
. 
It is well documented that the high chloride concentration can induce pitting corrosion of 
stainless steel and the subsequent release of Fe, Cr and Ni ions among many others 
30
.Hence, from these results, it is tempting to postulate that cathodic current affect the 
cells in a way that the accumulation of positive charges at this electrode and around 
negatively charged cells affect the membrane properties of the cells. Also, the generation 
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of cathodic electrochemical byproducts such as reactive oxygen species (ROS) has been 
proposed as one of the reasons why treatment of the cells with cathodic current was more 
potent 
31
. The results described in this chapter suggest that this technology may be 
extended to chronic infections associated with deep tissue or medical implants.  
   
The results also provide guidance for testing of safety and efficacy of the 
electrochemical treatments in animal models and the development of an electrochemical 
technology for infection control. The preliminary data collected in this chapter show that 
the delivery of appropriate level of electric current density at the infection site could 
result in the selective killing of bacterial cells 
29
. 
 
8.6. CONCLUSIONS 
Electrochemical treatments generated with 70 μA/cm2 DC using SS 304 electrodes were 
found to effectively kill PAO1 cells in co-cultures involving human epithelial cells. P. 
aeruginosa PAO1 cells can be selectively eliminated with appropriate level of current 
density. While anodic currents were found safer for epithelial cells, the cathodic current 
presents a greater advantage compared to the anodic current in killing bacterial cells. 
Also, synergistic killing of P. aeruginosa PAO1 cells was achieved between and 3 μg/mL 
Tob. Overall, this study demonstrated that electrochemical treatments using DC and 
antibiotics have potential to eliminate bacterial cells attached to medical devices or 
attached to epithelial cells. 
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FIGURE CAPTIONS 
Figure 8.1. Electrochemical cell used for DC treatment of epithelial cells adhered to a 
well-insert. The epithelial cells were attached to the well-insert and sandwiched 
between the working and the counter electrode to perform DC treatment. 
Figure 8.2. DC treatment of epithelial NCI-H1944 cells (60,000 cells/insert) seeded for 8 
days on collagen-coated inserts. The samples were treated without (A1, A2) or 
with 500 µA total DC of cathodic (B1, B2) or anodic (C1, C2) DC for 30 min 
using SS 304.  
 Figure 8.3. DC treatment of epithelial NCI-H1944 cells (130,000 cells/insert) seeded for 
7 days film on collagen-coated inserts. The samples were treated (A1, A2) 
without or with 500 µA total DC of (B1, B2) cathodic or (C1, C2) anodic DC 
for 30 min using SS 304. 
Figure 8.4. Viability of the epithelial cells after the electrochemical treatment of cells in 
suspension. (A) viability of the NCI-H1944 cells reported as a function of 
current level. (B) viability of different human epithelial cell lines including 
NCI-H1975, NCI-H1299, and ATCC® HTB-26 ™ after treatment with 70 
µA/cm
2
 DC using SS 304.  
 Figure 8.5. Viability of the PAO1 cells in the co-culture model after 1 h (A) or 2 h (B) 
treatment using Tob. The PAO1 cells were treated with 0-120 μg/mL Tob in the 
presence of NCI-H1975 or NCI-H1299 epithelial cells. The number of viable 
PAO1 cells was quantified by counting CFU. 
 Figure 8.6. Viability of the PAO1 cells in the co-culture model after 1 h treatment using 
Tob. The PAO1 cell suspension was added to adherent culture of NCI-H1975 
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and NCI-H1299 epithelial cells and treated with 0-120 μg/mL Tob. The number 
of viable PAO1 cells was quantified by counting CFU. 
Figure 8.7. Viability of PAO1 cells (A) and that of NCI-H1299 (B) in the co-culture 
model treated with 3µg/mL Tob only. The number of viable PAO1 cells was 
quantified by counting CFU, and that of the NCI-H1299 cell was quantified 
using the trypan blue exclusion method. 
Figure 8.8. Viability of PAO1 cells treated with different levels of DCs and antibiotics. 
The number of viable PAO1 cells was quantified by counting CFU, and that of 
the NCI-H1299 cell was quantified using the trypan blue exclusion method. 
 
 
 
 
  
 231 
 
 
 
 
 
 
 
 
 
 
Figure 8.1 
  
 
Working electrode Counter electrode 
Reference electrode 
insert 
2.5 cm 
 232 
 
Figure 8.2 
  
A1 
A2 B2 C2 
B1 C1 
 233 
 
 
Figure 8.3 
 
 
 
  
A1 
A2 
B1 C1 
B2 C2 
 234 
 
(A) 
 
(B) 
Figure 8.4 
 
  
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
0 20 40 60
N
u
m
b
er
 o
f 
V
ia
b
le
 C
el
ls
/m
L
 
Time (min) 
35 μA/cm² 56 μA/cm² 70 μA/cm² 
1.00E+00
1.00E+01
1.00E+02
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
0 20 40 60
N
u
m
b
er
 o
f 
V
ia
b
le
 C
el
ls
/m
L
 
Time (min) 
ATCC® HTB-26 ™ NCI-H1299 NCI-H1975
 235 
 
(A) 
 
 
(B) 
Figure 8.5 
 
  
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
0 10 20 30 40 50 60 70 80 90 100 110 120
C
F
U
/m
L
 
Concentration of Tob (µg/mL) 
1 h PAO1 Control
PAO1/NCI-H1299
PAO1/NCI-H1975
1.00E+03
1.00E+04
1.00E+05
1.00E+06
1.00E+07
1.00E+08
1.00E+09
1.00E+10
0 10 20 30 40 50 60 70 80 90 100 110 120
C
F
U
/m
L
 
Concentration of Tob (µg/mL) 
2 h 
Control PAO1
PAO1/NCI-H1299
PAO1/NCI-H1975
 236 
 
 
 
 
Figure 8.6 
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Figure 8.8 
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CHAPTER 9 
ELECTROCHEMICAL TREATMENT OF PSEUDOMONAS 
AERUGINOSA IN A RABBIT MODEL OF SINUSITIS 
 
 
 
 
 
 
 
 
 
 
 
 
 
The animal surgery described in this Chapter was conducted by Dr. Parul Goyal and Dr. 
Greg Haveman (SUNY Upstate Medical University). 
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9.1. ABSTRACT 
Sinusitis is a common medical condition related to the inflammation of sinuses. The 
presence of bacterial biofilms on the sinus mucosa renders antibiotic treatments 
ineffective, and contributes to the recurrence of infections. The potent activities of direct 
current (DC) to effectively kill the biofilm cells, or enhance the susceptibility of the 
embedded bacterial cells to antibiotics, have attracted increasing interest recently.  In 
chapter 3, we have demonstrated that such synergistic effects could also be extended to 
eradicate drug tolerant persister cells. In this chapter, the effects of electrochemical 
currents were further tested on an in vivo model of sinus infection. A model of sinusitis in 
rabbits was induced with Pseudomonas aeruginosa, and the infection was treated for 1 h 
with 15 μg/mL Tob in the presence or absence of a total direct current (DC) of 1mA. 
Compared to the untreated controls, treatment with Tob alone reduced the total number of 
cells within the pus by 88.3%, but failed to prevent the proliferation of biofilm cells. Co-
treatment of the infections with 1 mA DC and 15 μg/mL Tob had more profound effects, 
reducing the cells count in pus by 3 logs and the biofilm cells by 58.0%, compared to the 
treatment with Tob alone. These results corroborated with SEM analysis showing the 
presence of lyzed P. aeruginosa cells on mucosal specimen of sinus treated with both DC 
and Tob. In addition, histological analysis of the specimen validated the effectiveness and 
the safety of electrochemical treatments in reducing biofilms and eradicating planktonic 
cells of P. aeruginosa in rabbit model.   
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9.2. INTRODUCTION 
Rhinosinusitis constitutes a significant health care burden in the U.S. and worldwide.  It 
is estimated that over 30 million Americans are affected by sinusitis annually, leading to 
$5.8 billion cost in health care, and loss of productivity of affected individuals. In 
addition, many of the sinusitis patients suffer from persistent symptoms despite 
antimicrobial and surgical treatments 
1,2
. Biopsies of sinus tissues from patients with 
recalcitrant sinusitis have been found to harbor bacterial biofilms
3
, which are 
multicellular structures of bacteria embedded in a matrix with self-secreted proteins and 
extracellular DNA. The protection of the extracellular matrix enables the cells to escape 
from host immune response and antibiotics.  These microbial aggregates play a major 
role in a wide range of infections, particularly in chronic disease processes, and those 
associated with medical implants. In fact, bacterial biofilms are involved in up to two 
thirds of human infections
4
, such as head and neck infections, chronic otitis media
5
, and 
chronic tonsillitis
6
.  
  
It is well established that bacteria in biofilms are highly resistant to antibiotics, 
and require concentrations 500 to 5,000 times higher than those needed to treat free 
swimming cells
7
.  Multiple therapies have been developed in the hope to weaken or 
eradicate sinus biofilms. These methods involve high concentration antibiotics, various 
surfactants, and techniques to physically remove the biofilms.  However, no treatment 
method has been proven effective to treat biofilms without causing excessive damage to 
sinus mucosa 
8
. 
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In the early 90’s, several studies showed that the killing effects of antibiotics 
could be dramatically enhanced when given in the presence of a mild electrical field
9,10
.  
These findings have since been reproduced in multiple in vitro studies, using a variety of 
antibiotics and pathogens
11
.  Further investigations on the effects of electrical factors 
have demonstrated that electric current alone could also stimulate the detachment of  
biofilm cells from the substrate
12,13
.  As described in Chapter 3, we have revealed that 
chronic infections associated with biofilm and persister cells of P. aeruginosa could be 
eradicated with 70 μA/cm2 DC using SS 304 electrodes in the presence of tobramycin 
(Tob). For instance, co-treatment of P. aeruginosa biofilms with DC and 15 μg/mL Tob 
for 2 h reduced the number of viable persister cells in biofilm by 99.4% compared to the 
untreated control 
14
.  These findings motivated us to further evaluate this approach 
against mucosal biofilms in vivo in a model of sinusitis.   
  
The goal of the study outline in this chapter is to assess the effectiveness of 
electrical current delivered along with Tob in eradicating P. aeruginosa in a rabbit model.  
It also aims to evaluate the safety of such electrochemical treatment. The results can help 
develop new treatment for patients suffering chronic sinusitis.  
 
9.3. MATERIALS AND METHODS 
9.3.1. Experimental setup of the electrochemical treatment 
To understand how the impedance of animal tissues affect the delivery of electrochemical 
currents, different setups of DC treatment were experimented on previously sacrificed 
mice generously provided by Dr. Jing An at SUNY Upstate Medical University. DC at 1 
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mA level was delivered using SS 304 electrodes and a series of potentiodynamic curves 
were recorded. Four main conditions were tested: (1) The working electrode was 
introduced with the reference electrodes inside the tissue of the mouse, while the counter 
electrode was attached to the skin outside of the mouse; (2) The counter electrode was 
inserted inside the tissue with the reference electrodes, while the working electrode was 
attached to the skin outside; (3) Same as the setup but the skin of the mouse was shaved 
before the working electrode was placed. (4) Same as the third setup, DC treatment of the 
mouse snout was performed in the presence of electrolyte to evaluate the effects on the 
impedance of nasal cavities and tissues. In all the case, a potentiodynamic curve was 
recorded. 
 
9.3.2. Rabbit model of sinusitis.  
Eight New Zealand white male rabbits (3-4 kg each) were used to evaluate the safety and 
efficacy of electrochemical treatments of P. aeruginosa PAO1 involved in sinus 
infections. To induce the infection, P. aeruginosa PAO1 cells were grown overnight in 
25 mL Luria-Bertani (LB) medium 
15
 containing 10 g/L tryptone, 5 g/L yeast extract, and 
10 g/L NaCl. The overnight culture was incubated at 37°C with shaking at 200 rpm. On 
the next day, a subculture of PAO1 was made by adding 25 µL of the overnight culture in 
25 mL of fresh LB medium and the cells were grown to the log-phase and collected when 
the cell density reached an OD600 of 0.6. The cells were washed with 0.85% NaCl 
solution and re-suspended to the same cell density. Then 0.4 mL sample was drawn into 1 
mL syringes and stored on ice until needed in surgery.  
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The rabbits had a hind flank shaved prior to surgery, and a grounding pad was placed on 
the skin. Each animal was anesthetized with a combination of ketamine (50 mg/kg 
intramuscularly) and xylazine (5 mg/kg intramuscularly).  Once appropriately 
anesthetized, vital signs were monitored, and the nasal dorsum was shaved and prepped 
in a sterile fashion.  Local anesthetic was administered (1% lidocaine with 1:100,000 
epinephrine) subcutaneously over the maxillary sinuses.  A vertical incision was made in 
the midline of the face, and a subperiosteal plane elevated over the maxillary sinuses.  
The bone overlying the sinuses was drilled to expose the underlying sinus mucosa (Fig. 
9.1A).  This was incised to gain access to the maxillary sinus.  The maxillary ostium was 
visualized, and a small cotton pledget was cut to fit over the ostium.  This functioned as 
an ostium plug, and was secured with cyanomethacrylate glue, preventing the infection to 
spread to area other than the sinuses.  The previously prepared PAO1 culture was then 
instilled into the maxillary sinus (Fig. 9.1B).  Approximately 200-400 μL of the cell 
suspension was inoculated to fill each infected sinus. The skin was then closed with 
suture, and the same procedure repeated on the opposite side.  The animals were given 
buprenorphine (0.05 mg/kg BID) for post-operative analgesia, and kept for 5 days to 
allow for sufficient biofilm formation within the maxillary sinuses.  During this time, the 
animals were closely monitored and assessed clinically for evidence of complications 
from the procedure (infection, wound breakdown, hematoma).  Minor wound 
complications were addressed with local wound care if appropriate.  
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9.3.3. Electrochemical treatment.  
To perform the electrochemical treatment, the animals were anesthetized with a 
combination of ketamine and xylazine, as previously described.  After being prepped and 
draped in a sterile fashion, the previous incisions were reopened to gain access to the 
maxillary sinuses (Fig. 9.1C).  Evidence of successful inoculation was seen as frank 
purulence within the sinus. After the maxillary sinuses were exposed, purulent material 
was suctioned to quantify the initial cell count within the sinuses (Fig. 9.1D).  Stainless 
steel (SS) electrodes were connected to a WaveNow potentiostat (PINE Research 
Instrumentation, Raleigh, NC) to deliver the electrochemical current in a galvanostatic 
mode. According to the preliminary experiments, the working SS electrode and the 
Ag/AgCl reference electrode were placed under the skin and skull while the counter 
electrode was inserted with the treated sinus (Fig. 9.1E). The sinuses were filled with 
normal saline containing 15 µg/mL Tob during treatment. To minimize the variation 
among rabbits, each rabbit was used to perform two tests. One sinus was treated with DC 
and 15 µg/mL Tob only, and the other with 15 µg/mL Tob only as control. A total DC of 
1mA was supplied to the DC-treated sinus and the efficacy of the DC treatment was 
compared to the treatment with 15 µg/mL Tob only.  At the completion of each treatment, 
the electrodes were removed, and the skin overlying each sinus was closed by suture.  
The animals were given adequate pain control (0.05 mg/kg buprenorphine BID for an 
additional day), and closely monitored for activity and any development of post-operative 
complications over the next day (Fig. 9.1F).  
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9.3.4. Sample collection.   
As described above, we first collected purulent materials by suction before the DC 
treatment was performed (Fig. 9.1D) to evaluate the infection level by quantifying the 
number of viable PAO1 cells. The day following the electrochemical treatment, the 
animals were euthanized by an IV bolus of pentobarbital solution (150 mg/kg), followed 
by thoracotomy to ensure death. After aseptic preparations, the incisions were reopened 
to gain access to the maxillary sinuses and the purulence secreted was collected and 
stored on ice until analysis. In addition, the maxillary sinuses were dissected and the side 
of mucosa that was exposed to the treatments was stripped from the underlying bone for 
analysis. About 60% of the DC-treated mucosal specimen was collected for the viability 
test, while 20% was used for SEM analysis and the remaining 20% was used for 
histological study. 
 
9.3.5. Viability test and Colony Forming Units (CFUs).  
To quantify the number of cells in the specimens of purulence and mucosal tissues, the 
purulence was homogenized for 2 min using the Q125 SONICA sonicator with 500 Watt, 
20 KHz and 50% amplitude with 20 sec on and 20 sec off cycles (QSonica, LLC, Newton, 
CT). Then the samples were placed in LB agar plates to count CFU. Similarly, the sinus 
mucosa was homogenized to determine the viability of biofilm-associated cells. No 
significant effects of sonication on the viability of P. aeruginosa PAO1 was found 
(viability was not changed after 2 min of sonication as confirmed by CFU). 
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9.3.6. Scanning Electron Microscopy (SEM).  
The effects of DC treatment on the morphology of PAO1 cells were evaluated in both in 
vitro and in vivo. For in vitro experiments, stationary phase PAO1 cultures were used to 
insulate PAO1 biofilm cultures in a 12-well plate insert containing 2 mL LB, and the 
medium was replenished after 24 h of inoculation. PAO1 biofilms were formed on the 
inserts, which were cut to fit in an electrochemical cell. The samples were treated with a 
total DC of 1mA using SS 304 electrodes. Then the DC treated sample and untreated 
control were fixed with 2.5% gluteraldehyde and dehydrated with increasing 
concentration of ethanol comprised between 70%-100%. Dehydration in 100% ethanol 
was repeated three times. To achieve complete drying and preservation of the samples, 
critical-point drying in CO2 was performed. Finally, the samples were coated with gold 
and imaged using a JEOL JSM-5800 LV low vacuum SEM at an accelerating voltage of 
10kV. This protocol was also followed to evaluate the morphology of PAO1 in in vivo 
samples.  
 
9.3.7. Histology.  
To evaluate the cytotoxicity of the treatments and the inflammatory response within the 
sinuses, approximately 20% of the collected mucosal specimen was fixed in formalin 
containing 10% formaldehyde in PBS. The decalcified specimens was sectioned and 
embedded in paraffin before they were micro-dissected in thin films. Then, the samples 
were mounted on glass slides and H&E (Hematoxylin and Eosin) staining was performed. 
Finally, the samples were analyzed using light microscopy to determine if there was any 
change in histology
16
. 
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9.4. RESULTS 
9.4.1. Experimental design of the electrochemical treatment 
Preliminary experiments were performed on dead mice to determine appropriate 
electrochemical setup to deliver low-level DC in vivo. Placing the working electrode on 
mouse skin with the counter and the reference electrodes under the skin resulted in high 
resistance, and no DC was detected. As shown in Fig. 9.2A, the open circuit potential 
(4.2V) was recorded instead, showing that in this condition, no electric current was 
reaching the reference and the counter electrodes. However, insertion of the working 
electrode and reference electrode under the skin allowed the desired electric current to be 
established. As shown in Fig. 9.2B, a negative current was crossing the skin of the mouse. 
The delivery of the electric current was further improved when the counter electrode was 
placed on a skin previously shaved (Fig. 9.2C). Under that condition, a positive current 
was delivered, resulting in the decrease of impedance at the working electrode. Because 
sinusitis was the model of infection in this study, the impedance of the mouse snout was 
also investigated. As shown in Fig. 9.2D, the impedance of the mouse snout decreased 
from 2.5 kΩ to 2 kΩ when the pockets of air within the snout were reduced by 
compressive force. Addition of 0.85% NaCl solution resulted in a major decrease of the 
impedance. For example, in the presence of 0.85% NaCl saline solution, the impedance 
was reduced from 2.5 kΩ to 630Ω. These results suggest that filling the sinus with a 
saline solution could greatly improve the effectiveness of the DC treatment by increasing 
the conductivity across the tissues. 
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9.4.2. Efficacy of the electrochemical treatment in rabbits.  
To evaluate the efficacy of electrochemical treatment in infection control in vivo, rabbit 
sinusitis was established by instilling P. aeruginosa PAO1 in the maxillary sinuses of 
New Zeeland male rabbits and allowing the infection to develop for 5 days. Then the 
infections were treated with total DC of 1 mA and/or 15 μg/mL Tob for 1 h. The next day 
the rabbits were sacrificed to assess the viability of the bacterial cells and evaluate the 
synergy between DC and 15μg/mL Tob in vivo. To verify that DC treatment was 
successfully delivered, a potentiodynamic curve was recorded to evaluate the change in 
anodic potential. For a constant total DC of 1mA, the anodic potential decreased from 
600 mV to 300 mV during the DC treatment (Fig. 9.3). This indicates that the delivery of 
DC was successful, reducing the resistance of tissues between the skull and mucosa due 
to the release of ions from SS electrodes.   
 
The results of the viability test (Fig. 9.4) demonstrated that infection was 
successfully achieved in all tested rabbits. At 5 days after inoculation that the sinus were 
infected with 1.58x10
6
 ± 7.6x10
5
 P. aeruginosa PAO1 cells/mL. As shown in Fig. 9.2, 
the total number of PAO1 cells in the untreated sinuses increased by 7 times on the 
following day compared to the 5
th
 day after inoculation. The number of cells associated 
with mucosal biofilms was 5 times that of the PAO1 cells collected from the original 
purulence. The treatment using 15 μg/mL Tob reduced the level of infection significantly; 
e.g.: the number of PAO1 cells in the pus of Tob-treated sinuses was reduced by 88.3 ± 
4.5% compared to the number of cells found in the pus before treatment. While the 
number of bacteria in the untreated control sample increased by 495.6 ± 1.6%, the growth 
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of the PAO1 on mucosa treated with 15 µg/mL Tob alone was reduced to 143.6 ± 78.7%, 
compared to the untreated control, suggesting that Tob alone fails to inhibit biofilm 
growth on the mucosa. However, treatment combining DC and 15 µg/mL Tob was very 
effective in killing PAO1. Only 0.18 ± 0.12% of PAO1 cells were found viable after the 
co-treatment, suggesting a 3-log reduction compared to the number of cells found in the 
purulence before the treatment. The number of viable biofilm cells attached to the 
mucosa was reduced to 59.6 ± 53.7%, suggesting that DC and Tob exhibit synergistic 
lethal effects against PAO1 cells in vivo.  
 
9.4.3. Effects of electrochemical treatment on the morphology of PAO1 cells 
To directly visualize the PAO1 biofilms on the sinus mucosa and investigate the integrity 
of cilia of sinus mucosa, SEM imaging was performed to examine control and treated 
samples. Initially, electron micrographs of in vitro cultures of PAO1 biofilms on well-
inserts, which were treated with or without 140 μA/cm2 DC, were collected to determine 
if there is any DC-induced morphological change in the PAO1 cells. As shown in Fig. 
9.5A, untreated PAO1 biofilms were made up of rod-shape PAO1 cells. However, the 
DC treatment affected the morphology of the PAO1 cells in vitro. The cells, which were 
originally rod-shape, were found to swell and become round-shape after 1 h 
electrochemical treatment (Fig 5B).  
 
Representative SEM images of the sinus mucosa are shown in Fig. 9.6 and the 
images demonstrate that the biofilms were well established on the mucosa of the sinuses. 
Similarly to the in vitro results, both treatments (Tob only vs. DC+Tob) affected the 
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morphology of PAO1 cells, resulting in round-shaped cells. Many of the PAO1 cells on 
the specimen treated with DC and Tob were lyzed and misshaped.  Treatment of Tob 
only was not sufficient to eradicate PAO1 cells. In comparison, mucosa tissues free of 
PAO1 cells were observable after treatment with 1mA DC and 15 μg/mL Tob. These 
observations are consistent with CFUs data proving that the combination of DC and Tob 
was more effective in killing the PAO1 cells. Moreover, Fig. 9.6B showed intact cilia on 
DC+Tob treated samples, suggesting that DC treatment does not damage cilia. 
 
9.4.4. Safety of the electrochemical treatments. 
To further evaluate the safety of the DC treatment, specimen were collected from the 
sinus mucosa and prepared for H&E staining to perform histological analysis. The results 
of this analysis show that bacterial infection alone could cause damage to the structure of  
sinus mucosa. As shown in Fig. 9.7A, the infection resulted in the loss of the cilia and the 
presence of purulence within the tissues. Major ulcerations were found on the mucosa of 
the PAO1-infected rabbit. These observations were also recorded in the sinus treated with 
15 μg/mL Tob only (Fig. 9.7B). The layer of cilia was detached from the rest of the tissue, 
suggesting that the infections resulted in the loss of the cilia. Tissues underlying the 
ciliated-epithelial cells were lyzed and presented various vacuoles, which might correlate 
with the present of purulence materials within the tissues. The specimens collected from 
the DC-Tob treated sinus were not different from the untreated sample. Fig. 9.7C showed 
the presence of purulence and no further deformation in the structure of the mucosal 
tissues. 
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9.5. DISCUSSION 
The medical application of electricity has long been utilized in surgery. For instance, the 
utilization of the bovie electrocautery is nearly ubiquitous in head and neck surgical 
procedures.  This instrument, which generates high level electrical currents, is able to cut 
tissues and coagulate blood, while leaving surrounding tissue unharmed. However, the 
use of electrical current has had little application in the field of infection control. 
Interestingly, preliminary results show that low-level DC could be effective against 
bacterial cells in clinical settings.  
 
The in vivo study described in this chapter focuses on the ability of low-level DC 
to eliminate bacterial infection in a rabbit model of sinusitis. Co-current treatment 
methods of sinusitis using multiple antibiotics are unsatisfactory.  In addition to being 
time consuming and disruptive to the patients daily schedule, the treatments could be 
irritating to the sensitive nasal mucosa. Chronic use of antibiotics could also contribute to 
drug-resistance. Henceforth, developing novel approaches that can readily and more 
effectively eradicate the sinusitis would benefit numerous patients around the world.   
  
Through experimental setups, it was determined that DC was best delivered with 
the counter electrode (cathode in our case) implanted within the animal tissues, 
preferably at the site of infection. In order the bypass the impedance of the skin, the 
working electrode was inserted between the skin and the skull, while the cathode was 
introduced in the sinus in the presence of a saline solution. As shown by the 
potentiodynamic curve recorded from the DC treatments of the sinuses, effective level of 
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DC treatment could be applied to the sinuses and result in significant killing of bacterial 
cells suspended in the purulence material, as well as those associated with the sinus 
mucosa. Compared to the treatment with Tob only, more PAO1 cells were eliminated in 
the combined treatment, suggesting a synergy can be obtained in vivo as well. The 
finding that cell killing was observed around the cathodic electrode is consistent with our 
previous finding reported in Chapters 3 and 5. The cathodic current/potential was very 
effective in killing biofilm associated with the counter electrodes
14
. The use of a 2-
chamber system connected with a high resistance salt-bridge demonstrated that the high 
concentration of reactive oxygen species, as well as the cathodic potential, might 
contribute to the potency of the cathode.  
 
Overall, our data show that the treatment with Tob alone can reduce the number 
of viable PAO1 cells associated with the pus by 88.3% but it fails to inhibit the growth of 
the biofilm cells, which represented 143.6%, compared to the original population of cells. 
A previous study using a rabbit model of PAO1 biofilm infection has shown that Tob at 
concentrations of 80 µg/mL and 160 µg/mL can kill biofilm-associated P. aeruginosa 
cells by 2 and 2.5 log after a day of antibiotic treatment
17
. However, our results 
demonstrate that low-level DC delivered for 1 h with 15 μg/mL is more effective in 
killing P. aeruginosa cells. The cidal effects of DC and Tob were of 3 logs for the cells in 
the purulence and 60.3% for those associated with the mucosal biofilms, suggesting that 
the use of DC could lead to a decreased reliance on high doses of antibiotics. 
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In addition to CFU data, SEM imaging of the specimen revealed critical 
information about the bioactivity of the electrochemical treatments. Treatments of the 
sinuses with Tob or DC+Tob resulted in morphological changes to the PAO1 cells. The 
findings that P. aeruginosa cells ball up under physicochemical stress is consistent with 
previous reports. For example, morphological change of P. aeruginosa from a rod-shape 
to a round shape specifically has been reported by Yokochi et al.
18
 regarding antibiotic 
treatment with imipenem (a β-lactam) and ceftazidime (a cephalosporin). Under our 
condition, the cells become round in shape due to the treatment with 15µg/mL Tob and/or 
1 mA total DC. 
 
 Sanin et al. 
19
 showed that starvation could cause cells of Pseudomonas sp. to 
become round-shape. This report corroborates our finding that many of the round shape 
cells observed in the electron micrographs were under stress of Tob and DC treatments. 
On the other hand, the combined treatment resulted in the disruption of the cell 
membrane and lysis of PAO1 cells. The finding that the electrochemical stresses further 
disrupted the integrity of the P. aeruginosa PAO1 is consistent with our findings reported 
in Chapter 4.  
 
It was interesting to find that the combined treatment using DC and Tob resulted 
in the removal of PAO1 cells from the sinus mucosa. Intriguingly, the DC treatment did 
not exhibit significant detrimental effects on the rabbits.  All the animals tested with the 
DC survived the treatment and did not show any symptom of discomfort following the 
treatment (Fig. 9.1F). By successfully limiting the infection only to the mucosal tissues, 
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all animals behaved rather normally throughout the entire trial. These observations 
demonstrate that the DC treatments used in this study are safe and effective in killing 
PAO1 in vivo. Further tests with more animals will help design clinical studies.   
 
9.6. CONCLUSIONS 
In this study, a rabbit model of sinusitis was developed using P. aeruginosa. The 
electrochemical treatment of PAO1 infection using 1mA of total DC and 15 μg/mL Tob 
demonstrated that DC improved the bioactivity of Tob against P. aeruginosa in vivo. The 
effects of the cathodic potential/current and its related electrochemical products were 
effective in killing P. aeruginosa cells. Overall, these results demonstrated that this 
technology has a good potential for controlling chronic infections. 
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FIGURE CAPTIONS 
Figure 9.1. Potentiodynamic curves and related impedance from the DC treatment of 
mice. (A) Anode is placed over the skin and the counter and reference 
electrodes are under the skin. (B) Counter electrode is over the skin and 
reference and anodes are placed under the skin. (C) Condition (B) is repeated 
with the skin of the mouse shaved. (D) DC treatment of mouse snout under the 
condition presented in (C). 
Figure 9.2. Experimental design and electrochemical of rabbit model of sinusitis.  
Figure 9.3. Potentiodynamic curve recorded from the electrochemical treatment of the 
rabbit model of sinusitis.  
Figure 9.4. Effects of DC on PAO1 cells in a rabbit model of sinusitis. The number of 
viable cells was quantified by CFU after the treatment of the infection model 
with 15μg/mL Tob only or with 1 mA of total DC in the presence of 15μg/mL 
Tob.  The means and standard deviations are shown.  
Figure 9.5. Representative SEM images of PAO1 biofilm.  P. aeruginosa PAO1 cells 
were culture on a well-insert. The untreated cells (A) maintained their rod-like 
shape while the cells treated with 140 μA/cm2 DC equivalent to 1 mA of total 
DC for 1 h (B) became round-shape. 
Figure 9.6. Effects of DC on PAO1 biofilms associated to the sinus mucosa after 
treatment with (A) 15μg/mL Tob only or (B) with 1 mA of total DC in the 
presence of 15μg/mL Tob. Representative SEM image of PAO1 biofilm on the 
specimen are shown. 
 259 
Figure 9.7. Effects of DC on the sinus mucosa. The specimen were collected and H &E 
staining was performed to evaluate the histology of the untreated but infected 
sinus (A) and compared to the specimen treated with 15μg/mL Tob (B) or 
with 1 mA of total DC in the presence of with 15μg/mL Tob only.  
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CHAPTER 10 
CONCLUSIONS AND RECOMMENDATION FOR FUTURE WORKS 
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10. 1. CONCLUSIONS 
Motivated by the urgent need to control drug resistant infections and previous studies on 
bioelectric effects, we conducted this thesis research to systematically investigate 
persister control using low-level electric currents. P. aeruginosa was used as a model 
organism to test the effects of DC in the presence and absence of antibiotics. Our results 
revealed for the first time that P. aeruginosa persister cells can be effectively killed 
through synergistic effects between DC and antibiotics. For examples treatment using 70 
μA/cm2 DC using 304 electrodes resulted in 98% killing of the persister cells. However, 
5 logs killing were achieved in the presence of 1.5 μg/mL Tob.  We named this 
phenomenon electrochemical control of persister cells (ECCP) 
 
To understand the mechanism of ECCP, we characterized the current level and 
the generated species in the persister killing. Different effects were observed among the 
ions studied and the movement of the ions was found to be important. Consistently, the 
electrode materials used to mediate DC we also found to play an important role . 
Comparison of carbon-mediated DC with SS-mediated DC revealed that cell death was 
achieved more quickly with SS-mediated DC. At the same current density synergistic 
killing effect with Tob was only observed with SS-mediated DC. However, highly potent 
killing was achieved with sequential treatment using carbon-mediated DC followed by 
Tob . Further study of  ECCP has demonstrated that the treatment could be improved 
with the choice of the electrode materials. The testing of TGON, a carbon based materials 
has proven that the persister could be eradicated with 70 μA/cm2 DC after 1 h of 
treatment.  
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The study of these effects at the cellular level demonstrated that cells lysis occur 
under DC treatment using SS 304. In comparison, the cells appeared to be intact but with 
high permeability after DC treatment using carbon electrodes. The measurement of the 
cells membrane stiffness revealed that carbon treated cells were stiffer compared to SS-
treated cells. This finding might explain why the sequential treatment was effective.  
The treatment using carbon and SS 304 electrodes also cause major differences in the 
intracellular content of the treated cells. While SS-treated cells released proteins from cell 
lysis, cells treated with carbon electrodes appeared to have large protein aggregates. 
Differences in the persister response to DC treatments were also observed at the genetic 
level; e.g. induction of  pyocin genes was observed for cells treated with carbon and SOS 
response was induced in cells  treated with SS 304 electrodes. The following table 
summarizes the major differences (Table 1). 
 
The fact that the carbon-based electrode did not show any synergistic killing 
effects led us to investigate the interaction between antibiotic and the DC generated 
electrochemical species. Specifically, the interaction between  metal cations (Cr
2+
, Cr
3+
, 
Cr
6+
, Fe
2+
, Fe
3+
, Mn
2+
, Ni
2+
) and antibiotics (Tob and Kan) was investigated. It was found 
that DC contributes to interaction between Tob and Cr(III) ions, which may play a role in 
persister control. 
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Table 10.1: Comparison of persister killing using DC mediated with carbon and SS 
304 electrodes 
 Electrode materials 
 
carbon SS 304 
DC condition 
70 μA/cm2 DC, 
voltage from 0-800mV 
70 μA/cm2 DC, 
voltage from 0-200mV 
Persister 
killing effects 
Synergy in sequential treatment 
(DC and 1.5 μg/mL Tob) followed 
by 7-log killing 
Synergy in co-treatment with DC 
and 1.5 μg/mL Tob resulting in 5-
log killing 
Cellular 
configuration 
No significant accumulation of 
carbon particles, but 
compartmentalization of 
intracellular materials with protein 
aggregates 
Intracellular accumulation of metal 
cations 
Membrane 
properties 
Cells are intact but stiffer and more 
permeable 
Cell lysis observed 
No change in surface charge Decreased surface charge 
Gene 
expression 
Induction of genes related to pyocin 
and antibiotic resistance 
More genes related to transport of 
small molecules, metabolism, 
protein secretion /export were 
affected Repression of genes related to SOS 
response 
 
Furthermore, the efficacy of the ECCP was studied in co-culture model involving 
human epithelial cells and P. aeruginosa PAO1. The treatment of such co-cultures 
demonstrated that P. aeruginosa cells could be selectively eliminated through ECCP in 
the presence of the human cells at appropriate conditions. Finally, these findings were 
integrated to design an in vivo study in a rabbit model of sinusitis. The results of the 
animal study demonstrated that, compared to the treatment with Tob only, DC treatment 
in the presence of 15 μg/mL Tob was more effective in killing PAO1 cells associated to 
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the sinus mucosa, as well as the cells contained in the purulence materials. Moreover, the 
treatment was also safe for the animal. 
 
Overall, this study demonstrate that DC treatment has a great potential for 
developing novel strategies to control bacterial infections associated with biofilms and 
persister cells. However, more need to be done to optimize the effectiveness of such 
treatments for real application. 
 
10.2. RECOMMENDATION FOR FUTURE WORK 
10.2.1. Genetic basis of persisters’ response to electrochemical stress 
The study on DC treatment of mutant cells showed that several genes may be important 
to both persister formation and persister control through ECCP. In Chapter 6, we 
demonstrated that the mutant of PA1897 has defect in persister formation. Compared to 
PAO1, which has 1% of persisters in stationary-phase cultures, the number of persister 
cells in the mutant of PA1897 represented only 0.01% of the total cell population. Also, 
this mutant exhibited an increased sensitivity to DC treatment mediated with carbon 
electrodes. It will be important to test the effects on a strain with genetic 
complementation of this mutation. It will also be helpful to conduct DNA microarrays to 
understand the genes expression of this mutant to DC treatments. 
 
10.2.2. Interaction between metal cations and Tobramycin 
In Chapters 3 and 7, we demonstrated the interactions between Cr
3+
 and Tob could result 
in both agonistic and antagonistic effects. This led us to speculate that the intracellular 
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accumulation of such complexes could lead to cell death, through increased interaction 
with DNA or RNA. This hypothesis could be tested by studying the binding affinity 
between the Cr
III
(Tob) complexes and 16 S rRNA. Wang et al.
1
, studied the interaction 
16S rRNA and aminoglycosides including Kan, Tob and their conjugates. Using a similar 
approach, the interaction between the CrIII(Tob) complexes could be studied to 
understand if the complex indeed kills persister cells more efficiently. 
 
10.2.3. Design of a prototype for treatment infections in vivo 
Our findings reported in Chapter 4 demonstrated that SS 304 is effective in killing 
persister cells in the 2-chamber system. Because of the resistance of the salt bridge, the 
results from this 2-chamber system provided existing information that DC treatment may 
be effective to cross the skin and kill bacteria in vivo, including those attached to 
implanted devices. Further study can help designing a prototype to treat infection with 
minimum invasion to ensure safety and efficacy. 
 
10.3. REFERENCE 
1 Wang, H. & Tor, Y. Electrostatic interactions in RNA aminoglycosides binding. 
Journal of the American Chemical Society 119, 8734-8735 (1997). 
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Figure S3.1. Schematic representation of the electrochemical cell system for generating 
electrochemical current. The electrochemical cell was constructed by inserting two 
electrodes (4.5 cm x 0.95 cm x 0.05 cm) in a plastic cuvette. The working, counter and 
reference electrodes were connected to a potentiostat to obtain the desired current. 
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Figure S3.2: Potentiodynamic curves during 70 µA/cm
2
 DC treatments of 0.85% NaCl 
solution. 
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Figure S3.3: ICP-MS analysis of the ions generated during treatments with 70 µA/cm
2
 
DC using Carbon and SS 304 electrodes.  
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(C) 
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(G) 
Figure S3.4: The effects of metal cations with different oxidation states on PAO1 
persister cells. The persister cells were exposed for 1 h to Fe
2+
, Fe
3+
, Cr
2+
, Cr
3+
, Cr
6+
, Ni
2+
, 
Mn
2+
 at various concentrations in the absence of an electrical field.  
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Figure S3.5: Polarization curves of carbon, SS 304 and iron electrodes. Voltages ranging 
from -2V to 1V (vs. Ag/AgCl potential) were generated across sterile 0.85% NaCl 
solution using SS 304, carbon or 99.5% c.p. Fe electrodes.  Voltammograms were 
recorded at a polarization scan rate of 1 mV/s. 
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1. SEM Imaging of P. aeruginosa PAO1 after DC treatment using SS 304 
 
 
(A) 
 
(B) 
 
 
Figure S5.1: SEM images of P. aeruginosa PAO1 treated with DC using SS 304 
electrodes (A) vs. untreated PAO1 cells. The cells were dried on TGON 805, which is a 
carbon based material, to perform SEM imaging (Joel 5600, Joel, Japan). The 
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accumulation of metal cations allowed imaging of the cells treated with SS electrodes, 
which were not previously coated with Au. In contrast, PAO1 control cells did not 
contain any metal cation and could not be imaged using the Joel 5600 SEM (Joel, Japan). 
 
 
2. Nano indentation of P. aeruginosa after DC treatment. 
 
(A)  
 
(B) 
0.00E+00
5.00E+01
1.00E+02
1.50E+02
2.00E+02
2.50E+02
3.00E+02
3.50E+02
4.00E+02
4.50E+02
5.00E+02
0.00E+00 5.00E+00 1.00E+01 1.50E+01 2.00E+01 2.50E+01 3.00E+01 3.50E+01
F
o
rc
e 
(n
N
) 
Indent (nm) 
0.00E+00
5.00E+01
1.00E+02
1.50E+02
2.00E+02
2.50E+02
3.00E+02
3.50E+02
4.00E+02
4.50E+02
0.00E+00 2.00E+00 4.00E+00 6.00E+00 8.00E+00 1.00E+01 1.20E+01 1.40E+01
F
o
rc
e 
(n
N
) 
Indent (nm) 
 
 
 
291 
 
(C) 
 
Figure S5.2: Nonindentation was performed on P. aeruginosa cells treated with DC using 
SS 304 or carbon electrodes. A force curve was derived from the indentation data, which 
allowed the computation of the elasticity modulus of the cells. (A) Untreated control, (B) 
PAO1 treated with DC using carbon, and (C) PAO1 treated with DC using SS304.  
 
3.  Proteomics of P. aeruginosa PAO1 treated with DC using SS304 electrodes 
for 1h (Contributed by Henry L. Peterson) 
The observations of P. aeruginosa cells during DC treatments led to the hypothesis that 
proteins were released from the cells treated using SS 304. To evaluate the significance 
of the cell response to the DC treatment, the protein expression of DC-treated cells was 
mapped and compared to the untreated control. Extraction of proteins of P. aeruginosa 
PAO1 was performed according to standard lab protocol described in Appendix VI and 
VI, and the protein expression between the cells treated with DC using SS304 vs. the 
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untreated control was analyzed.  Extracted protein gel plugs were prepared for LC Mass 
Spectrometry by the In-Gel Digestion and Extraction Protocol provided by Cornell 
University’s Institute of Biotechnology’s Proteomics and Mass Spectrometry Facility. 
 
Figure S5.3: 2D protein gels of control and treated samples. Four representative proteins 
were picked for sequencing.  These proteins were found to be: 1) 50s ribosomal protein 
L25 involved in general stress response. This protein seems to assist in protein formation, 
and peptidyl hydrolysis 2) a single-stranded DNA binding protein stress protein involved 
in the inhibition of DNA replication and repair; 3) an outer membrane porin F (OprF) 
regulating the cross-membrane transport of glucose, nutrients, ions, and water; 4) DsbA 
(PA5489), a soluble thioldisulfide oxidoreductase periplasmic protein involved in type III 
secretion system, and detection of eukaryotic cells during bacterial infection.  
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4. SDS page of protein isolated from P. aeruginosa PAO1 treated with DC using 
carbon electrodes for 1h. 
 
1 Control - Solubilized cell pellet  
2 Control - cell pellet 
3 Control - intracellular content 
4 DC carbon - solubilized cell pellet 
5 DC carbon - cell pellet  
6 DC carbon – intracellular content 
  
  
  
Figure S5.4: SDS gel of membrane and cellular proteins isolated from DC-free control 
(lane 1-3) and DC-treated P. aeruginosa PAO1 cells.  Following the protocol for 
solubilization of expressed proteins from inclusion bodies (Green, M. R. & Sambrook, J. 
Molecular cloning: a laboratory manual (Cold Spring Harbor Laboratory Press Cold 
Spring Harbor, New York:, 2012), it was found that the level of proteins associated to the 
cell membrane of P. aeruginosa (lane 2) was reduced by the DC treatment (lane 5). In 
contrast, DC treatment induced the accumulation of intracellular protein as shown on lane 
6 (vs lane 3). 
  1     2      3              4       5       6 
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Table S6.1: List of genes commonly induced during the DC treatments using carbon 
electrodes for 20 min and 40 min 
 
Gene description 
fold 
change  
at 20 min 
fold 
change at  
40 min 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
ribH riboflavin synthase subunit beta 3.07 2.7 
'Carbon compound catabolism' 
glk glucokinase 3.2 8.5 
'Hypothetical, unclassified, unknown' 
PA4010 3-methyladenine DNA glycosylase 2.1 4.8 
PA0612 hypothetical protein 2.4 2.5 
PA1042 hypothetical protein 2.2 2.5 
PA1913 hypothetical protein 2.3 5.0 
PA1967 hypothetical protein 2.3 2.8 
PA2613 hypothetical protein 3.7 2.5 
PA3205 hypothetical protein 2.4 2.5 
PA3320 hypothetical protein 2.9 2.2 
'Membrane proteins' 
PA1897 hypothetical protein 2.3 4.1 
oprG Outer membrane protein OprG precursor 4.5 2.4 
'Putative enzymes' 
PA1470 probable short-chain dehydrogenase 2.1 2.0 
'Related to phage, transposon, or plasmid' 
PA0627 hypothetical protein 2.5 2.1 
PA0628 hypothetical protein 2.1 3.1 
PA0629 hypothetical protein 3.0 2.6 
PA0633 hypothetical protein 2.4 2.8 
PA0636 hypothetical protein 2.1 2.4 
PA0617 probable bacteriophage protein 2.7 2.4 
Translation, post-translational modification, degradation' 
fusA2 elongation factor G 4.7 6.1 
fusA1 elongation factor G 2.4 3.4 
'Transport of small molecules' 
fruK 1-phosphofructokinase 2.1 2.9 
ccmA heme exporter protein CcmA 2.2 2.7 
 
 
 
Table S6.2: List of genes commonly repressed during the DC treatments using 
carbon electrodes for 20 min and 40 min 
Gene description 
fold 
change  
at 20 min 
fold 
change at 
40 min 
'Energy metabolism' 
PA0510 probable uroporphyrin-III c-methyltransferase -2.2 -2.1 
'Putative enzymes' 
PA4621 probable oxidoreductase -2.0 -2.2 
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Table S6.3: List of genes commonly induced during the DC treatments using SS 304 
electrodes for 20 min and 40 min 
Gene description 
fold 
change  
at 20 min 
fold 
change at 
40 min 
'Amino acid biosynthesis and metabolism' 
leuA 2-isopropylmalate synthase 5.1 6.3 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
pqsB beta-keto-acyl-acyl-carrier protein synthase-like protein 7.0 2.1 
'Carbon compound catabolism' 
PA0810 probable haloacid dehalogenase 5.8 2.6 
PA3517 probable lyase 2.2 2.4 
'Cell wall / LPS / capsule' 
wbpB probable oxidoreductase WpbB 2.2 3.9 
comL competence protein ComL 3.1 2.1 
rmlA glucose-1-phosphate thymidylyltransferase 2.1 2.2 
'DNA replication, recombination, modification and repair' 
gyrA DNA gyrase subunit A 2.7 2.8 
'Energy metabolism' 
norC nitric-oxide reductase subunit C 2.1 2.7 
norB nitric-oxide reductase subunit B 2.4 3.0 
sdhD succinate dehydrogenase (D subunit) 17.9 2.7 
nuoF NADH dehydrogenase I chain F 3.2 2.2 
nuoJ NADH dehydrogenase subunit J 2.6 2.1 
PA4430 probable cytochrome b 3.1 16.9 
'Fatty acid and phospholipid metabolism' 
fabI NADH-dependent enoyl-ACP reductase 2.0 2.5 
psd phosphatidylserine decarboxylase 2.6 2.7 
'Hypothetical, unclassified, unknown' 
PA0310 hypothetical protein 3.8 4.8 
PA0359 hypothetical protein 3.7 2.2 
PA0368 hypothetical protein 3.8 2.0 
PA0392 hypothetical protein 2.0 4.2 
PA0451 hypothetical protein 3.1 2.0 
PA0615 hypothetical protein 2.3 2.1 
PA0926 hypothetical protein 2.6 2.8 
PA1057 hypothetical protein 6.9 3.2 
PA1343 hypothetical protein 5.8 8.0 
PA1518 hypothetical protein 3.0 2.1 
PA1939 hypothetical protein 10.5 3.5 
PA1944 hypothetical protein 3.9 8.5 
PA2380 hypothetical protein 3.9 2.4 
PA2485 hypothetical protein 2.4 6.6 
PA2659 hypothetical protein 4.5 6.2 
PA2756 hypothetical protein 2.3 5.9 
PA2808 hypothetical protein 2.5 2.3 
PA2898 hypothetical protein 4.6 4.4 
PA3388 hypothetical protein 2.2 4.6 
PA3685 hypothetical protein 2.2 4.0 
PA3794 hypothetical protein 2.6 4.1 
PA4015 hypothetical protein 2.2 4.0 
PA4132 hypothetical protein 2.5 2.1 
PA4140 hypothetical protein 3.1 2.9 
PA4338 hypothetical protein 3.9 3.2 
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PA4372 hypothetical protein 2.3 2.1 
PA4451 hypothetical protein 2.4 3.9 
PA5461 hypothetical protein 9.7 12.5 
PA5492 GTP-binding protein 2.4 2.8 
PA5502 hypothetical protein 2.1 3.1 
'Protein secretion/export apparatus' 
secE translocase 6.6 2.0 
'Putative enzymes' 
PA0840 probable oxidoreductase 3.1 2.1 
PA1344 probable short-chain dehydrogenase 2.7 2.3 
PA2355 probable FMNH2-dependent monooxygenase 3.0 2.0 
PA4431 probable iron-sulfur protein 3.5 6.9 
'Related to phage, transposon, or plasmid' 
PA0616 hypothetical protein 2.2 2.0 
PA0639 hypothetical protein 2.0 2.1 
PA0643 hypothetical protein 3.9 2.7 
PA0647 hypothetical protein 3.2 2.3 
PA0720 helix destabilizing protein of bacteriophage Pf1 2.4 2.7 
'Secreted Factors (toxins, enzymes, alginate)' 
pvcA pyoverdine biosynthesis protein PvcA 6.2 2.4 
algC phosphomannomutase AlgC 3.8 2.8 
'Transcription, RNA processing and degradation' 
hepA ATP-dependent helicase HepA 3.0 2.4 
rimM 16S rRNA-processing protein 2.1 2.2 
PA1526 probable transcriptional regulator 3.0 6.4 
PA3689 probable transcriptional regulator 3.0 2.2 
PA4769 probable transcriptional regulator 3.2 2.8 
rpsP 30S ribosomal protein S16 3.0 2.4 
rplW 50S ribosomal protein L23 2.2 4.4 
PA4671 50S ribosomal protein L25 4.1 2.2 
'Transport of small molecules' 
cysW sulfate transport protein CysW 2.4 2.9 
ccmA heme exporter protein CcmA 1.9 1.9 
PA1485 probable amino acid permease 2.8 3.0 
PA2135 probable transporter 2.5 5.1 
mscL large-conductance mechanosensitive channel 2.0 2.3 
'Two-component regulatory systems' 
cheY two-component response regulator CheY 3.6 2.6 
PA2479 probable two-component response regulator 3.2 3.0 
PA4843 probable two-component response regulator 2.2 2.4 
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Table S6.4: List of genes commonly repressed during the DC treatments using SS 
304 electrodes for 20 min and 40 min 
Gene Description 
fold 
change  at 
20 min 
fold 
change at 
40 min 
'Amino acid biosynthesis and metabolism' 
cysH phosphoadenosine phosphosulfate reductase -4.9 -2.4 
glyA3 serine hydroxymethyltransferase -2.5 -2.6 
'Antibiotic resistance and susceptibility' 
PA2018 RND multidrug efflux transporter -2.5 -2.0 
'DNA replication, recombination, modification and repair' 
PA4282 probable exonuclease -2.1 -2.0 
'Hypothetical, unclassified, unknown' 
PA0099 hypothetical protein -2.4 -2.2 
PA1972 hypothetical protein -3.2 -2.1 
PA2296 hypothetical protein -2.6 -2.8 
PA2353 hypothetical protein -2.9 -3.0 
PA2768 hypothetical protein -3.4 -2.8 
PA3230 hypothetical protein -2.1 -2.1 
PA4057 hypothetical protein -2.8 -2.2 
PA4347 hypothetical protein -2.3 -2.3 
PA4485 hypothetical protein -2.0 -2.2 
PA4863 hypothetical protein -2.8 -2.1 
'Membrane proteins' 
PA0345 hypothetical protein -3.2 -2.0 
'Protein secretion/export apparatus' 
PA2673 probable type II secretion system protein -2.7 -2.1 
pcrG regulator in type III secretion -2.2 -2.1 
pscF type III export protein PscF -3.1 -2.4 
pscQ type III secretion protein -3.4 -2.1 
'Putative enzymes' 
ispG 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase -2.0 -2.2 
PA4724 glutamyl-tRNA synthetase -2.4 -2.3 
PA4008 probable hydrolase -2.1 -2.2 
PA0147 probable oxidoreductase -2.2 -2.0 
PA0364 probable oxidoreductase -2.4 -2.4 
PA1171 probable transglycolase -2.2 -2.1 
'Transcriptional regulators' 
PA0181 probable transcriptional regulator -2.0 -2.4 
PA1627 probable transcriptional regulator -2.4 -2.1 
PA3630 probable transcriptional regulator -3.4 -2.0 
PA4165 probable transcriptional regulator -2.6 -2.2 
'Translation, post-translational modification, degradation' 
gatC aspartyl/glutamyl-tRNA amidotransferase subunit C -2.5 -2.2 
lasB elastase LasB -3.2 -2.0 
'Transport of small molecules' 
PA0240 probable porin -3.1 -2.1 
PA0166 probable transporter -2.4 -2.0 
'Two-component regulatory systems' 
pmrA 
PmrA: two-component regulator system response regulator 
PmrA -2.1 -2.5 
PA0600 probable two-component sensor -3.1 -2.6 
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Table S6.5: List of the PAO1 persister genes induced by the treatment with 
70μA/cm2 DC using carbon electrodes for 20 min and 40 min.  
 
    Fold Change 
Gene Description 20 min 40 min 
'Adaptation, protection' 
bfrB bacterioferritin 1.2 3.2 
'Amino acid biosynthesis and metabolism' 
hpd 4-hydroxyphenylpyruvate dioxygenase 1.3 2.5 
aroK shikimate kinase 2.1 1.2 
'Antibiotic resistance and susceptibility' 
PA1032 probable penicillin amidase 1.8 3.5 
mexA 
Resistance-Nodulation-Cell Division (RND) multidrug efflux membrane 
fusion protein MexA precursor -1.4 2.9 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
folD 5,10-methylene-tetrahydrofolate dehydrogenase 1.3 2.2 
ribH riboflavin synthase subunit beta 3.1 2.7 
pqsC beta-keto-acyl-acyl-carrier protein synthase-like protein 2.1 -1.3 
thiL thiamine monophosphate kinase 1.5 2.5 
'Carbon compound catabolism' 
glk glucokinase 3.2 8.5 
mdcC malonate decarboxylase subunit delta 1.3 3.0 
PA0743 probable 3-hydroxyisobutyrate dehydrogenase 1.4 3.0 
PA2098 probable esterase/deacetylase 2.4 1.9 
cbrA two-component sensor CbrA 1.2 3.0 
'Cell wall / LPS / capsule' 
mdoH glucosyltransferase MdoH 3.3 1.7 
waaF heptosyltransferase II -1.2 2.2 
lpxO2 lipopolysaccharide biosynthetic protein LpxO2 1.4 3.0 
'Central intermediary metabolism' 
cpo chloroperoxidase precursor -1.1 3.1 
PA4880 probable bacterioferritin 1.6 2.2 
PA3471 probable malic enzyme 2.8 1.2 
'Chaperones & heat shock proteins' 
grpE heat shock protein GrpE -1.0 2.5 
'Chemotaxis' 
aer aerotaxis receptor Aer 1.5 4.0 
pctB chemotactic transducer PctB 0.9 4.0 
'Energy metabolism' 
atpG ATP synthase subunit C 4.2 1.0 
cioA cyanide insensitive terminal oxidase 1.0 2.3 
nuoA NADH dehydrogenase alpha subunit 0.8 2.9 
nuoB NADH dehydrogenase beta subunit -1.1 17.1 
PA1554 probable cytochrome oxidase subunit (cbb3-type) -1.1 2.2 
sucD succinyl-CoA synthetase alpha subunit -1.0 2.4 
 
'Fatty acid and phospholipid metabolism' 
fabG 3-oxoacyl-[acyl-carrier-protein] reductase 1.7 3.3 
PA1869 probable acyl carrier protein 2.4 -1.1 
PA4351 probable acyltransferase 2.6 1.2 
'Hypothetical, unclassified, unknown' 
PA4010 3-methyladenine DNA glycosylase 2.1 4.8 
PA1701 conserved hypothetical protein in type III secretion 1.4 2.2 
PA0050 hypothetical protein -1.0 3.3 
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PA0052 hypothetical protein 1.1 2.9 
PA0081 hypothetical protein 2.7 1.9 
PA0109 hypothetical protein 1.2 2.4 
PA0329 hypothetical protein 1.4 4.2 
PA0526 hypothetical protein 1.1 2.1 
PA0554 hypothetical protein 1.3 2.4 
PA0566 hypothetical protein 1.1 4.4 
PA0572 hypothetical protein 1.3 2.1 
PA0587 hypothetical protein 1.5 2.6 
PA0612 hypothetical protein 2.4 2.5 
PA0822 hypothetical protein 2.4 1.3 
PA0851 hypothetical protein 2.3 1.7 
PA0907 hypothetical protein -1.1 2.8 
PA0959 hypothetical protein 1.4 2.9 
PA1042 hypothetical protein 2.2 2.5 
PA1134 hypothetical protein 2.8 -1.4 
PA1349 hypothetical protein 2.0 -1.2 
PA1426 hypothetical protein 1.6 2.4 
PA1451 hypothetical protein 1.1 2.9 
PA1474 hypothetical protein -1.3 2.7 
PA1679 hypothetical protein -1.1 3.1 
PA1784 hypothetical protein 2.2 1.4 
PA1849 hypothetical protein 1.5 2.5 
PA1913 hypothetical protein 2.3 5.0 
PA1967 hypothetical protein 2.3 2.8 
PA1995 hypothetical protein 1.3 3.2 
PA2106 hypothetical protein 1.1 2.6 
PA2171 hypothetical protein 1.5 2.4 
PA2313 hypothetical protein 1.0 4.3 
PA2364 hypothetical protein 2.1 1.9 
PA2370 hypothetical protein 2.3 -1.0 
PA2441 hypothetical protein 1.6 2.5 
PA2484 hypothetical protein 2.6 1.3 
PA2590 hypothetical protein 1.0 2.2 
PA2613 hypothetical protein 3.7 2.5 
PA2630 hypothetical protein 1.1 2.8 
PA2756 hypothetical protein -1.6 6.6 
PA2774 hypothetical protein -1.0 3.0 
PA2795 hypothetical protein 1.0 6.8 
pelE hypothetical protein 1.2 4.7 
PA3127 hypothetical protein 2.1 -1.1 
PA3205 hypothetical protein 2.4 2.5 
PA3273 hypothetical protein 1.1 2.4 
PA3320 hypothetical protein 2.9 2.2 
PA3370 hypothetical protein 1.6 2.2 
PA3572 hypothetical protein 1.1 2.7 
PA3716 hypothetical protein 3.1 1.8 
PA3945 hypothetical protein 1.1 2.7 
PA3978 hypothetical protein 1.0 2.5 
PA4140 hypothetical protein 1.6 2.1 
PA4326 hypothetical protein 3.3 1.3 
PA4510 hypothetical protein 1.0 2.2 
PA4577 hypothetical protein 1.1 2.2 
PA4591 hypothetical protein 1.1 2.3 
PA4623 hypothetical protein 1.0 3.4 
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PA4657 hypothetical protein 1.4 5.6 
PA4782 hypothetical protein 1.2 2.7 
PA4826 hypothetical protein -1.1 2.2 
PA4916 hypothetical protein -1.3 4.0 
PA4918 hypothetical protein 1.4 2.8 
PA5061 hypothetical protein 1.4 2.1 
PA5306 hypothetical protein 1.1 2.1 
PA5444 hypothetical protein 1.3 2.2 
PA5506 hypothetical protein 1.1 3.4 
'Membrane proteins' 
PA1897 hypothetical protein 2.3 4.1 
oprG Outer membrane protein OprG precursor 4.5 2.4 
'Motility & Attachment' 
flgL flagellar hook-associated protein type 3 FlgL 1.7 2.5 
fliF flagellar M-ring protein -1.0 2.8 
'Putative enzymes' 
PA0421 hypothetical protein 2.8 1.8 
PA0836 probable acetate kinase 1.2 2.7 
PA0507 probable acyl-CoA dehydrogenase 1.1 2.5 
PA2125 probable aldehyde dehydrogenase 3.0 -1.1 
PA5508 probable glutamine synthetase 1.7 2.8 
PA2865 probable glycosylase 1.1 2.7 
PA1470 probable short-chain dehydrogenase 2.1 2.0 
PA2554 probable short-chain dehydrogenase 1.7 3.0 
PA3128 short chain dehydrogenase 1.5 2.9 
PA3277 short chain dehydrogenase -1.5 3.4 
PA4786 short-chain dehydrogenase 1.1 3.5 
'Related to phage, transposon, or plasmid' 
PA0616 hypothetical protein -1.4 2.5 
PA0624 hypothetical protein 2.4 1.4 
PA0626 hypothetical protein 1.5 6.1 
PA0627 hypothetical protein 2.5 2.1 
PA0628 hypothetical protein 2.1 3.1 
PA0629 hypothetical protein 3.0 2.6 
PA0633 hypothetical protein 2.4 2.8 
PA0636 hypothetical protein 2.1 2.4 
PA0637 hypothetical protein 1.6 4.6 
PA0639 hypothetical protein 1.4 2.2 
PA0644 hypothetical protein -1.1 2.0 
PA0717 hypothetical protein of bacteriophage Pf1 -1.2 2.3 
PA0617 probable bacteriophage protein 2.7 2.4 
PA0619 probable bacteriophage protein 3.7 1.7 
PA0622 probable bacteriophage protein 2.3 -1.1 
PA0623 probable bacteriophage protein 1.2 4.6 
PA0638 probable bacteriophage protein 1.6 2.4 
PA0640 probable bacteriophage protein 2.6 1.7 
'Secreted Factors toxins, enzymes, alginate' 
algW AlgW protein 1.6 2.4 
'Transcription, RNA processing and degradation' 
nusG transcription antitermination protein NusG 1.6 3.9 
nusA transcription elongation factor NusA 1.1 2.1 
PA0207 probable transcriptional regulator 1.0 2.4 
PA0225 probable transcriptional regulator 1.1 2.3 
PA2897 probable transcriptional regulator 1.5 3.0 
PA2930 probable transcriptional regulator -1.1 2.1 
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rsaL regulatory protein RsaL 1.2 2.2 
psrA transcriptional regulator PsrA -1.3 2.7 
 
 
Translation, post-translational modification, degradation' 
rpsL 30S ribosomal protein S12 2.1 1.3 
rpsP 30S ribosomal protein S16 1.3 2.8 
rpsS 30S ribosomal protein S19 -1.5 2.3 
rpsB 30S ribosomal protein S2 -1.3 2.7 
rpmE 50S ribosomal protein L31 1.2 2.6 
rplL 50S ribosomal protein L7/L12 1.8 2.4 
clpB ClpB protein -1.1 2.2 
fusA2 elongation factor G 4.7 6.1 
fusA1 elongation factor G 2.4 3.4 
lexA LexA repressor 1.5 1.9 
prc periplasmic tail-specific protease 1.3 2.8 
PA2371 probable ClpA/B-type protease -1.0 2.5 
infA translation initiation factor IF-1 1.0 2.4 
'Transport of small molecules' 
fruK 1-phosphofructokinase 2.1 2.9 
oprD 
Basic amino acid, basic peptide and imipenem outer membrane porin OprD 
precursor 1.6 2.5 
braC branched-chain amino acid transport protein BraC 1.2 2.4 
ccmA heme exporter protein CcmA 2.2 2.7 
oprM 
Major intrinsic multiple antibiotic resistance efflux outer membrane protein 
OprM precursor -1.0 2.5 
PA0206 probable ATP-binding component of ABC transporter 1.1 7.3 
PA2912 probable ATP-binding component of ABC transporter -1.0 2.1 
PA0273 probable major facilitator superfamily (MFS) transporter 1.5 4.0 
PA3647 probable outer membrane protein precursor 1.9 2.0 
PA4292 probable phosphate transporter 1.1 3.6 
PA4375 probable RND efflux transporter 1.4 2.2 
PA2466 probable TonB-dependent receptor 1.4 2.2 
'Two-component regulatory systems' 
PA1243 probable sensor/response regulator hybrid 2.5 1.2 
PA1458 probable two-component sensor 1.3 2.3 
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Table S6.6: List of the PAO1 persister genes repressed after DC treatment with 70 
μA/cm2 DC using carbon electrodes. 
 
    Fold change 
Gene Description 20 min  40 min 
'Amino acid biosynthesis and metabolism' 
aguB N-carbamoylputrescine amidohydrolase -4.7 1.3 
PA1818 probable Orn/Arg/Lys decarboxylase -2.3 -1.1 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
panB 3-methyl-2-oxobutanoate hydroxymethyltransferase 1.0 -2.0 
moaA1 molybdopterin biosynthetic protein A1 -1.2 -2.2 
serC phosphoserine aminotransferase -1.7 -2.1 
'Carbon compound catabolism' 
fbp fructose-1,6-bisphosphatase -1.3 -2.1 
'Cell wall / LPS / capsule' 
gmd GDP-mannose 4,6-dehydratase -3.9 -1.9 
'Central intermediary metabolism' 
PA5435 oxaloacetate decarboxylase 1.1 -2.0 
'DNA replication, recombination, modification and repair' 
PA2138 DNA ligase -2.0 1.0 
ogt methylated-DNA--protein-cysteine methyltransferase -2.0 1.4 
recR recombination protein RecR -1.7 -2.5 
'Energy metabolism' 
ccmH cytochrome C-type biogenesis protein CcmH -1.8 -2.0 
cyoD cytochrome o ubiquinol oxidase subunit IV -2.9 1.1 
nirJ heme d1 biosynthesis protein NirJ 1.2 -2.2 
PA1600 probable cytochrome c -2.3 1.1 
PA2716 probable FMN oxidoreductase -1.1 -2.5 
PA0510 probable uroporphyrin-III c-methyltransferase -2.2 -2.1 
'Hypothetical, unclassified, unknown' 
PA0238 hypothetical protein -2.0 -1.1 
PA0317 hypothetical protein 1.0 -2.0 
PA0486 hypothetical protein -1.2 -2.1 
PA0498 hypothetical protein -1.1 -2.0 
PA0539 hypothetical protein -1.5 -2.1 
PA0549 hypothetical protein -1.2 -2.0 
PA0550 hypothetical protein 1.1 -2.7 
PA0709 hypothetical protein -1.3 -2.0 
PA0729 hypothetical protein -1.2 -2.8 
PA0847 hypothetical protein -2.3 -1.3 
PA1866 hypothetical protein -2.1 1.1 
PA1975 hypothetical protein 2.4 -2.3 
PA2075 hypothetical protein -1.7 -2.4 
PA2200 hypothetical protein -2.1 -1.7 
PA2404 hypothetical protein -1.2 -2.0 
PA2567 hypothetical protein -1.4 -3.0 
PA2650 hypothetical protein -3.8 -1.2 
PA2765 hypothetical protein -2.1 1.1 
PA2880 hypothetical protein 1.3 -3.0 
PA2936 hypothetical protein -2.1 -1.0 
PA3578 hypothetical protein -1.3 -2.3 
PA3892 hypothetical protein -2.3 -1.4 
PA3983 hypothetical protein -1.3 -2.2 
PA4319 hypothetical protein -2.1 1.7 
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PA4321 hypothetical protein -1.6 -2.6 
PA4347 hypothetical protein -1.3 -2.1 
PA4872 hypothetical protein 1.1 -2.0 
PA4894 hypothetical protein -1.2 -2.8 
PA4929 hypothetical protein 1.2 -2.2 
PA5237 hypothetical protein 1.0 -2.2 
PA5477 hypothetical protein 1.0 -2.2 
'Protein secretion/export apparatus' 
lepA GTP-binding protein LepA -1.2 -2.8 
pscF type III export protein PscF -2.5 -1.4 
'Putative enzymes' 
PA2324 hypothetical protein -2.8 -1.5 
PA2889 probable acyl-CoA dehydrogenase -1.4 -2.0 
PA2499 probable deaminase -1.2 -2.5 
PA1991 probable iron-containing alcohol dehydrogenase -2.2 -1.8 
PA0237 probable oxidoreductase -1.3 -2.1 
PA4621 probable oxidoreductase -2.0 -2.2 
PA5327 probable oxidoreductase -1.1 -2.2 
PA0975 probable radical activating enzyme -1.3 -2.1 
PA2892 short chain dehydrogenase 1.1 -2.4 
'Secreted Factors (toxins, enzymes, alginate)' 
exoT exoenzyme T -2.5 -1.2 
'Transcriptional regulators' 
PA0163 probable transcriptional regulator 1.2 -2.1 
PA2047 probable transcriptional regulator -2.5 -1.6 
PA3895 probable transcriptional regulator -2.2 1.0 
PA1911 probable transmembrane sensor -1.5 -2.3 
PA3900 probable transmembrane sensor -2.5 -1.7 
'Translation, post-translational modification, degradation' 
ileS isoleucyl-tRNA synthetase -2.1 -1.0 
'Transport of small molecules' 
hisJ periplasmic histidine-binding protein HisJ -2.7 -1.0 
trkA potassium uptake protein TrkA -1.1 -2.0 
PA0458 probable major facilitator superfamily (MFS) transporter -2.1 -1.7 
PA1848 probable major facilitator superfamily (MFS) transporter -1.2 -2.7 
PA4179 probable porin -1.1 -2.4 
PA4898 probable porin -2.3 -1.2 
PA4334 probable transport protein -2.0 -1.2 
PA0322 probable transporter -2.5 -1.7 
msbA transport protein MsbA 1.2 -2.9 
'Two-component regulatory systems' 
PA2798 probable two-component response regulator -2.1 -1.6 
PA4380 probable two-component sensor -1.1 -2.3 
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Table S6.7: List of the PAO1 persister genes induced after DC treatment with 70 
μA/cm2 DC using SS304 electrodes. 
 
    Fold Change 
Gene Description 20 min 40 min 
'Adaptation, protection' 
lytB 4-hydroxy-3-methylbut-2-enyl diphosphate reductase 4.2 1.1 
dnaJ DnaJ protein 1.2 2.2 
'Amino acid biosynthesis and metabolism' 
PA0399 cystathionine beta-synthase 3.2 1.9 
PA0400 probable cystathionine gamma-lyase 4.7 1.5 
trpG anthranilate synthase component II 1.7 2.6 
trpC indole-3-glycerol-phosphate synthase 1.3 2.3 
leuA 2-isopropylmalate synthase 5.1 6.3 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
PA0503 probable biotin synthesis protein BioC 6.3 -1.1 
bioD dithiobiotin synthetase 1.2 2.6 
nirF heme d1 biosynthesis protein NirF 3.1 1.6 
nadA quinolinate synthetase 1.7 2.1 
pdxH pyridoxamine 5'-phosphate oxidase 2.2 1.9 
PA1125 probable cobalamin biosynthetic protein 2.6 -1.3 
cobO cob(I)yrinic acid a,c-diamide adenosyltransferase 3.2 1.3 
folE1 GTP cyclohydrolase I precursor 1.3 2.5 
moaD molybdopterin converting factor, small subunit 2.2 1.7 
ispB octaprenyl-diphosphate synthase 3.3 -1.2 
ipk 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase 2.2 1.8 
folP dihydropteroate synthase 19.3 1.1 
nadE NAD(+) synthetase 4.2 -1.8 
pqsB beta-keto-acyl-acyl-carrier protein synthase-like protein 7.0 2.1 
pqsD 3-oxoacyl-[acyl-carrier-protein] synthase III 2.5 1.3 
'Carbon compound catabolism' 
prpC citrate synthase 2 1.4 2.1 
PA0810 probable haloacid dehalogenase 5.8 2.6 
xylZ toluate 1,2-dioxygenase electron transfer component 1.4 2.3 
glk glucokinase 3.7 -1.1 
PA3517 probable lyase 2.2 2.4 
pgm phosphoglyceromutase 2.1 -1.3 
PA5417 sarcosine oxidase delta subunit 2.2 -1.5 
'Cell wall / LPS / capsule' 
wbpB probable oxidoreductase WpbB 2.2 3.9 
ftsI penicillin-binding protein 3 2.6 -1.2 
comL competence protein ComL 3.1 2.1 
rmlA glucose-1-phosphate thymidylyltransferase 2.1 2.2 
glmU 
glucosamine-1-phosphate acetyltransferase/N-acetylglucosamine-1-
phosphate uridyltransferase 1.4 2.0 
'Central intermediary metabolism' 
PA2140 probable metallothionein -1.3 2.2 
gloA3 lactoylglutathione lyase 5.2 1.2 
'Chemotaxis' 
chpE probable chemotaxis protein 4.2 1.0 
PA1459 probable methyltransferase 2.6 -1.4 
motA flagellar motor protein 2.8 1.0 
'DNA replication, recombination, modification and repair' 
ruvC Holliday junction resolvase 2.4 1.1 
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ruvB Holliday junction DNA helicase RuvB 3.4 -1.2 
uvrB excinuclease ABC subunit B 2.5 -1.6 
ihfB integration host factor beta subunit 1.8 3.1 
gyrA DNA gyrase subunit A 2.7 2.8 
PA5348 probable DNA-binding protein 3.5 -1.2 
'Energy metabolism' 
nirS nitrite reductase precursor 4.4 1.8 
norC nitric-oxide reductase subunit C 2.1 2.7 
norB nitric-oxide reductase subunit B 2.4 3.0 
glpE thiosulfate sulfurtransferase 2.4 -1.6 
napD NapD protein of periplasmic nitrate reductase 4.6 1.4 
ccmG cytochrome C biogenesis protein CcmG 3.3 1.9 
sdhD succinate dehydrogenase (D subunit) 17.9 2.7 
nuoD NADH dehydrogenase I chain C,D 2.9 1.1 
nuoF NADH dehydrogenase I chain F 3.2 2.2 
nuoI NADH dehydrogenase subunit I 4.9 1.1 
nuoJ NADH dehydrogenase subunit J 2.6 2.1 
nosZ nitrous-oxide reductase precurser 2.0 1.5 
PA4430 probable cytochrome b 3.1 16.9 
cc4 cytochrome c4 precursor 3.3 1.7 
'Fatty acid and phospholipid metabolism' 
fabI NADH-dependent enoyl-ACP reductase 2.0 2.5 
pgsA CDP-diacylglycerol--glycerol-3-phosphate 3-phosphatidyltransferase 4.6 1.6 
faoA fatty-acid oxidation complex alpha-subunit 4.7 -1.4 
PA3334 probable acyl carrier protein 1.1 4.4 
psd phosphatidylserine decarboxylase 2.6 2.7 
'Hypothetical, unclassified, unknown' 
PA0022 hypothetical protein 2.2 1.1 
PA0160 hypothetical protein 3.3 1.5 
PA0250 hypothetical protein 2.6 1.8 
PA0255 hypothetical protein 2.6 1.3 
PA0308 hypothetical protein 2.7 1.8 
PA0310 hypothetical protein 3.8 4.8 
PA0359 hypothetical protein 3.7 2.2 
PA0368 hypothetical protein 3.8 2.0 
PA0392 hypothetical protein 2.0 4.2 
PA0451 hypothetical protein 3.1 2.0 
PA0461 hypothetical protein 2.0 1.1 
PA0495 hypothetical protein 4.4 -1.0 
PA0565 hypothetical protein 2.1 1.0 
PA0614 hypothetical protein 2.9 1.9 
PA0615 hypothetical protein 2.3 2.1 
PA0713 hypothetical protein 1.7 2.6 
PA0777 hypothetical protein 2.7 1.0 
PA0808 hypothetical protein 4.7 1.9 
PA0862 hypothetical protein 2.3 1.9 
PA0907 hypothetical protein 4.8 1.0 
PA0915 hypothetical protein 1.4 2.4 
PA0926 hypothetical protein 2.6 2.8 
PA0943 hypothetical protein 2.4 -1.2 
PA0948 hypothetical protein 1.7 2.2 
PA0957 hypothetical protein 3.6 1.5 
PA1034 hypothetical protein 2.7 1.1 
PA1052 hypothetical protein 1.0 2.2 
PA1057 hypothetical protein 6.9 3.2 
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PA1062 hypothetical protein 1.6 2.2 
PA1107 hypothetical protein 2.7 1.9 
PA1210 hypothetical protein 2.1 1.4 
PA1211 hypothetical protein 1.3 2.1 
PA1263 hypothetical protein 1.7 2.0 
PA1343 hypothetical protein 5.8 8.0 
PA1348 hypothetical protein 6.4 -1.2 
PA1404 hypothetical protein 2.1 1.8 
PA1415 hypothetical protein 14.4 1.7 
PA1427 hypothetical protein 2.0 -1.0 
PA1503 hypothetical protein 3.1 -1.0 
PA1516 hypothetical protein 2.7 -1.3 
PA1517 hypothetical protein 2.5 1.5 
PA1518 hypothetical protein 3.0 2.1 
PA1644 hypothetical protein 2.9 -1.3 
exsD ExsD 4.5 1.6 
PA1790 hypothetical protein 2.1 1.3 
PA1857 hypothetical protein 4.1 1.8 
PA1895 hypothetical protein 1.9 2.5 
PA1939 hypothetical protein 10.5 3.5 
PA1944 hypothetical protein 3.9 8.5 
PA2116 hypothetical protein 4.1 1.1 
PA2192 hypothetical protein 2.1 -1.2 
PA2287 hypothetical protein 1.7 2.1 
PA2313 hypothetical protein -1.0 2.0 
PA2331 hypothetical protein 5.0 1.6 
PA2369 hypothetical protein 4.5 1.3 
PA2380 hypothetical protein 3.9 2.4 
PA2484 hypothetical protein 1.3 2.9 
PA2485 hypothetical protein 2.4 6.6 
PA2544 hypothetical protein 6.0 1.4 
PA2659 hypothetical protein 4.5 6.2 
PA2706 hypothetical protein 3.4 1.8 
PA2736 hypothetical protein 1.2 2.7 
PA2756 hypothetical protein 2.3 5.9 
PA2797 hypothetical protein 1.7 2.4 
PA2808 hypothetical protein 2.5 2.3 
PA2845 hypothetical protein 2.5 1.3 
PA2864 hypothetical protein 4.3 1.0 
PA2875 hypothetical protein 1.9 3.9 
PA2880 hypothetical protein 2.5 -1.4 
PA2898 hypothetical protein 4.6 4.4 
PA2929 hypothetical protein 2.3 -1.2 
PA2946 hypothetical protein 6.8 -1.3 
PA2971 hypothetical protein 2.8 1.3 
PA3009 hypothetical protein 2.9 1.8 
PA3018 hypothetical protein 1.1 2.4 
PA3042 hypothetical protein 3.5 1.1 
gbt glycine betaine transmethylase 4.5 1.3 
PA3239 hypothetical protein 2.8 -1.3 
PA3278 hypothetical protein 2.0 2.4 
PA3289 hypothetical protein 2.4 -1.2 
PA3323 hypothetical protein 1.2 2.3 
PA3388 hypothetical protein 2.2 4.6 
PA3435 flavodoxin 2.3 -1.4 
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PA3496 hypothetical protein 2.9 1.4 
PA3539 hypothetical protein 2.6 1.2 
PA3552 hypothetical protein 9.7 1.2 
PA3634 hypothetical protein 2.0 1.8 
PA3685 hypothetical protein 2.2 4.0 
PA3726 hypothetical protein 5.2 -1.0 
PA3740 hypothetical protein 1.7 3.0 
PA3794 hypothetical protein 2.6 4.1 
PA3808 hypothetical protein 1.9 3.3 
PA3833 hypothetical protein 1.4 2.4 
PA3864 hypothetical protein 2.3 1.3 
PA3952 hypothetical protein 2.3 1.4 
PA3958 hypothetical protein 2.0 1.3 
PA3992 hypothetical protein 3.0 -1.2 
PA4015 hypothetical protein 2.2 4.0 
PA4132 hypothetical protein 2.5 2.1 
PA4140 hypothetical protein 3.1 2.9 
PA4317 hypothetical protein 2.7 -1.2 
PA4324 hypothetical protein 2.9 1.6 
PA4338 hypothetical protein 3.9 3.2 
PA4372 hypothetical protein 2.3 2.1 
PA4379 hypothetical protein 2.9 1.3 
PA4395 hypothetical protein 2.1 1.8 
PA4451 hypothetical protein 2.4 3.9 
PA4460 hypothetical protein 14.6 -1.0 
PA4511 hypothetical protein 16.1 1.4 
PA4575 hypothetical protein 1.4 2.9 
PA4623 hypothetical protein 1.4 2.1 
PA4638 hypothetical protein 3.0 -1.3 
PA4658 hypothetical protein -1.2 2.2 
PA4736 hypothetical protein 1.7 2.1 
PA4792 hypothetical protein 2.5 1.4 
PA4842 hypothetical protein 1.7 2.3 
PA5002 hypothetical protein 2.8 -2.3 
PA5007 hypothetical protein 1.8 2.9 
PA5017 hypothetical protein 2.6 1.3 
PA5078 hypothetical protein 2.2 1.0 
PA5087 hypothetical protein 3.6 1.2 
PA5209 hypothetical protein 2.8 1.6 
PA5227 hypothetical protein 2.5 1.4 
PA5228 hypothetical protein 1.9 2.8 
PA5233 flagellar protein 2.4 -1.0 
PA5248 hypothetical protein 2.3 -1.2 
PA5251 hypothetical protein 2.9 1.5 
PA5270 hypothetical protein 3.3 -1.4 
PA5271 hypothetical protein 8.1 1.2 
PA5329 hypothetical protein 3.1 1.4 
PA5359 hypothetical protein 2.8 1.2 
PA5423 hypothetical protein 3.3 -1.0 
PA5461 hypothetical protein 9.7 12.5 
PA5471 hypothetical protein 3.1 -1.6 
PA5492 GTP-binding protein 2.4 2.8 
PA5502 hypothetical protein 2.1 3.1 
'Membrane proteins' 
PA0452 probable stomatin-like protein 2.1 -1.1 
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PA1305 hypothetical protein 3.1 1.3 
PA4924 hypothetical protein 2.2 1.4 
PA5264 hypothetical protein 2.7 1.9 
 
Motility & Attachment' 
flgJ peptidoglycan hydrolase 2.2 1.0 
cupB6 fimbrial subunit CupB6 2.5 0.9 
pilC still frameshift type 4 fimbrial biogenesis protein PilC 3.5 1.2 
pilQ Type 4 fimbrial biogenesis outer membrane protein PilQ precursor 3.4 2.0 
'Nucleotide biosynthesis and metabolism' 
apaH diadenosinetetraphosphatase 7.4 1.0 
prs ribose-phosphate pyrophosphokinase 2.0 1.4 
'Protein secretion/export apparatus' 
popD Translocator outer membrane protein PopD precursor 2.4 -1.0 
xcpS general secretion pathway protein F 1.6 2.8 
PA3404 probable outer membrane protein precursor 1.6 2.2 
secE translocase 6.6 2.0 
secG secretion protein SecG 2.3 1.5 
'Putative enzymes' 
PA0562 probable hydrolase 3.0 -1.4 
PA0779 probable ATP-dependent protease 1.5 3.3 
PA0840 probable oxidoreductase 3.1 2.1 
PA1224 probable NAD(P)H dehydrogenase 2.8 1.7 
PA1306 probable HIT family protein 1.9 2.0 
PA1344 probable short-chain dehydrogenase 2.7 2.3 
PA1576 probable 3-hydroxyisobutyrate dehydrogenase 1.9 2.8 
PA1628 probable 3-hydroxyacyl-CoA dehydrogenase 1.6 2.7 
PA2271 probable acetyltransferase 1.8 2.8 
PA2355 probable FMNH2-dependent monooxygenase 3.0 2.0 
PA3330 probable short chain dehydrogenase 2.9 1.4 
PA3504 probable aldehyde dehydrogenase 1.9 3.1 
PA3567 probable oxidoreductase 3.8 1.7 
PA3795 probable oxidoreductase 2.9 1.5 
PA4431 probable iron-sulfur protein 3.5 6.9 
PA4786 short-chain dehydrogenase 2.2 1.0 
PA5313 probable pyridoxal-dependent aminotransferase 2.1 1.1 
'Related to phage, transposon, or plasmid' 
PA0616 hypothetical protein 2.2 2.0 
PA0631 hypothetical protein 2.3 1.7 
PA0639 hypothetical protein 2.0 2.1 
PA0643 hypothetical protein 3.9 2.7 
PA0644 hypothetical protein 1.8 2.1 
PA0645 hypothetical protein 2.4 1.4 
PA0647 hypothetical protein 3.2 2.3 
PA0648 hypothetical protein 1.2 2.3 
PA0718 hypothetical protein of bacteriophage Pf1 13.8 2.0 
PA0720 helix destabilizing protein of bacteriophage Pf1 2.4 2.7 
PA0725 hypothetical protein of bacteriophage Pf1 2.4 1.3 
'Secreted Factors (toxins, enzymes, alginate)' 
pvcA pyoverdine biosynthesis protein PvcA 6.2 2.4 
algC phosphomannomutase AlgC 3.8 2.8 
'Transcription, RNA processing and degradation' 
rne ribonuclease E 2.3 1.3 
hepA ATP-dependent helicase HepA 3.0 2.4 
rimM 16S rRNA-processing protein 2.1 2.2 
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rluD pseudouridine synthase 1.9 2.5 
rnr exoribonuclease RNase R 2.8 1.3 
'Transcriptional regulators' 
PA0533 probable transcriptional regulator 2.8 -1.1 
prtR transcriptional regulator PrtR 4.3 -1.1 
argR transcriptional regulator ArgR 4.5 -1.3 
PA0942 probable transcriptional regulator 1.1 3.2 
PA1504 probable transcriptional regulator -1.7 4.0 
PA1526 probable transcriptional regulator 3.0 6.4 
cysB transcriptional regulator CysB 2.0 1.7 
PA2432 probable transcriptional regulator 1.1 2.2 
PA2885 probable transcriptional regulator 2.1 1.2 
PA3689 probable transcriptional regulator 3.0 2.2 
PA4184 probable transcriptional regulator 2.0 1.0 
PA4203 probable transcriptional regulator -1.1 2.8 
PA4769 probable transcriptional regulator 3.2 2.8 
PA4784 probable transcriptional regulator 2.0 -1.9 
PA4896 probable sigma-70 factor, ECF subfamily 2.5 0.7 
PA5380 probable transcriptional regulator 3.4 1.1 
PA5438 probable transcriptional regulator 4.3 1.3 
'Translation, post-translational modification, degradation' 
aspS aspartyl-tRNA synthetase 2.3 1.1 
lexA LexA repressor 1.8 6.0 
map methionine aminopeptidase 4.0 0.9 
rpsP 30S ribosomal protein S16 3.0 2.4 
rpsD 30S ribosomal protein S4 3.1 1.7 
rplW 50S ribosomal protein L23 2.2 4.4 
rpsI 30S ribosomal protein S9 3.0 2.0 
PA4671 50S ribosomal protein L25 4.1 2.2 
rnpA ribonuclease P 4.2 1.1 
'Transport of small molecules' 
PA0137 probable permease of ABC transporter 2.5 1.5 
PA0206 probable ATP-binding component of ABC transporter 3.0 1.8 
PA0215 probable transporter 2.3 1.4 
cysW sulfate transport protein CysW 2.4 2.9 
spuG polyamine transport protein PotH 4.9 1.1 
PA0313 probable permease of ABC transporter -1.2 2.3 
PA0314 probable binding protein component of ABC transporter 2.4 1.5 
PA0470 probable hydroxamate-type ferrisiderophore receptor 7.8 1.1 
exbD2 transport protein ExbD 2.2 1.9 
PA0811 probable major facilitator superfamily (MFS) transporter 1.6 2.3 
PA0860 probable ATP-binding/permease fusion ABC transporter 2.0 -1.1 
aotQ arginine/ornithine transport protein AotQ 2.7 1.0 
tolB translocation protein TolB precursor 3.3 1.3 
PA1108 probable major facilitator superfamily (MFS) transporter 1.1 2.7 
PA1194 probable amino acid permease 3.2 1.6 
ccmA heme exporter protein CcmA 1.9 1.9 
PA1485 probable amino acid permease 2.8 3.0 
PA1808 probable permease of ABC transporter 1.7 2.8 
PA1964 probable ATP-binding component of ABC transporter 5.3 1.1 
PA2055 probable major facilitator superfamily (MFS) transporter 2.7 1.3 
PA2135 probable transporter 2.5 5.1 
PA3336 probable major facilitator superfamily (MFS) transporter -1.2 3.1 
PA3441 probable molybdopterin-binding protein 2.4 1.4 
potC polyamine transport protein PotC 2.8 1.2 
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opmD probable outer membrane protein precursor 3.3 1.3 
PA4374 
probable Resistance-Nodulation-Cell Division (RND) efflux 
membrane fusion protein precursor 2.5 1.4 
mscL large-conductance mechanosensitive channel 2.0 2.3 
PA4909 probable ATP-binding component of ABC transporter 1.6 2.5 
PA5376 probable ATP-binding component of ABC transporter 2.1 -1.1 
'Two-component regulatory systems' 
cheY two-component response regulator CheY 3.6 2.6 
PA2479 probable two-component response regulator 3.2 3.0 
PA4101 probable two-component response regulator 2.3 1.8 
PA4843 probable two-component response regulator 2.2 2.4 
envZ two-component sensor EnvZ 2.6 -1.2 
ompR two-component response regulator OmpR 2.2 1.6 
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Table S6.8: List of the PAO1 persister genes repressed by DC treatment with 70 
μA/cm2 DC using SS304 electrodes. 
 
    Fold Change 
Gene Description 20 min 40 min 
'Adaptation, protection' 
ampC beta-lactamase precursor -2.5 1.1 
betA choline dehydrogenase -2.3 -1.0 
katN non-heme catalase KatN -1.1 -2.1 
pmbA PmbA protein -1.1 -2.4 
PA2314 probable major facilitator superfamily (MFS) transporter -2.3 -1.4 
pvdO PvdO -1.4 -2.3 
pvdP PvdP -1.2 -2.4 
'Amino acid biosynthesis and metabolism' 
ilvI acetolactate synthase III large subunit -2.5 1.0 
argB acetylglutamate kinase -2.9 -1.4 
hisF2 imidazole glycerol phosphate synthase subunit HisF -2.5 1.1 
sdaB L-serine dehydratase -1.3 -2.3 
cysH phosphoadenosine phosphosulfate reductase -4.9 -2.4 
glyA3 serine hydroxymethyltransferase -2.5 -2.6 
aruE succinylglutamate desuccinylase -2.0 -1.3 
'Antibiotic resistance and susceptibility' 
PA1129 probable fosfomycin resistance protein -2.1 -1.1 
PA1237 probable multidrug resistance efflux pump -2.3 -1.3 
PA2018 RND multidrug efflux transporter -2.5 -2.0 
'Biosynthesis of cofactors, prosthetic groups and carriers' 
panB 3-methyl-2-oxobutanoate hydroxymethyltransferase -2.0 -1.1 
ubiA 4-hydroxybenzoate octaprenyltransferase -2.3 -1.0 
bioA adenosylmethionine--8-amino-7-oxononanoate transaminase -2.0 -1.9 
ureG urease accessory protein UreG -2.0 -1.1 
cobA uroporphyrin-III C-methyltransferase -3.5 -1.7 
'Carbon compound catabolism' 
PA2040 probable glutamine synthetase -2.3 -1.1 
antA anthranilate dioxygenase large subunit -3.4 -1.8 
antC anthranilate dioxygenase reductase -3.6 -1.7 
PA0226 probable CoA transferase, subunit A -2.2 -1.2 
PA0227 probable CoA transferase, subunit B -2.1 -1.5 
PA5411 probable ferredoxin -3.0 -1.0 
PA5410 probable ring hydroxylating dioxygenase, alpha-subunit -2.5 -1.1 
vanB vanillate O-demethylase oxidoreductase -1.9 -2.1 
'Cell wall / LPS / capsule' 
rfaD ADP-L-glycero-D-mannoheptose 6-epimerase -2.2 -1.4 
murI glutamate racemase -2.2 1.0 
wbpX glycosyltransferase WbpX -2.9 -1.1 
pbpC penicillin-binding protein 3A -3.2 -1.0 
sltB1 soluble lytic transglycosylase B -2.4 -1.2 
'Central intermediary metabolism' 
phaC2 poly(3-hydroxyalkanoic acid) synthase 2 -2.8 1.5 
PA2726 probable radical activating enzyme -2.5 -1.0 
ureB urease beta subunit 1.2 -2.9 
'Chemotaxis' 
motD flagellar motor protein -2.4 1.4 
PA3349 probable chemotaxis protein -1.4 -2.1 
PA2561 probable chemotaxis transducer -2.4 -1.5 
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'DNA replication, recombination, modification and repair' 
uvrC excinuclease ABC subunit C -2.4 -1.5 
PA4282 probable exonuclease -2.1 -2.0 
PA1405 probable helicase -3.5 -1.9 
'Energy metabolism' 
snr1 cytochrome c Snr1 -2.7 -1.2 
cycH cytochrome c-type biogenesis protein -2.2 1.1 
PA2165 glycogen synthase -2.0 -1.3 
nosD NosD protein -1.7 -2.8 
nirN probable c-type cytochrome -2.3 1.0 
PA1600 probable cytochrome c -2.2 -1.6 
PA0521 probable cytochrome c oxidase subunit -2.1 -2.0 
PA2714 probable molybdopterin oxidoreductase -3.1 -1.8 
rpe ribulose-phosphate 3-epimerase -1.9 -2.4 
'Fatty acid and phospholipid metabolism' 
plsX fatty acid/phospholipid synthesis protein -2.0 -1.2 
'Hypothetical, unclassified, unknown' 
engA GTP-binding protein EngA -2.2 -1.5 
PA0099 hypothetical protein -2.4 -2.2 
PA0161 hypothetical protein -2.1 1.0 
PA0317 hypothetical protein -1.5 -2.3 
PA0328 hypothetical protein 1.1 -2.7 
PA0356 hypothetical protein -2.9 1.1 
PA0394 hypothetical protein -3.0 -1.3 
PA0462 hypothetical protein -3.1 -1.2 
PA0497 hypothetical protein -1.4 -2.0 
PA0561 hypothetical protein 2.4 -2.3 
PA0574 hypothetical protein -1.1 -2.5 
PA0834 hypothetical protein -2.0 -1.3 
PA0875 hypothetical protein -2.5 -1.7 
PA0878 hypothetical protein -1.9 -2.2 
PA0902 hypothetical protein -2.7 -1.4 
PA0946 hypothetical protein -3.2 -1.1 
PA1059 hypothetical protein -2.2 -1.3 
PA1089 hypothetical protein -2.7 -1.5 
PA1111 hypothetical protein -2.1 -1.1 
PA1192 hypothetical protein -1.9 -2.2 
PA1203 hypothetical protein -1.7 -2.2 
PA1354 hypothetical protein -2.1 -1.8 
PA1371 hypothetical protein -2.1 1.0 
PA1372 hypothetical protein -2.1 -1.2 
PA1378 hypothetical protein -2.1 -1.6 
PA1428 hypothetical protein -2.1 -1.3 
PA1439 hypothetical protein 4.4 -2.0 
PA1494 hypothetical protein -1.9 -2.4 
PA1612 hypothetical protein -2.4 -1.4 
PA1640 hypothetical protein -2.9 -1.5 
PA1664 hypothetical protein -2.1 -1.8 
PA1688 hypothetical protein -2.6 -1.9 
PA1755 hypothetical protein -1.8 -3.9 
PA1874 hypothetical protein -2.2 -1.1 
PA1879 hypothetical protein -2.6 -1.7 
PA1906 hypothetical protein -2.6 1.2 
PA1926 hypothetical protein -1.5 -2.5 
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PA1956 hypothetical protein -1.5 -3.0 
PA1963 hypothetical protein -1.1 -2.2 
PA1972 hypothetical protein -3.2 -2.1 
PA2033 hypothetical protein -2.4 -1.7 
PA2077 hypothetical protein -2.5 -1.2 
PA2078 hypothetical protein -2.9 -1.3 
PA2110 hypothetical protein -2.3 -1.4 
PA2154 hypothetical protein -2.1 -1.2 
PA2205 hypothetical protein -2.0 -2.6 
PA2268 hypothetical protein -2.2 -1.2 
PA2296 hypothetical protein -2.6 -2.8 
PA2353 hypothetical protein -2.9 -3.0 
PA2428 hypothetical protein -2.5 -1.0 
PA2439 hypothetical protein -2.9 -1.1 
PA2543 hypothetical protein -3.3 -1.8 
PA2610 hypothetical protein -3.2 -1.0 
PA2628 hypothetical protein -3.6 -1.4 
PA2684 hypothetical protein -1.5 -2.8 
PA2720 hypothetical protein -2.7 -1.5 
PA2721 hypothetical protein -2.3 -1.0 
PA2750 hypothetical protein -1.7 -2.1 
PA2768 hypothetical protein -3.4 -2.8 
PA2814 hypothetical protein -3.0 -1.4 
PA2829 hypothetical protein -2.8 -1.6 
PA2839 hypothetical protein -3.5 -1.5 
PA2872 hypothetical protein -2.2 -1.5 
PA3054 hypothetical protein -2.1 -1.2 
PA3057 hypothetical protein -2.9 -1.0 
pelA hypothetical protein -2.2 -1.2 
PA3130 hypothetical protein -1.2 -2.4 
PA3230 hypothetical protein -2.1 -2.1 
PA3237 hypothetical protein -2.4 -1.0 
PA3282 hypothetical protein -2.1 -1.5 
PA3292 hypothetical protein -2.3 -1.0 
PA3318 hypothetical protein -2.7 -1.9 
PA3419 hypothetical protein -2.2 -1.4 
PA3424 hypothetical protein -2.6 -1.4 
PA3449 hypothetical protein -2.1 -1.1 
PA3670 hypothetical protein -1.2 -2.2 
PA3680 hypothetical protein -4.0 -1.7 
PA3733 hypothetical protein -3.5 -1.8 
PA3772 hypothetical protein -2.4 -1.1 
PA3826 hypothetical protein -3.4 1.0 
PA3851 hypothetical protein -2.1 -1.1 
PA3862 hypothetical protein -2.7 1.1 
PA3868 hypothetical protein -3.2 1.0 
PA3902 hypothetical protein -2.2 -1.3 
PA3904 hypothetical protein -2.2 -1.7 
PA3953 hypothetical protein -2.1 -1.3 
PA4057 hypothetical protein -2.8 -2.2 
PA4095 hypothetical protein -2.4 1.7 
PA4177 hypothetical protein -2.6 -1.2 
PA4181 hypothetical protein -2.1 -1.5 
PA4295 hypothetical protein -1.5 -2.1 
PA4319 hypothetical protein -2.5 1.1 
 
 
 
315 
PA4327 hypothetical protein -2.6 -1.6 
PA4340 hypothetical protein -1.8 -2.0 
PA4347 hypothetical protein -2.3 -2.3 
PA4391 hypothetical protein -1.9 -2.1 
PA4405 hypothetical protein -2.1 -1.8 
PA4438 hypothetical protein -2.3 -1.5 
PA4473 hypothetical protein 1.1 -2.2 
PA4485 hypothetical protein -2.0 -2.2 
PA4617 hypothetical protein -2.3 -1.7 
PA4629 hypothetical protein -2.1 -1.1 
PA4639 hypothetical protein -2.2 -1.2 
PA4684 hypothetical protein -2.5 1.2 
PA4734 hypothetical protein -2.7 -1.1 
PA4858 hypothetical protein -3.0 -1.7 
PA4863 hypothetical protein -2.8 -2.1 
PA4866 hypothetical protein -1.1 -2.4 
PA4894 hypothetical protein -1.8 -2.2 
PA5104 hypothetical protein -2.5 -1.5 
PA5109 hypothetical protein -2.0 -1.5 
PA5130 hypothetical protein -3.1 -1.7 
PA5132 hypothetical protein -2.6 -1.1 
PA5135 hypothetical protein -3.1 1.1 
PA5144 hypothetical protein -2.0 -2.0 
PA5180 hypothetical protein -1.7 -2.5 
PA5310 hypothetical protein -3.1 -1.1 
PA5385 hypothetical protein -2.1 -1.9 
PA5396 hypothetical protein -3.0 -1.3 
PA5414 hypothetical protein -2.4 -1.5 
PA3494 NADH-ubiquinone oxidoreductase -2.3 1.1 
PA5568 putative inner membrane protein translocase component YidC -3.6 -1.1 
'Membrane proteins' 
PA0260 hypothetical protein -1.0 -2.0 
PA0345 hypothetical protein -3.2 -2.0 
'Motility & Attachment' 
flhF flagellar biosynthesis protein -1.5 -2.1 
PA5498 probable adhesin -1.6 -2.4 
PA2407 probable adhesion protein -2.1 -1.6 
wspA probable chemotaxis transducer -2.2 -1.1 
fimT type 4 fimbrial biogenesis protein FimT -2.3 -1.8 
pilB type 4 fimbrial biogenesis protein PilB -2.1 -1.1 
'Nucleotide biosynthesis and metabolism' 
tmk thymidylate kinase -2.3 -1.7 
'Protein secretion/export apparatus' 
xcpX general secretion pathway protein K -1.2 -2.8 
hasE metalloprotease secretion protein -2.1 -1.6 
PA2673 probable type II secretion system protein -2.7 -2.1 
pcrG regulator in type III secretion -2.2 -2.1 
pscF type III export protein PscF -3.1 -2.4 
pscK type III export protein PscK -3.0 -1.4 
pscQ type III secretion protein -3.4 -2.1 
pcrV type III secretion protein PcrV -2.0 1.0 
'Putative enzymes' 
ispG 4-hydroxy-3-methylbut-2-en-1-yl diphosphate synthase -2.0 -2.2 
PA0494 acetyl-CoA carboxylase -2.1 -1.3 
PA4198 acyl-CoA synthase -3.4 -1.1 
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PA0704 amidase 1.4 -2.5 
cysQ CysQ protein -2.6 -1.1 
PA4724 glutamyl-tRNA synthetase -2.4 -2.3 
PA1966 hypothetical protein -2.0 -1.5 
PA2324 hypothetical protein -3.0 -1.4 
PA2263 probable 2-hydroxyacid dehydrogenase 1.1 -2.4 
PA4979 probable acyl-CoA dehydrogenase 1.4 -2.4 
PA4995 probable acyl-CoA dehydrogenase -2.6 -1.5 
PA3454 probable acyl-CoA thiolase -2.7 1.1 
PA3759 probable aminotransferase -2.1 -1.3 
PA1417 probable decarboxylase -2.0 -1.7 
PA3328 probable FAD-dependent monooxygenase -2.4 -1.4 
PA0842 probable glycosyl transferase -2.4 -1.8 
PA1391 probable glycosyl transferase -2.2 -1.8 
PA4819 probable glycosyl transferase -2.2 1.0 
PA2934 probable hydrolase -2.5 -1.2 
PA4008 probable hydrolase -2.1 -2.2 
PA0147 probable oxidoreductase -2.2 -2.0 
PA0364 probable oxidoreductase -2.4 -2.4 
PA4889 probable oxidoreductase -3.7 -1.6 
PA1832 probable protease -2.2 -1.1 
PA1303 probable signal peptidase -2.3 -1.2 
PA1171 probable transglycolase -2.2 -2.1 
PA0372 probable zinc protease -1.3 -2.2 
PA3957 short chain dehydrogenase -2.3 -1.5 
'Related to phage, transposon, or plasmid' 
PA0987 hypothetical protein -2.2 -1.8 
'Secreted Factors (toxins, enzymes, alginate)' 
algI alginate o-acetyltransferase AlgI -2.4 -1.1 
PA0985 pyocin S5 -2.2 -1.8 
algF alginate o-acetyltransferase AlgF -2.1 -1.3 
'Transcription, RNA processing and degradation' 
pcnB poly(A) polymerase -2.5 -1.5 
'Transcriptional regulators' 
PA0961 probable cold-shock protein -2.5 -1.3 
PA2093 probable sigma-70 factor, ECF subfamily -2.4 -1.3 
PA0181 probable transcriptional regulator -2.0 -2.4 
PA0243 probable transcriptional regulator -2.8 -1.5 
PA0701 probable transcriptional regulator -2.3 -1.1 
PA1138 probable transcriptional regulator -2.3 -1.4 
PA1184 probable transcriptional regulator -2.3 -1.0 
PA1269 probable transcriptional regulator -2.1 -2.0 
PA1309 probable transcriptional regulator -3.0 -1.6 
PA1312 probable transcriptional regulator -2.3 1.5 
PA1520 probable transcriptional regulator -2.7 -1.6 
PA1627 probable transcriptional regulator -2.4 -2.1 
PA1738 probable transcriptional regulator -3.0 1.5 
PA2005 probable transcriptional regulator -1.0 -2.1 
PA2206 probable transcriptional regulator -2.1 -1.4 
PA2758 probable transcriptional regulator -3.1 -1.5 
PA2848 probable transcriptional regulator -1.3 -2.2 
PA3027 probable transcriptional regulator -3.0 1.2 
PA3215 probable transcriptional regulator -3.5 -2.0 
PA3433 probable transcriptional regulator -2.6 -1.9 
PA3630 probable transcriptional regulator -3.4 -2.0 
 
 
 
317 
PA3932 probable transcriptional regulator -2.9 -1.1 
PA4165 probable transcriptional regulator -2.6 -2.2 
PA1364 probable transmembrane sensor -1.3 -2.0 
algU sigma factor AlgU -1.3 -2.2 
pvdS sigma factor PvdS -2.5 -1.1 
gpuR transcriptional activator GpuR -2.3 1.3 
exsA transcriptional regulator ExsA -1.0 -3.2 
gntR transcriptional regulator GntR -3.8 -1.3 
pchR transcriptional regulator PchR -2.1 -1.0 
'Translation, post-translational modification, degradation' 
gatC aspartyl/glutamyl-tRNA amidotransferase subunit C -2.5 -2.2 
lasB elastase LasB -3.2 -2.0 
gatA glutamyl-tRNA amidotransferase subunit A -2.0 -1.8 
hemA glutamyl-tRNA reductase -1.0 -2.5 
stk1 serine-threonine kinase Stk1 -1.4 -2.5 
'Transport of small molecules' 
aroP1 aromatic amino acid transport protein AroP1 -1.3 -2.4 
phnC ATP-binding component of ABC phosphonate transporter -1.1 -2.3 
citA citrate transporter -2.3 -1.1 
gabP gamma-aminobutyrate permease -2.1 -1.8 
kdpA potassium-transporting ATPase subunit A -1.5 -2.1 
PA3314 probable ATP-binding component of ABC transporter -2.2 -1.5 
PA3442 probable ATP-binding component of ABC transporter -1.8 -2.4 
PA4910 probable ATP-binding component of ABC transporter -1.3 -2.2 
PA4358 probable ferrous iron transport protein -2.4 -1.0 
PA1908 probable major facilitator superfamily (MFS) transporter -2.3 1.2 
PA2701 probable major facilitator superfamily (MFS) transporter -2.6 -1.6 
PA3595 probable major facilitator superfamily (MFS) transporter -1.3 -2.5 
PA4343 probable major facilitator superfamily (MFS) transporter -2.2 -1.4 
PA5530 probable MFS dicarboxylate transporter -2.1 -1.8 
PA4837 probable outer membrane protein precursor -2.4 -1.8 
PA5377 probable permease of ABC transporter -2.6 0.5 
PA0450 probable phosphate transporter -2.2 -1.2 
PA3760 probable phosphotransferase protein -2.0 -1.5 
PA0162 probable porin -4.7 -1.6 
PA0240 probable porin -3.1 -2.1 
PA4501 probable porin -2.6 -1.4 
PA0156 
probable Resistance-Nodulation-Cell Division (RND) efflux membrane 
fusion protein precursor -2.5 -1.9 
PA2836 probable secretion protein -2.5 -1.1 
PA1365 probable siderophore receptor -2.3 1.1 
PA2533 probable sodium:alanine symporter -2.6 -1.9 
PA2983 probable tolQ-type transport protein -2.1 -1.4 
PA0151 probable TonB-dependent receptor -2.5 -1.8 
PA0166 probable transporter -2.4 -2.0 
PA0322 probable transporter -1.3 -2.7 
PA1507 probable transporter -3.2 -1.8 
gltP proton-glutamate symporter -1.6 -2.2 
czcB 
Resistance-Nodulation-Cell Division (RND) divalent metal cation 
efflux membrane fusion protein CzcB precursor -5.3 -1.3 
cysP sulfate-binding protein of ABC transporter -2.2 -1.1 
sbp sulfate-binding protein precursor -2.5 -1.3 
'Two-component regulatory systems' 
pmrA PmrA: two-component regulator system response regulator PmrA -2.1 -2.5 
PA1611 probable sensor/response regulator hybrid -1.3 -2.1 
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PA2583 probable sensor/response regulator hybrid -2.2 -1.9 
PA5166 probable two-component response regulator -2.2 -1.9 
PA0600 probable two-component sensor -3.1 -2.6 
PA1798 probable two-component sensor -2.4 -1.9 
PA3191 probable two-component sensor -2.6 1.1 
PA4036 probable two-component sensor -2.4 -1.8 
pfeR two-component response regulator PfeR -2.1 -1.1 
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APPENDIX IV- PROTOCOL: 
 
 
ELECTROCHEMICAL TREATMENT OF PSEUDOMONAS AERUGINOSA 
PAO1 AND MUTANTS 
  
1. Overnight Cultures 
a. Media:  LB media (+ 10 μg/mL tetracycline for mutants). 25 mL of LB is 
poured in a 250 mL flask to and inoculation is performed with a 
previously sterilized inoculation loop. 
b. Conditions: Incubate overnight at 37 degrees Celsius while shaking at 200 
rpm  
 
2. Preparation of samples for ciprofloxacin testing: Persister isolation 
a. For each sample to be tested, aliquot 10 mL into to a 50 mL conical tube.   
b. Centrifuge sample(s) at 8000 rpm for 10 minutes at 10 degrees C. 
c. Wash 2X with 30 mL of 0.85% NaCl.   
d. Following second wash, decant and add 10 mL of 0.85% NaCl for restore 
the sample to the initial concentration. 
e. Add 1 mL of sample to labeled microcentrifuge tubes.  Add ciprofloxacin 
as seen in table below.  
Ciprofloxacin Concentration for experiment (Stock 25 mg/mL) 
Desired concentration (μg/mL) Stock to add (uL/mL) 
25 1 
50 2 
75 3 
100 4 
200 8 
 
f. Incubate for 3.5 h at 37 degrees C while shaking at 200 rpm. 
g. Centrifuge and wash 3X with 1 mL of 0.85% NaCl to remove 
ciprofloxacin and debris. Microcentrifuge settings: 10,000 rpm, 10 °C, 1.5 
min. 
h. Following washings add enough 0.85% NaCl to obtain final volume of 1 
mL in each vial. 
i. Prepare to perform dilution series and plate. 
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3. Plating 
a. Each sample is performed with five replicates, but the amount of dilution 
depends on the conditions. For control (no treatment), plate from D3-D8 
(dilution 3-8). For the isolated persister cells, plate from D2-D7.  
b. Add 180 uL of 0.85% NaCl to the wells in plate needed per dilution series. 
Add 20 uL of sample to first row of wells (Dilution 1). 
c. Mixing well, add 20 uL from each dilution row to the next to form a 10x 
dilution series. 
d. Plate using 10 uL of each sample dilution point.   
e. Let plates dry in biosafety cabinet.  
f. Incubate overnight at 37 degrees C.  
g. Count CFUs the following day 
h. Normalize the cell count based on 1 mL 
 
 
4. Preparation of Samples for Electrochemical Experiments 
a. For each sample to be tested, aliquot 10 mL into to a 50 mL conical tube.   
b. Centrifuge sample(s) at 8000 rpm for 10 minutes at 10 degrees C. 
c. Wash 2X wash with 30 mL of 0.85% NaCl.   
d. Following second wash, decant and add 10 mL of 0.85% NaCl for restore 
the sample to the initial concentration. 
e. Add 200 μg/mL ciprofloxacin for persister cell isolation (e.g. 80 uL from a 
25 mg/mL stock) 
f. Incubate for 3.5 h at 37 degrees C while shaking at 200 rpm. 
g. Centrifuge and wash 2X with 30 mL of 0.85% NaCl, using same 
centrifuge settings as above. 
h. Following washings add enough 0.85% NaCl to obtain an OD600 between 
~0.7-0.8. (typically this requires between 30-45 mL of 0.85% NaCl) 
 
5. Aftermath Software Setup 
a. Set up the laptop computer that has Aftermath software and connect 
potentiostat (s).   
b. There is no password to open Aftermath software; enter as a guest. 
c. Under the “Experiments” file menu, select “chronopotentiometric.” Enter 
the following settings: 500 μA and 1 hr. Select the potentiometer serial 
number you are using and click “perform” to begin the experiment.  An 
mV profile will be able to be observed over the course of the experiment. 
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6. Cuvette set up 
a.  Prior the treatment sterilize the electrodes 
b. There are three electrodes in the cuvette: the working electrode (in our 
case, anode), counter electrode (cathode) and reference electrode.   
c. The carbon and SS304 electrodes were soaked in acetone overnight to 
remove any potential organic materials (the electrodes are cut by the 
machine shop). Then Soak in 190 proof ethanol for 1h. Dry the SS304 
coupons in the oven, cover the coupons with aluminium foil, insert them 
in a 50 mL conical tube and autoclave. Keep the carbon electrode in 
ethanol until use. 
d. The working and counter electrodes (e.g. SS304, carbon, TGON 805) 
connect to the red and green alligator clips, using copper wire.  The 
reference electrode (Ag/AgCl) connects to the white alligator clip.  
e. The SS304 electrodes need to be discarded following use. The Ag/AgCl 
can be reused after sterilizing in bleach and ethanol.  Carbon was also able 
to be reused. Soak in acetone and then ethanol.   Sand the surface with 
sandpaper and repeat the same sterilization process. But ideally, carbon 
electrodes are not reused to avoid variation in experimental results. Indeed, 
due to the reaction, change of the surface density could occurs and affect 
the electrochemical properties of the electrodes.  
 
7. Performing the DC treatment 
a. Add 3 mL of sample to the experimental cuvette with electrodes and 3 mL 
of sample to a control cuvette, as needed.  For the 2-chamber system, 3 
mL of sample is added in each chamber and 0.85% NaCl solution is 
introduced into the salt bridge. The salt bridge is made out of long Pasteur 
pipet. The thin end is deformed using a flame. 
b. One the setup is ready, DC treatment is performed 
c. Click “perform”  in Aftermath software to start experiment  
d. Plate control (no treatment) 
e. Meanwhile, take 100 uL of sample every 20 minutes for testing (add 20 
uL to each of the five wells in D1).  Plate D1-D6 for persister experiment. 
f. At 60 minutes, the termination of the experiment, plate D0-D5.   
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APPENDIX V- PROTOCOL 
 
NANOINDENTATION OF BACTERIAL CELLS USING AN ATOMIC FORCE 
MICROSCOPE 
 
Data acquisition 
 
AFM is a useful tool, which could serve to 
describe the mechanical properties of 
microstructures such as bacterial cells. In this 
study, nanoidentation was used to study the change 
in the mechanical properties of the P. aeuruginosa 
cells following DC treatment using carbon or SS 
304 electrodes. The elastic property of the cell 
membrane was characterized through measurement 
of the young’s modulus and the hardness of the 
cells using atomic force microscopy (AFM) 
(Digital Instruments Nanoscope III, Veeco, NY). 
Here we describe the procedure, which was used: 
 
 
1) The DC-treated cells and the untreated control cells are fixed with 2.5% 
glutaraldehyde in PBS for 1 h to conserve the morphology of the cells; 100 μL of 
the samples were mixed with 400 μL of 2.5% glutaraldehyde (in PBS). 
2) The cell suspensions are pipetted onto a gold coated-glass slide. The drops of the 
samples are allowed to dry on gold-coated glass coupons, which were previously 
cleaned with 190 proof ethanol. Gold-coated surfaces are used to reduce the 
charge accumulation on substrate during AFM analysis. The slides are previously 
cut in a size, which could fit on the AFM sample stage. 
3) The samples are washed gently with Milli-Q water to remove the salt from the 
fixing solution 
4) The samples are placed in a petri dish and introduced in a desiccator until 
dehydration of the cells. 
5) Once dried, the samples are ready for imaging.  
6) NSC14/AIBS probe (MikroMasch, CA, USA), with a force constant of 5.7 N/m, 
was used in tapping mode to locate the bacterial cells. 
7) For controls use a bare glass coverslip to measure the deflection sensitivity of the 
AFM tip by performing an Auto tune function and immediately doing a single 
indent on the hard substrate (without sample). Deflection sensitivity is measured 
by fitting a line on the descending curve of a force – distance graph using the 
AFM software. In the recent software, the deflection sensitivity is directly used to 
compute the deflection of the cantilever. 
8) Load the glass slide with the cells on them 
9) Image the sample to locate cells on the slide using the tapping mode.  
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10) Once a cell is located, zoom onto the location where the cell is located to make 
the total field of view composed of the cell of interest.  
11) Offset the sample to that location. 
12)  Disengage the tip.  
13) Switch to contact mode and do a single indent to generate a force curve 
14) Save the force distance curve as an ASCI format. 
15) Switch to tapping mode, zoom out, and find another cell and repeat the above 
procedure (8-14) again.  
Data processing. 
16) Open an Excel spreadsheet 
17) Open the ASCI file after selecting the “All files” format 
18) Once the “Text Imort Wizard” is opened, select “Tab, semicolon, comma and 
space” delimiters 
19) The column data format should be general 
20) The data comprise the Time (s), Calculated (Z), Deflection (V), Deflection (nm), 
and Deflection (nN) displayed in 5 separate columns. 
The data could also be expressed in Bit: 1V=7.62939x10
-5
 Bit. In this case, the Deflection 
(V), Deflection (nm), and Deflection (nN) could be derived according to the following 
formula: 
Deflection (V)=Bit * 7.62939x10
-5
, 
Deflection (nm)= Deflection (V)* Deflection sensitivity (see step 7), and 
Deflection (nN)= Deflection (nm)*Probe Spring constant 
The deflection force is computed based on the spring constant. Therefore, this constant is 
provided by the manufacturer and should be added as a parameter for the nanoindentation 
experiment. 
21)  Since the calculated (Z) described the position of the actuator of the probe 
(cantilever) in reference to its previous position, the initial position of the probe at 
the beginning of the “unloading” (labeled as Retract) is considered “0”. Insert a 
column to calculate a “normalized Z” as a function of the original position before 
“loading” (labeled as Extend). The final value of the “loading” (Extend) 
becomes the initial value of the “unloading” (Retract). Any value of the 
calculated (Z) for the unloading part will be subtracted from the final value of the 
“loading” in order to generate the “normalized Z”. 
22) The intramolecular interactions between the probe (tip) and the sample affect the 
displacement of the cantilever referred to as Deflection (nm). To evaluate the real 
distance travelled by the probe, the Deflection (nm) of the cantilever is subtracted 
from the normalized Z (nm). Therefore follow the formula H=normalized Z (nm)-
Deflection (nm). 
23) Plot H to determine when the indentation begins (characterized by the 
deformation of the plots). 
24) Plot Deflection (nN) to determine when the indentation begins and stops. The 
indentation stop when the deflection force stays at constant value 
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25) Normalize both H (normalized H) and the Deflection force (nN) based on the 
starting point and end point of the indent. The initial values should be “0” and the 
final value of the “loading curve” should be the initial value of the “unloading 
curve” for both the normalized H and the normalized deflection force. 
26) Plot the normalized deflection force as a function of the normalized deflection H. 
27) Determine slope of the linear phase of the “unloading curve” by plotting its 
trendline. This slope corresponds to k, the elastic constant of the sample. 
 
Computation of the mechanical properties 
28) The modulus and the Hardness of the cells are calculated according to the 
following:  
Modulus: E 
(    )   √     
 √  
; with ν=0.5 
Hardness: H  
            
  
 
Ai is the surface area of the tip in contact with the sample during indentation. It is 
computed based on the characteristics of the tip. The tip of the NSC14/AIBS probe 
(MikroMasch, CA, USA) is conical, with a radius of curvature of 30º over 10 nm. For an 
indent “I” using this probe: 
the Area of indentation: Ai = [π * I * 
   (           )
   (           )
        (nm2) 
The value I is derived from the plot in step (26) or from the maximum value of the 
normalized deflection H (nm) 
The maximum load is maximum value of the normalized deflection force (nN) 
 
y = 32.863x - 521.04 
R² = 0.9942 
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